US20190195864A1 - Cell-free sensor systems - Google Patents
Cell-free sensor systems Download PDFInfo
- Publication number
- US20190195864A1 US20190195864A1 US16/325,649 US201716325649A US2019195864A1 US 20190195864 A1 US20190195864 A1 US 20190195864A1 US 201716325649 A US201716325649 A US 201716325649A US 2019195864 A1 US2019195864 A1 US 2019195864A1
- Authority
- US
- United States
- Prior art keywords
- switch
- binding protein
- protein sensor
- target molecule
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 139
- 239000000203 mixture Substances 0.000 claims abstract description 68
- 238000001514 detection method Methods 0.000 claims abstract description 41
- 230000003281 allosteric effect Effects 0.000 claims description 187
- 108090000623 proteins and genes Proteins 0.000 claims description 168
- 210000004027 cell Anatomy 0.000 claims description 159
- 102000004169 proteins and genes Human genes 0.000 claims description 151
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 147
- 101710096438 DNA-binding protein Proteins 0.000 claims description 147
- 102000039446 nucleic acids Human genes 0.000 claims description 109
- 108020004707 nucleic acids Proteins 0.000 claims description 109
- 150000007523 nucleic acids Chemical class 0.000 claims description 109
- 108700008625 Reporter Genes Proteins 0.000 claims description 67
- 238000013518 transcription Methods 0.000 claims description 63
- 230000035897 transcription Effects 0.000 claims description 63
- 230000004044 response Effects 0.000 claims description 52
- 238000000338 in vitro Methods 0.000 claims description 51
- 239000003446 ligand Substances 0.000 claims description 47
- 108020004414 DNA Proteins 0.000 claims description 46
- 238000013519 translation Methods 0.000 claims description 44
- 238000004519 manufacturing process Methods 0.000 claims description 38
- 239000013598 vector Substances 0.000 claims description 32
- 230000003115 biocidal effect Effects 0.000 claims description 31
- 239000003153 chemical reaction reagent Substances 0.000 claims description 31
- 239000007787 solid Substances 0.000 claims description 25
- 238000012216 screening Methods 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 238000000126 in silico method Methods 0.000 claims description 17
- 230000002255 enzymatic effect Effects 0.000 claims description 16
- 230000002103 transcriptional effect Effects 0.000 claims description 15
- 239000003242 anti bacterial agent Substances 0.000 claims description 13
- 238000002708 random mutagenesis Methods 0.000 claims description 13
- 230000009149 molecular binding Effects 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 230000009466 transformation Effects 0.000 claims description 10
- 230000035939 shock Effects 0.000 claims description 9
- 230000003595 spectral effect Effects 0.000 claims description 9
- 150000003384 small molecules Chemical class 0.000 claims description 8
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 239000011324 bead Substances 0.000 claims description 7
- 239000004033 plastic Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 230000005782 double-strand break Effects 0.000 claims description 6
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 6
- 238000010362 genome editing Methods 0.000 claims description 6
- 230000007246 mechanism Effects 0.000 claims description 6
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 6
- 241000238631 Hexapoda Species 0.000 claims description 5
- 239000002041 carbon nanotube Substances 0.000 claims description 5
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 5
- 230000021615 conjugation Effects 0.000 claims description 5
- 238000004520 electroporation Methods 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 210000004962 mammalian cell Anatomy 0.000 claims description 5
- 239000002071 nanotube Substances 0.000 claims description 5
- 210000001938 protoplast Anatomy 0.000 claims description 5
- 238000012163 sequencing technique Methods 0.000 claims description 5
- 239000011325 microbead Substances 0.000 claims description 4
- 239000011859 microparticle Substances 0.000 claims description 4
- 239000002102 nanobead Substances 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- 230000005783 single-strand break Effects 0.000 claims description 3
- -1 glucorinidases Proteins 0.000 description 139
- 235000018102 proteins Nutrition 0.000 description 135
- 239000013612 plasmid Substances 0.000 description 49
- 230000014616 translation Effects 0.000 description 42
- 241000588724 Escherichia coli Species 0.000 description 41
- 244000063299 Bacillus subtilis Species 0.000 description 36
- 235000014469 Bacillus subtilis Nutrition 0.000 description 36
- 239000000839 emulsion Substances 0.000 description 32
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 31
- 230000027455 binding Effects 0.000 description 31
- 108090000790 Enzymes Proteins 0.000 description 24
- 239000012636 effector Substances 0.000 description 24
- 230000014509 gene expression Effects 0.000 description 24
- 102000004190 Enzymes Human genes 0.000 description 23
- 230000000694 effects Effects 0.000 description 23
- 229940088598 enzyme Drugs 0.000 description 23
- 239000006166 lysate Substances 0.000 description 23
- 108091023040 Transcription factor Proteins 0.000 description 20
- 102000040945 Transcription factor Human genes 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 125000003275 alpha amino acid group Chemical group 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 18
- 101150061166 tetR gene Proteins 0.000 description 18
- 241000187432 Streptomyces coelicolor Species 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 230000001413 cellular effect Effects 0.000 description 16
- 238000013461 design Methods 0.000 description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000000758 substrate Substances 0.000 description 12
- 230000002101 lytic effect Effects 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 229930101283 tetracycline Natural products 0.000 description 10
- 230000009089 cytolysis Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 210000001995 reticulocyte Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- IMZBXSAKACGTPH-UHFFFAOYSA-N (3-oxo-6'-phosphonooxyspiro[2-benzofuran-1,9'-xanthene]-3'-yl) dihydrogen phosphate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(OP(O)(O)=O)C=C1OC1=CC(OP(O)(=O)O)=CC=C21 IMZBXSAKACGTPH-UHFFFAOYSA-N 0.000 description 8
- 230000004568 DNA-binding Effects 0.000 description 8
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- 241000187747 Streptomyces Species 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000005090 green fluorescent protein Substances 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 102100026189 Beta-galactosidase Human genes 0.000 description 7
- 108091033409 CRISPR Proteins 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 239000010459 dolomite Substances 0.000 description 7
- 229910000514 dolomite Inorganic materials 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 7
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 6
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 102000006995 beta-Glucosidase Human genes 0.000 description 6
- 108010047754 beta-Glucosidase Proteins 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 6
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 241000186359 Mycobacterium Species 0.000 description 5
- 101710163270 Nuclease Proteins 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000003705 ribosome Anatomy 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 201000008827 tuberculosis Diseases 0.000 description 5
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 4
- ZTOBILYWTYHOJB-LWXMCBIJSA-N 3',6'-bis[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]spiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C3(C4=CC=CC=C4C(=O)O3)C3=CC=C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C=C3OC2=C1 ZTOBILYWTYHOJB-LWXMCBIJSA-N 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 4
- 241000192542 Anabaena Species 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000193755 Bacillus cereus Species 0.000 description 4
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- 241000186216 Corynebacterium Species 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- 108060001084 Luciferase Proteins 0.000 description 4
- 239000005089 Luciferase Substances 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 102000018120 Recombinases Human genes 0.000 description 4
- 108010091086 Recombinases Proteins 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 101710137500 T7 RNA polymerase Proteins 0.000 description 4
- 239000004098 Tetracycline Substances 0.000 description 4
- 241000204652 Thermotoga Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 102000018146 globin Human genes 0.000 description 4
- 108060003196 globin Proteins 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000001243 protein synthesis Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960002180 tetracycline Drugs 0.000 description 4
- 235000019364 tetracycline Nutrition 0.000 description 4
- 150000003522 tetracyclines Chemical class 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 3
- 241000193388 Bacillus thuringiensis Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 241001138401 Kluyveromyces lactis Species 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 101001059240 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Site-specific recombinase Flp Proteins 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 description 3
- 241000589499 Thermus thermophilus Species 0.000 description 3
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 210000004671 cell-free system Anatomy 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 102000034287 fluorescent proteins Human genes 0.000 description 3
- 108091006047 fluorescent proteins Proteins 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002824 mRNA display Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002702 ribosome display Methods 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 3
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 101150059521 AHRR gene Proteins 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 241000194106 Bacillus mycoides Species 0.000 description 2
- 241000589513 Burkholderia cepacia Species 0.000 description 2
- 101100395324 Caenorhabditis elegans hmg-1.2 gene Proteins 0.000 description 2
- 101100400624 Caenorhabditis elegans mbr-1 gene Proteins 0.000 description 2
- 101100294112 Caenorhabditis elegans nhr-47 gene Proteins 0.000 description 2
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 2
- 241000588881 Chromobacterium Species 0.000 description 2
- 241000589519 Comamonas Species 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- 241001464430 Cyanobacterium Species 0.000 description 2
- 108091005941 EBFP Proteins 0.000 description 2
- 101001017362 Enterobacteria phage T4 Holin Proteins 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108091029795 Intergenic region Proteins 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 2
- 101100111646 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) blaI gene Proteins 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 241000187560 Saccharopolyspora Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000122971 Stenotrophomonas Species 0.000 description 2
- 101100232102 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) SCO4008 gene Proteins 0.000 description 2
- 241000589596 Thermus Species 0.000 description 2
- 241000589500 Thermus aquaticus Species 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 101150057353 Ttk gene Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 241000235013 Yarrowia Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
- 229960003644 aztreonam Drugs 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940106164 cephalexin Drugs 0.000 description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229940047766 co-trimoxazole Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 108010082025 cyan fluorescent protein Proteins 0.000 description 2
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000007843 droplet-based assay Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 108010045262 enhanced cyan fluorescent protein Proteins 0.000 description 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000002421 fluorescence-activated droplet sorting Methods 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000005734 heterodimerization reaction Methods 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 101150094737 pdm2 gene Proteins 0.000 description 2
- WSHJJCPTKWSMRR-RXMQYKEDSA-N penam Chemical compound S1CCN2C(=O)C[C@H]21 WSHJJCPTKWSMRR-RXMQYKEDSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000004952 protein activity Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 229960000885 rifabutin Drugs 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 229940118696 vibrio cholerae Drugs 0.000 description 2
- 238000002424 x-ray crystallography Methods 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
- MRTPISKDZDHEQI-YFKPBYRVSA-N (2s)-2-(tert-butylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(C)(C)C MRTPISKDZDHEQI-YFKPBYRVSA-N 0.000 description 1
- NPDBDJFLKKQMCM-SCSAIBSYSA-N (2s)-2-amino-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)[C@H](N)C(O)=O NPDBDJFLKKQMCM-SCSAIBSYSA-N 0.000 description 1
- PSONHUYFSWYIME-QSIPGKSISA-N (2s,3s,4r,5s,6r)-5-acetamido-3-[(2r,3r,4s,5r,6r)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy-6-[(2r,3s,4r,5r,6r)-5-acetamido-4-hydroxy-6-[hydroxy-[hydroxy-[(2z,6z,10z,14z,18z,22z,26z,30z,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraco Chemical compound O[C@@H]1[C@@H](O)[C@@H](NC(C)=O)[C@@H](C)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@@H]2[C@H](O[C@H](OP(O)(=O)OP(O)(=O)OC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)[C@H](NC(C)=O)[C@H]2O)CO)[C@@H](NC(C)=O)[C@H]1O PSONHUYFSWYIME-QSIPGKSISA-N 0.000 description 1
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3s)-3,6-diamino-n-[[(2s,5s,8e,11s,15s)-15-amino-11-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3s)-3,6-diamino-n-[[(2s,5s,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4s,4as,5ar,12ar)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O SOVUOXKZCCAWOJ-HJYUBDRYSA-N 0.000 description 1
- GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 description 1
- HBUJYEUPIIJJOS-PBHICJAKSA-N (5r)-3-[4-[1-[(2s)-2,3-dihydroxypropanoyl]-3,6-dihydro-2h-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one Chemical compound C1N(C(=O)[C@@H](O)CO)CCC(C=2C(=CC(=CC=2F)N2C(O[C@@H](COC3=NOC=C3)C2)=O)F)=C1 HBUJYEUPIIJJOS-PBHICJAKSA-N 0.000 description 1
- WDLWHQDACQUCJR-ZAMMOSSLSA-N (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)/C=C/C)C(O)=O)=CC=C(O)C=C1 WDLWHQDACQUCJR-ZAMMOSSLSA-N 0.000 description 1
- YWKJNRNSJKEFMK-PQFQYKRASA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 YWKJNRNSJKEFMK-PQFQYKRASA-N 0.000 description 1
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- QKDHBVNJCZBTMR-LLVKDONJSA-N (R)-temafloxacin Chemical compound C1CN[C@H](C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1F QKDHBVNJCZBTMR-LLVKDONJSA-N 0.000 description 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
- NCCJWSXETVVUHK-ZYSAIPPVSA-N (z)-7-[(2r)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1s)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid;(5r,6s)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1r)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1C(SCC\N=C/N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21.CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O NCCJWSXETVVUHK-ZYSAIPPVSA-N 0.000 description 1
- DIXONZOTEIIZKO-UHFFFAOYSA-N 2,2-difluoropentanoic acid Chemical compound CCCC(F)(F)C(O)=O DIXONZOTEIIZKO-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- IOOWNWLVCOUUEX-WPRPVWTQSA-N 2-[(3r,6s)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic acid Chemical compound OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1 IOOWNWLVCOUUEX-WPRPVWTQSA-N 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical class O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- HGGAKXAHAYOLDJ-FHZUQPTBSA-N 6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid Chemical compound S([C@@H]1[C@H](C(N1C=1C(O)=O)=O)[C@H](O)C)C=1[C@H]1CCCO1 HGGAKXAHAYOLDJ-FHZUQPTBSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 241000266272 Acidithiobacillus Species 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 241000187362 Actinomadura Species 0.000 description 1
- 102100032157 Adenylate cyclase type 10 Human genes 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 101100001475 Aeromonas hydrophila subsp. hydrophila (strain ATCC 7966 / DSM 30187 / BCRC 13018 / CCUG 14551 / JCM 1027 / KCTC 2358 / NCIMB 9240 / NCTC 8049) alr-1 gene Proteins 0.000 description 1
- 101100103731 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) APE_0142 gene Proteins 0.000 description 1
- 101100105203 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) APE_0778 gene Proteins 0.000 description 1
- 101100175628 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) glk gene Proteins 0.000 description 1
- 101100256787 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) sfsA gene Proteins 0.000 description 1
- 101100424893 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) tfb gene Proteins 0.000 description 1
- 101100536771 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) tfe gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000059559 Agriotes sordidus Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241001136561 Allomyces Species 0.000 description 1
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
- 241000192531 Anabaena sp. Species 0.000 description 1
- 241000193741 Aneurinibacillus aneurinilyticus Species 0.000 description 1
- 241001468259 Anoxybacillus flavithermus Species 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 241001550224 Apha Species 0.000 description 1
- 101100058739 Arabidopsis thaliana BZR2 gene Proteins 0.000 description 1
- 241000180579 Arca Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241001143891 Bacillus aquimaris Species 0.000 description 1
- 241000193410 Bacillus atrophaeus Species 0.000 description 1
- 241000966273 Bacillus boroniphilus Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241001385703 Bacillus galliciensis Species 0.000 description 1
- 241001515794 Bacillus infernus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000202341 Bacillus sporothermodurans Species 0.000 description 1
- 101100544166 Bacillus subtilis (strain 168) yhcK gene Proteins 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241001148536 Bacteroides sp. Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
- 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 1
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 241000722885 Brettanomyces Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000534628 Brevibacillus centrosporus Species 0.000 description 1
- 241000193417 Brevibacillus laterosporus Species 0.000 description 1
- 101150107019 CEP1 gene Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 101100001231 Caenorhabditis elegans aha-1 gene Proteins 0.000 description 1
- 101100001271 Caenorhabditis elegans ahr-1 gene Proteins 0.000 description 1
- 101100452003 Caenorhabditis elegans ape-1 gene Proteins 0.000 description 1
- 101100492584 Caenorhabditis elegans ast-1 gene Proteins 0.000 description 1
- 101100026251 Caenorhabditis elegans atf-2 gene Proteins 0.000 description 1
- 101100164160 Caenorhabditis elegans atf-7 gene Proteins 0.000 description 1
- 101100381481 Caenorhabditis elegans baz-2 gene Proteins 0.000 description 1
- 101100326201 Caenorhabditis elegans blmp-1 gene Proteins 0.000 description 1
- 101100437861 Caenorhabditis elegans brc-1 gene Proteins 0.000 description 1
- 101100327050 Caenorhabditis elegans cbp-1 gene Proteins 0.000 description 1
- 101100383153 Caenorhabditis elegans cdk-9 gene Proteins 0.000 description 1
- 101100231506 Caenorhabditis elegans ceh-1 gene Proteins 0.000 description 1
- 101100231513 Caenorhabditis elegans ceh-10 gene Proteins 0.000 description 1
- 101100231514 Caenorhabditis elegans ceh-12 gene Proteins 0.000 description 1
- 101100231515 Caenorhabditis elegans ceh-13 gene Proteins 0.000 description 1
- 101100124474 Caenorhabditis elegans ceh-14 gene Proteins 0.000 description 1
- 101100124475 Caenorhabditis elegans ceh-16 gene Proteins 0.000 description 1
- 101100059612 Caenorhabditis elegans ceh-17 gene Proteins 0.000 description 1
- 101100124476 Caenorhabditis elegans ceh-18 gene Proteins 0.000 description 1
- 101100124477 Caenorhabditis elegans ceh-19 gene Proteins 0.000 description 1
- 101100231507 Caenorhabditis elegans ceh-2 gene Proteins 0.000 description 1
- 101100124486 Caenorhabditis elegans ceh-20 gene Proteins 0.000 description 1
- 101100124487 Caenorhabditis elegans ceh-21 gene Proteins 0.000 description 1
- 101100124488 Caenorhabditis elegans ceh-22 gene Proteins 0.000 description 1
- 101100178161 Caenorhabditis elegans ceh-23 gene Proteins 0.000 description 1
- 101100059613 Caenorhabditis elegans ceh-28 gene Proteins 0.000 description 1
- 101100178166 Caenorhabditis elegans ceh-31 gene Proteins 0.000 description 1
- 101100178167 Caenorhabditis elegans ceh-32 gene Proteins 0.000 description 1
- 101100178168 Caenorhabditis elegans ceh-33 gene Proteins 0.000 description 1
- 101100178169 Caenorhabditis elegans ceh-34 gene Proteins 0.000 description 1
- 101100178171 Caenorhabditis elegans ceh-36 gene Proteins 0.000 description 1
- 101100178172 Caenorhabditis elegans ceh-37 gene Proteins 0.000 description 1
- 101100178173 Caenorhabditis elegans ceh-38 gene Proteins 0.000 description 1
- 101100178174 Caenorhabditis elegans ceh-39 gene Proteins 0.000 description 1
- 101100178175 Caenorhabditis elegans ceh-40 gene Proteins 0.000 description 1
- 101100178176 Caenorhabditis elegans ceh-43 gene Proteins 0.000 description 1
- 101100231508 Caenorhabditis elegans ceh-5 gene Proteins 0.000 description 1
- 101100231509 Caenorhabditis elegans ceh-6 gene Proteins 0.000 description 1
- 101100059615 Caenorhabditis elegans ceh-60 gene Proteins 0.000 description 1
- 101100231510 Caenorhabditis elegans ceh-7 gene Proteins 0.000 description 1
- 101100231511 Caenorhabditis elegans ceh-8 gene Proteins 0.000 description 1
- 101100231512 Caenorhabditis elegans ceh-9 gene Proteins 0.000 description 1
- 101100166838 Caenorhabditis elegans ces-2 gene Proteins 0.000 description 1
- 101100439236 Caenorhabditis elegans cfi-1 gene Proteins 0.000 description 1
- 101100220553 Caenorhabditis elegans chd-3 gene Proteins 0.000 description 1
- 101100459917 Caenorhabditis elegans cnd-1 gene Proteins 0.000 description 1
- 101100008635 Caenorhabditis elegans daf-12 gene Proteins 0.000 description 1
- 101100008636 Caenorhabditis elegans daf-14 gene Proteins 0.000 description 1
- 101100447050 Caenorhabditis elegans daf-16 gene Proteins 0.000 description 1
- 101100008637 Caenorhabditis elegans daf-19 gene Proteins 0.000 description 1
- 101100008646 Caenorhabditis elegans daf-3 gene Proteins 0.000 description 1
- 101100386238 Caenorhabditis elegans daf-8 gene Proteins 0.000 description 1
- 101100386717 Caenorhabditis elegans dcp-66 gene Proteins 0.000 description 1
- 101100277917 Caenorhabditis elegans dmd-3 gene Proteins 0.000 description 1
- 101100277918 Caenorhabditis elegans dmd-4 gene Proteins 0.000 description 1
- 101100388124 Caenorhabditis elegans dpy-26 gene Proteins 0.000 description 1
- 101100223811 Caenorhabditis elegans dsc-1 gene Proteins 0.000 description 1
- 101100011365 Caenorhabditis elegans egl-13 gene Proteins 0.000 description 1
- 101100445049 Caenorhabditis elegans elt-1 gene Proteins 0.000 description 1
- 101100445050 Caenorhabditis elegans elt-2 gene Proteins 0.000 description 1
- 101100445051 Caenorhabditis elegans elt-4 gene Proteins 0.000 description 1
- 101100445052 Caenorhabditis elegans elt-7 gene Proteins 0.000 description 1
- 101100065718 Caenorhabditis elegans ets-4 gene Proteins 0.000 description 1
- 101100065720 Caenorhabditis elegans ets-5 gene Proteins 0.000 description 1
- 101100172900 Caenorhabditis elegans eya-1 gene Proteins 0.000 description 1
- 101100226769 Caenorhabditis elegans fax-1 gene Proteins 0.000 description 1
- 101100120165 Caenorhabditis elegans fkh-3 gene Proteins 0.000 description 1
- 101100120166 Caenorhabditis elegans fkh-4 gene Proteins 0.000 description 1
- 101100120167 Caenorhabditis elegans fkh-5 gene Proteins 0.000 description 1
- 101100120168 Caenorhabditis elegans fkh-6 gene Proteins 0.000 description 1
- 101100120169 Caenorhabditis elegans fkh-9 gene Proteins 0.000 description 1
- 101100174180 Caenorhabditis elegans fos-1 gene Proteins 0.000 description 1
- 101100281537 Caenorhabditis elegans fozi-1 gene Proteins 0.000 description 1
- 101100175353 Caenorhabditis elegans gei-13 gene Proteins 0.000 description 1
- 101100025924 Caenorhabditis elegans gei-8 gene Proteins 0.000 description 1
- 101100394231 Caenorhabditis elegans ham-2 gene Proteins 0.000 description 1
- 101100016516 Caenorhabditis elegans hbl-1 gene Proteins 0.000 description 1
- 101100450705 Caenorhabditis elegans hif-1 gene Proteins 0.000 description 1
- 101100451196 Caenorhabditis elegans hizr-1 gene Proteins 0.000 description 1
- 101100124469 Caenorhabditis elegans hlh-10 gene Proteins 0.000 description 1
- 101100124470 Caenorhabditis elegans hlh-11 gene Proteins 0.000 description 1
- 101100124471 Caenorhabditis elegans hlh-12 gene Proteins 0.000 description 1
- 101100124472 Caenorhabditis elegans hlh-13 gene Proteins 0.000 description 1
- 101100124473 Caenorhabditis elegans hlh-14 gene Proteins 0.000 description 1
- 101100017496 Caenorhabditis elegans hlh-15 gene Proteins 0.000 description 1
- 101100017497 Caenorhabditis elegans hlh-17 gene Proteins 0.000 description 1
- 101100017499 Caenorhabditis elegans hlh-2 gene Proteins 0.000 description 1
- 101100017498 Caenorhabditis elegans hlh-26 gene Proteins 0.000 description 1
- 101100017502 Caenorhabditis elegans hlh-3 gene Proteins 0.000 description 1
- 101100017500 Caenorhabditis elegans hlh-30 gene Proteins 0.000 description 1
- 101100017503 Caenorhabditis elegans hlh-4 gene Proteins 0.000 description 1
- 101100017504 Caenorhabditis elegans hlh-6 gene Proteins 0.000 description 1
- 101100538958 Caenorhabditis elegans hlh-8 gene Proteins 0.000 description 1
- 101100257817 Caenorhabditis elegans hmg-3 gene Proteins 0.000 description 1
- 101100257815 Caenorhabditis elegans hmg-4 gene Proteins 0.000 description 1
- 101100395331 Caenorhabditis elegans hmg-5 gene Proteins 0.000 description 1
- 101100451306 Caenorhabditis elegans hnd-1 gene Proteins 0.000 description 1
- 101100124874 Caenorhabditis elegans hsf-1 gene Proteins 0.000 description 1
- 101100126292 Caenorhabditis elegans irx-1 gene Proteins 0.000 description 1
- 101100074187 Caenorhabditis elegans lag-1 gene Proteins 0.000 description 1
- 101100335314 Caenorhabditis elegans let-381 gene Proteins 0.000 description 1
- 101100454442 Caenorhabditis elegans let-418 gene Proteins 0.000 description 1
- 101100511175 Caenorhabditis elegans lim-4 gene Proteins 0.000 description 1
- 101100511176 Caenorhabditis elegans lim-6 gene Proteins 0.000 description 1
- 101100511177 Caenorhabditis elegans lim-7 gene Proteins 0.000 description 1
- 101100343342 Caenorhabditis elegans lin-11 gene Proteins 0.000 description 1
- 101100074836 Caenorhabditis elegans lin-22 gene Proteins 0.000 description 1
- 101100074840 Caenorhabditis elegans lin-26 gene Proteins 0.000 description 1
- 101100181921 Caenorhabditis elegans lin-31 gene Proteins 0.000 description 1
- 101100181922 Caenorhabditis elegans lin-32 gene Proteins 0.000 description 1
- 101100181923 Caenorhabditis elegans lin-35 gene Proteins 0.000 description 1
- 101100181928 Caenorhabditis elegans lin-39 gene Proteins 0.000 description 1
- 101100181931 Caenorhabditis elegans lin-41 gene Proteins 0.000 description 1
- 101100235539 Caenorhabditis elegans lin-49 gene Proteins 0.000 description 1
- 101100235550 Caenorhabditis elegans lin-54 gene Proteins 0.000 description 1
- 101100021264 Caenorhabditis elegans lin-59 gene Proteins 0.000 description 1
- 101100021266 Caenorhabditis elegans lin-61 gene Proteins 0.000 description 1
- 101100075828 Caenorhabditis elegans mab-23 gene Proteins 0.000 description 1
- 101100075829 Caenorhabditis elegans mab-3 gene Proteins 0.000 description 1
- 101100075830 Caenorhabditis elegans mab-5 gene Proteins 0.000 description 1
- 101100313161 Caenorhabditis elegans mab-9 gene Proteins 0.000 description 1
- 101100236847 Caenorhabditis elegans mdl-1 gene Proteins 0.000 description 1
- 101100290713 Caenorhabditis elegans mef-2 gene Proteins 0.000 description 1
- 101100512897 Caenorhabditis elegans mes-2 gene Proteins 0.000 description 1
- 101100512901 Caenorhabditis elegans mes-4 gene Proteins 0.000 description 1
- 101100512904 Caenorhabditis elegans mes-6 gene Proteins 0.000 description 1
- 101100456968 Caenorhabditis elegans mex-5 gene Proteins 0.000 description 1
- 101100237383 Caenorhabditis elegans mex-6 gene Proteins 0.000 description 1
- 101100260020 Caenorhabditis elegans mls-1 gene Proteins 0.000 description 1
- 101100428830 Caenorhabditis elegans mml-1 gene Proteins 0.000 description 1
- 101100459234 Caenorhabditis elegans mxl-1 gene Proteins 0.000 description 1
- 101100404599 Caenorhabditis elegans nfi-1 gene Proteins 0.000 description 1
- 101100079899 Caenorhabditis elegans nfx-1 gene Proteins 0.000 description 1
- 101100516502 Caenorhabditis elegans ngn-1 gene Proteins 0.000 description 1
- 101100240516 Caenorhabditis elegans nhr-10 gene Proteins 0.000 description 1
- 101100348501 Caenorhabditis elegans nhr-100 gene Proteins 0.000 description 1
- 101100348502 Caenorhabditis elegans nhr-103 gene Proteins 0.000 description 1
- 101100348503 Caenorhabditis elegans nhr-106 gene Proteins 0.000 description 1
- 101100348504 Caenorhabditis elegans nhr-108 gene Proteins 0.000 description 1
- 101100240517 Caenorhabditis elegans nhr-11 gene Proteins 0.000 description 1
- 101100348505 Caenorhabditis elegans nhr-111 gene Proteins 0.000 description 1
- 101100348506 Caenorhabditis elegans nhr-114 gene Proteins 0.000 description 1
- 101100348507 Caenorhabditis elegans nhr-115 gene Proteins 0.000 description 1
- 101100240518 Caenorhabditis elegans nhr-12 gene Proteins 0.000 description 1
- 101100348508 Caenorhabditis elegans nhr-121 gene Proteins 0.000 description 1
- 101100348509 Caenorhabditis elegans nhr-124 gene Proteins 0.000 description 1
- 101100348510 Caenorhabditis elegans nhr-125 gene Proteins 0.000 description 1
- 101100348511 Caenorhabditis elegans nhr-127 gene Proteins 0.000 description 1
- 101100240519 Caenorhabditis elegans nhr-13 gene Proteins 0.000 description 1
- 101100348512 Caenorhabditis elegans nhr-130 gene Proteins 0.000 description 1
- 101100460291 Caenorhabditis elegans nhr-133 gene Proteins 0.000 description 1
- 101100460292 Caenorhabditis elegans nhr-134 gene Proteins 0.000 description 1
- 101100460293 Caenorhabditis elegans nhr-136 gene Proteins 0.000 description 1
- 101100240520 Caenorhabditis elegans nhr-14 gene Proteins 0.000 description 1
- 101100460294 Caenorhabditis elegans nhr-150 gene Proteins 0.000 description 1
- 101100460295 Caenorhabditis elegans nhr-153 gene Proteins 0.000 description 1
- 101100460296 Caenorhabditis elegans nhr-154 gene Proteins 0.000 description 1
- 101100240521 Caenorhabditis elegans nhr-16 gene Proteins 0.000 description 1
- 101100460297 Caenorhabditis elegans nhr-164 gene Proteins 0.000 description 1
- 101100460298 Caenorhabditis elegans nhr-167 gene Proteins 0.000 description 1
- 101100460299 Caenorhabditis elegans nhr-169 gene Proteins 0.000 description 1
- 101100460300 Caenorhabditis elegans nhr-174 gene Proteins 0.000 description 1
- 101100240522 Caenorhabditis elegans nhr-18 gene Proteins 0.000 description 1
- 101100240523 Caenorhabditis elegans nhr-19 gene Proteins 0.000 description 1
- 101100460301 Caenorhabditis elegans nhr-197 gene Proteins 0.000 description 1
- 101100460302 Caenorhabditis elegans nhr-199 gene Proteins 0.000 description 1
- 101100294102 Caenorhabditis elegans nhr-2 gene Proteins 0.000 description 1
- 101100240526 Caenorhabditis elegans nhr-20 gene Proteins 0.000 description 1
- 101100460303 Caenorhabditis elegans nhr-213 gene Proteins 0.000 description 1
- 101100460304 Caenorhabditis elegans nhr-217 gene Proteins 0.000 description 1
- 101100460305 Caenorhabditis elegans nhr-218 gene Proteins 0.000 description 1
- 101100240527 Caenorhabditis elegans nhr-22 gene Proteins 0.000 description 1
- 101100240528 Caenorhabditis elegans nhr-23 gene Proteins 0.000 description 1
- 101100240529 Caenorhabditis elegans nhr-25 gene Proteins 0.000 description 1
- 101100460306 Caenorhabditis elegans nhr-268 gene Proteins 0.000 description 1
- 101100240530 Caenorhabditis elegans nhr-27 gene Proteins 0.000 description 1
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 description 1
- 101100294103 Caenorhabditis elegans nhr-31 gene Proteins 0.000 description 1
- 101100294104 Caenorhabditis elegans nhr-34 gene Proteins 0.000 description 1
- 101100294105 Caenorhabditis elegans nhr-35 gene Proteins 0.000 description 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 description 1
- 101100294107 Caenorhabditis elegans nhr-40 gene Proteins 0.000 description 1
- 101100294108 Caenorhabditis elegans nhr-41 gene Proteins 0.000 description 1
- 101100294109 Caenorhabditis elegans nhr-42 gene Proteins 0.000 description 1
- 101100294110 Caenorhabditis elegans nhr-43 gene Proteins 0.000 description 1
- 101100294111 Caenorhabditis elegans nhr-44 gene Proteins 0.000 description 1
- 101100294113 Caenorhabditis elegans nhr-48 gene Proteins 0.000 description 1
- 101100294114 Caenorhabditis elegans nhr-49 gene Proteins 0.000 description 1
- 101100516554 Caenorhabditis elegans nhr-5 gene Proteins 0.000 description 1
- 101100294116 Caenorhabditis elegans nhr-51 gene Proteins 0.000 description 1
- 101100294117 Caenorhabditis elegans nhr-52 gene Proteins 0.000 description 1
- 101100294118 Caenorhabditis elegans nhr-53 gene Proteins 0.000 description 1
- 101100294119 Caenorhabditis elegans nhr-54 gene Proteins 0.000 description 1
- 101100294120 Caenorhabditis elegans nhr-55 gene Proteins 0.000 description 1
- 101100294121 Caenorhabditis elegans nhr-57 gene Proteins 0.000 description 1
- 101100516553 Caenorhabditis elegans nhr-59 gene Proteins 0.000 description 1
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 description 1
- 101100516555 Caenorhabditis elegans nhr-60 gene Proteins 0.000 description 1
- 101100516556 Caenorhabditis elegans nhr-61 gene Proteins 0.000 description 1
- 101100516557 Caenorhabditis elegans nhr-62 gene Proteins 0.000 description 1
- 101100516558 Caenorhabditis elegans nhr-64 gene Proteins 0.000 description 1
- 101100516559 Caenorhabditis elegans nhr-65 gene Proteins 0.000 description 1
- 101100516560 Caenorhabditis elegans nhr-67 gene Proteins 0.000 description 1
- 101100516561 Caenorhabditis elegans nhr-68 gene Proteins 0.000 description 1
- 101100516562 Caenorhabditis elegans nhr-69 gene Proteins 0.000 description 1
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 description 1
- 101100516564 Caenorhabditis elegans nhr-71 gene Proteins 0.000 description 1
- 101100516565 Caenorhabditis elegans nhr-76 gene Proteins 0.000 description 1
- 101100516566 Caenorhabditis elegans nhr-77 gene Proteins 0.000 description 1
- 101100516567 Caenorhabditis elegans nhr-79 gene Proteins 0.000 description 1
- 101100516572 Caenorhabditis elegans nhr-8 gene Proteins 0.000 description 1
- 101100516569 Caenorhabditis elegans nhr-85 gene Proteins 0.000 description 1
- 101100516570 Caenorhabditis elegans nhr-86 gene Proteins 0.000 description 1
- 101100516571 Caenorhabditis elegans nhr-89 gene Proteins 0.000 description 1
- 101100079984 Caenorhabditis elegans nhr-9 gene Proteins 0.000 description 1
- 101100079979 Caenorhabditis elegans nhr-90 gene Proteins 0.000 description 1
- 101100079980 Caenorhabditis elegans nhr-91 gene Proteins 0.000 description 1
- 101100079981 Caenorhabditis elegans nhr-96 gene Proteins 0.000 description 1
- 101100079982 Caenorhabditis elegans nhr-97 gene Proteins 0.000 description 1
- 101100079983 Caenorhabditis elegans nhr-98 gene Proteins 0.000 description 1
- 101100404912 Caenorhabditis elegans nob-1 gene Proteins 0.000 description 1
- 101100027170 Caenorhabditis elegans nurf-1 gene Proteins 0.000 description 1
- 101100518205 Caenorhabditis elegans odr-7 gene Proteins 0.000 description 1
- 101100346154 Caenorhabditis elegans oma-1 gene Proteins 0.000 description 1
- 101100346155 Caenorhabditis elegans oma-2 gene Proteins 0.000 description 1
- 101100518995 Caenorhabditis elegans pax-3 gene Proteins 0.000 description 1
- 101100297395 Caenorhabditis elegans pha-4 gene Proteins 0.000 description 1
- 101100297538 Caenorhabditis elegans php-3 gene Proteins 0.000 description 1
- 101100243951 Caenorhabditis elegans pie-1 gene Proteins 0.000 description 1
- 101100084421 Caenorhabditis elegans pros-1 gene Proteins 0.000 description 1
- 101100476924 Caenorhabditis elegans sdc-1 gene Proteins 0.000 description 1
- 101100256304 Caenorhabditis elegans sdc-2 gene Proteins 0.000 description 1
- 101100256309 Caenorhabditis elegans sdc-3 gene Proteins 0.000 description 1
- 101100313164 Caenorhabditis elegans sea-1 gene Proteins 0.000 description 1
- 101100149246 Caenorhabditis elegans sem-4 gene Proteins 0.000 description 1
- 101100149536 Caenorhabditis elegans skn-1 gene Proteins 0.000 description 1
- 101100257127 Caenorhabditis elegans sma-2 gene Proteins 0.000 description 1
- 101100257133 Caenorhabditis elegans sma-3 gene Proteins 0.000 description 1
- 101100257134 Caenorhabditis elegans sma-4 gene Proteins 0.000 description 1
- 101100366098 Caenorhabditis elegans snpc-4 gene Proteins 0.000 description 1
- 101100310641 Caenorhabditis elegans sop-2 gene Proteins 0.000 description 1
- 101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 description 1
- 101100257372 Caenorhabditis elegans sox-3 gene Proteins 0.000 description 1
- 101100355949 Caenorhabditis elegans spr-1 gene Proteins 0.000 description 1
- 101100366556 Caenorhabditis elegans sptf-3 gene Proteins 0.000 description 1
- 101100045312 Caenorhabditis elegans taf-4 gene Proteins 0.000 description 1
- 101100313160 Caenorhabditis elegans tbx-11 gene Proteins 0.000 description 1
- 101100152579 Caenorhabditis elegans tbx-2 gene Proteins 0.000 description 1
- 101100152587 Caenorhabditis elegans tbx-31 gene Proteins 0.000 description 1
- 101100152588 Caenorhabditis elegans tbx-32 gene Proteins 0.000 description 1
- 101100152589 Caenorhabditis elegans tbx-33 gene Proteins 0.000 description 1
- 101100152590 Caenorhabditis elegans tbx-34 gene Proteins 0.000 description 1
- 101100152591 Caenorhabditis elegans tbx-35 gene Proteins 0.000 description 1
- 101100152592 Caenorhabditis elegans tbx-36 gene Proteins 0.000 description 1
- 101100152593 Caenorhabditis elegans tbx-37 gene Proteins 0.000 description 1
- 101100152594 Caenorhabditis elegans tbx-38 gene Proteins 0.000 description 1
- 101100152595 Caenorhabditis elegans tbx-39 gene Proteins 0.000 description 1
- 101100206161 Caenorhabditis elegans tbx-40 gene Proteins 0.000 description 1
- 101100206162 Caenorhabditis elegans tbx-41 gene Proteins 0.000 description 1
- 101100424704 Caenorhabditis elegans tbx-7 gene Proteins 0.000 description 1
- 101100424705 Caenorhabditis elegans tbx-8 gene Proteins 0.000 description 1
- 101100424706 Caenorhabditis elegans tbx-9 gene Proteins 0.000 description 1
- 101100370282 Caenorhabditis elegans tra-4 gene Proteins 0.000 description 1
- 101100483112 Caenorhabditis elegans ttx-3 gene Proteins 0.000 description 1
- 101100366604 Caenorhabditis elegans unc-120 gene Proteins 0.000 description 1
- 101100155407 Caenorhabditis elegans unc-130 gene Proteins 0.000 description 1
- 101100048443 Caenorhabditis elegans unc-3 gene Proteins 0.000 description 1
- 101100048438 Caenorhabditis elegans unc-30 gene Proteins 0.000 description 1
- 101100048442 Caenorhabditis elegans unc-37 gene Proteins 0.000 description 1
- 101100178170 Caenorhabditis elegans unc-39 gene Proteins 0.000 description 1
- 101100048445 Caenorhabditis elegans unc-42 gene Proteins 0.000 description 1
- 101100316121 Caenorhabditis elegans unc-55 gene Proteins 0.000 description 1
- 101100539485 Caenorhabditis elegans unc-86 gene Proteins 0.000 description 1
- 101100540120 Caenorhabditis elegans vab-3 gene Proteins 0.000 description 1
- 101100540121 Caenorhabditis elegans vab-7 gene Proteins 0.000 description 1
- 101100317454 Caenorhabditis elegans xbp-1 gene Proteins 0.000 description 1
- 101100268056 Caenorhabditis elegans zag-1 gene Proteins 0.000 description 1
- 101100489396 Caenorhabditis elegans zip-2 gene Proteins 0.000 description 1
- 101100489405 Caenorhabditis elegans zip-3 gene Proteins 0.000 description 1
- 101100433229 Caenorhabditis elegans zip-4 gene Proteins 0.000 description 1
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
- 101100203088 Caldivirga maquilingensis (strain ATCC 700844 / DSM 13496 / JCM 10307 / IC-167) sfsA gene Proteins 0.000 description 1
- 101100424897 Caldivirga maquilingensis (strain ATCC 700844 / DSM 13496 / JCM 10307 / IC-167) tfb gene Proteins 0.000 description 1
- 101100536773 Caldivirga maquilingensis (strain ATCC 700844 / DSM 13496 / JCM 10307 / IC-167) tfe gene Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- 101150027751 Casr gene Proteins 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 101100041257 Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS) rub2 gene Proteins 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 241000588879 Chromobacterium violaceum Species 0.000 description 1
- 108091005960 Citrine Proteins 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108010078777 Colistin Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000589518 Comamonas testosteroni Species 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 108010013198 Daptomycin Proteins 0.000 description 1
- 241000235035 Debaryomyces Species 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 101000805606 Deinagkistrodon acutus Zinc metalloproteinase-disintegrin-like acurhagin Proteins 0.000 description 1
- 241000192091 Deinococcus radiodurans Species 0.000 description 1
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000006867 Discosoma Species 0.000 description 1
- 108010003661 Distal-less homeobox proteins Proteins 0.000 description 1
- 102000004648 Distal-less homeobox proteins Human genes 0.000 description 1
- 241001147784 Domibacillus aminovorans Species 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 101100512902 Drosophila melanogaster Mes-4 gene Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 101150029010 Edc3 gene Proteins 0.000 description 1
- 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 101100378884 Escherichia coli (strain K12) allR gene Proteins 0.000 description 1
- 101100269658 Escherichia coli (strain K12) allS gene Proteins 0.000 description 1
- 101100132752 Escherichia coli (strain K12) nanR gene Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 102100022366 Fatty acyl-CoA reductase 1 Human genes 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- JRZJKWGQFNTSRN-UHFFFAOYSA-N Geldanamycin Natural products C1C(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)CCC=C(C)C(=O)NC2=CC(=O)C(OC)=C1C2=O JRZJKWGQFNTSRN-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241001135750 Geobacter Species 0.000 description 1
- 241000589236 Gluconobacter Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- AIJTTZAVMXIJGM-UHFFFAOYSA-N Grepafloxacin Chemical compound C1CNC(C)CN1C(C(=C1C)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 AIJTTZAVMXIJGM-UHFFFAOYSA-N 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 101710130691 HTH-type transcriptional regulator TnrA Proteins 0.000 description 1
- 101100356765 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) ribK gene Proteins 0.000 description 1
- 101100486258 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) rrnAC0199 gene Proteins 0.000 description 1
- 101100133429 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) rrnAC1238 gene Proteins 0.000 description 1
- 101100158099 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) rrnAC2519 gene Proteins 0.000 description 1
- 101100480758 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) tbp gene Proteins 0.000 description 1
- 101100536775 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) tfe gene Proteins 0.000 description 1
- 241000033197 Hemibarbus labeo Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000775498 Homo sapiens Adenylate cyclase type 10 Proteins 0.000 description 1
- 101000824458 Homo sapiens Fatty acyl-CoA reductase 1 Proteins 0.000 description 1
- 101000582994 Homo sapiens Myelin regulatory factor Proteins 0.000 description 1
- 101001041393 Homo sapiens Serine protease HTRA1 Proteins 0.000 description 1
- 101000987025 Homo sapiens Serine/threonine-protein phosphatase 4 regulatory subunit 3A Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 101100369189 Hyperthermus butylicus (strain DSM 5456 / JCM 9403 / PLM1-5) tfe gene Proteins 0.000 description 1
- 101100424904 Ignicoccus hospitalis (strain KIN4/I / DSM 18386 / JCM 14125) tfb gene Proteins 0.000 description 1
- 101100369190 Ignicoccus hospitalis (strain KIN4/I / DSM 18386 / JCM 14125) tfe gene Proteins 0.000 description 1
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
- JUZNIMUFDBIJCM-ANEDZVCMSA-N Invanz Chemical compound O=C([C@H]1NC[C@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)NC1=CC=CC(C(O)=O)=C1 JUZNIMUFDBIJCM-ANEDZVCMSA-N 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 241000186984 Kitasatospora aureofaciens Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- XIGSAGMEBXLVJJ-YFKPBYRVSA-N L-homocitrulline Chemical compound NC(=O)NCCCC[C@H]([NH3+])C([O-])=O XIGSAGMEBXLVJJ-YFKPBYRVSA-N 0.000 description 1
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical compound N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- ZFOMKMMPBOQKMC-KXUCPTDWSA-N L-pyrrolysine Chemical compound C[C@@H]1CC=N[C@H]1C(=O)NCCCC[C@H]([NH3+])C([O-])=O ZFOMKMMPBOQKMC-KXUCPTDWSA-N 0.000 description 1
- 229940123930 Lactamase inhibitor Drugs 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 108050005311 LexA-like Proteins 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 102000006830 Luminescent Proteins Human genes 0.000 description 1
- 108010047357 Luminescent Proteins Proteins 0.000 description 1
- 241001134775 Lysinibacillus fusiformis Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 101000819644 Lysinibacillus sphaericus UPF0309 protein in nagA 3'region Proteins 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 101100264987 Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2) Msed_1725 gene Proteins 0.000 description 1
- 101100369207 Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2) tfe gene Proteins 0.000 description 1
- 101100487029 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) Msm_0453 gene Proteins 0.000 description 1
- 101100365615 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) sfsA gene Proteins 0.000 description 1
- 101100480768 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) tbp gene Proteins 0.000 description 1
- 101100260193 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) tfb gene Proteins 0.000 description 1
- 101100369206 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) tfe gene Proteins 0.000 description 1
- 101100178102 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) MJECL29 gene Proteins 0.000 description 1
- 101100480763 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) tbp gene Proteins 0.000 description 1
- 101100424910 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) tfb gene Proteins 0.000 description 1
- 101100369198 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) tfe gene Proteins 0.000 description 1
- 101100294176 Methanocella arvoryzae (strain DSM 22066 / NBRC 105507 / MRE50) UNCMA_03340 gene Proteins 0.000 description 1
- 101100485949 Methanocella arvoryzae (strain DSM 22066 / NBRC 105507 / MRE50) UNCMA_15260 gene Proteins 0.000 description 1
- 101100369193 Methanocella arvoryzae (strain DSM 22066 / NBRC 105507 / MRE50) tfe gene Proteins 0.000 description 1
- 101100374133 Methanococcoides burtonii (strain DSM 6242 / NBRC 107633 / OCM 468 / ACE-M) Mbur_1811 gene Proteins 0.000 description 1
- 101100294177 Methanococcoides burtonii (strain DSM 6242 / NBRC 107633 / OCM 468 / ACE-M) Mbur_2041 gene Proteins 0.000 description 1
- 101100365609 Methanococcoides burtonii (strain DSM 6242 / NBRC 107633 / OCM 468 / ACE-M) sfsA gene Proteins 0.000 description 1
- 101100369196 Methanococcoides burtonii (strain DSM 6242 / NBRC 107633 / OCM 468 / ACE-M) tfe gene Proteins 0.000 description 1
- 101100294175 Methanococcus aeolicus (strain ATCC BAA-1280 / DSM 17508 / OCM 812 / Nankai-3) Maeo_1182 gene Proteins 0.000 description 1
- 101100480762 Methanococcus aeolicus (strain ATCC BAA-1280 / DSM 17508 / OCM 812 / Nankai-3) tbp gene Proteins 0.000 description 1
- 101100424907 Methanococcus aeolicus (strain ATCC BAA-1280 / DSM 17508 / OCM 812 / Nankai-3) tfb gene Proteins 0.000 description 1
- 101100159104 Methanococcus maripaludis (strain C5 / ATCC BAA-1333) MmarC5_0898 gene Proteins 0.000 description 1
- 101100294180 Methanococcus maripaludis (strain C5 / ATCC BAA-1333) MmarC5_1664 gene Proteins 0.000 description 1
- 101100424912 Methanococcus maripaludis (strain C5 / ATCC BAA-1333) tfb gene Proteins 0.000 description 1
- 101100369201 Methanococcus maripaludis (strain C5 / ATCC BAA-1333) tfe gene Proteins 0.000 description 1
- 101100104151 Methanococcus maripaludis (strain C6 / ATCC BAA-1332) MmarC6_0210 gene Proteins 0.000 description 1
- 101100080028 Methanococcus maripaludis (strain C6 / ATCC BAA-1332) MmarC6_0929 gene Proteins 0.000 description 1
- 101100480765 Methanococcus maripaludis (strain C6 / ATCC BAA-1332) tbp gene Proteins 0.000 description 1
- 101100260186 Methanococcus maripaludis (strain C6 / ATCC BAA-1332) tfb gene Proteins 0.000 description 1
- 101100080029 Methanococcus maripaludis (strain C7 / ATCC BAA-1331) MmarC7_1017 gene Proteins 0.000 description 1
- 101100157698 Methanococcus maripaludis (strain C7 / ATCC BAA-1331) MmarC7_1702 gene Proteins 0.000 description 1
- 101100480766 Methanococcus maripaludis (strain C7 / ATCC BAA-1331) tbp gene Proteins 0.000 description 1
- 101100260187 Methanococcus maripaludis (strain C7 / ATCC BAA-1331) tfb gene Proteins 0.000 description 1
- 101100369202 Methanococcus maripaludis (strain C7 / ATCC BAA-1331) tfe gene Proteins 0.000 description 1
- 101100080030 Methanococcus maripaludis (strain S2 / LL) MMP0020 gene Proteins 0.000 description 1
- 101100373526 Methanococcus maripaludis (strain S2 / LL) MMP0086 gene Proteins 0.000 description 1
- 101100266167 Methanococcus maripaludis (strain S2 / LL) MMP0678 gene Proteins 0.000 description 1
- 101100517201 Methanococcus maripaludis (strain S2 / LL) nrpR gene Proteins 0.000 description 1
- 101100480767 Methanococcus maripaludis (strain S2 / LL) tbp gene Proteins 0.000 description 1
- 101100260190 Methanococcus maripaludis (strain S2 / LL) tfb gene Proteins 0.000 description 1
- 101100369205 Methanococcus maripaludis (strain S2 / LL) tfe gene Proteins 0.000 description 1
- 101100103462 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) Mevan_1098 gene Proteins 0.000 description 1
- 101100080032 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) Mevan_1201 gene Proteins 0.000 description 1
- 101100541695 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) Mevan_1514 gene Proteins 0.000 description 1
- 101100480773 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) tbp gene Proteins 0.000 description 1
- 101100157654 Methanocorpusculum labreanum (strain ATCC 43576 / DSM 4855 / Z) Mlab_0160 gene Proteins 0.000 description 1
- 101100141070 Methanocorpusculum labreanum (strain ATCC 43576 / DSM 4855 / Z) ribK gene Proteins 0.000 description 1
- 101100369200 Methanocorpusculum labreanum (strain ATCC 43576 / DSM 4855 / Z) tfe gene Proteins 0.000 description 1
- 101100265313 Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1) Memar_2347 gene Proteins 0.000 description 1
- 101100260189 Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1) tfb gene Proteins 0.000 description 1
- 101100369204 Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1) tfe gene Proteins 0.000 description 1
- 101100480764 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) tbp gene Proteins 0.000 description 1
- 101100424911 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) tfb gene Proteins 0.000 description 1
- 101100369199 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) tfe gene Proteins 0.000 description 1
- 101100211347 Methanoregula boonei (strain DSM 21154 / JCM 14090 / 6A8) Mboo_0195 gene Proteins 0.000 description 1
- 101100424909 Methanoregula boonei (strain DSM 21154 / JCM 14090 / 6A8) tfb gene Proteins 0.000 description 1
- 101100050991 Methanosarcina barkeri (strain Fusaro / DSM 804) Mbar_A2318 gene Proteins 0.000 description 1
- 101100001240 Methanosarcina barkeri (strain Fusaro / DSM 804) ahbB gene Proteins 0.000 description 1
- 101100369195 Methanosarcina barkeri (strain Fusaro / DSM 804) tfe gene Proteins 0.000 description 1
- 101100050251 Methanosphaera stadtmanae (strain ATCC 43021 / DSM 3091 / JCM 11832 / MCB-3) Msp_1143 gene Proteins 0.000 description 1
- 101100365617 Methanosphaera stadtmanae (strain ATCC 43021 / DSM 3091 / JCM 11832 / MCB-3) sfsA gene Proteins 0.000 description 1
- 101100480769 Methanosphaera stadtmanae (strain ATCC 43021 / DSM 3091 / JCM 11832 / MCB-3) tbp gene Proteins 0.000 description 1
- 101100260194 Methanosphaera stadtmanae (strain ATCC 43021 / DSM 3091 / JCM 11832 / MCB-3) tfb gene Proteins 0.000 description 1
- 101100369208 Methanosphaera stadtmanae (strain ATCC 43021 / DSM 3091 / JCM 11832 / MCB-3) tfe gene Proteins 0.000 description 1
- 101100318707 Methanospirillum hungatei JF-1 (strain ATCC 27890 / DSM 864 / NBRC 100397 / JF-1) Mhun_2548 gene Proteins 0.000 description 1
- 101100141067 Methanospirillum hungatei JF-1 (strain ATCC 27890 / DSM 864 / NBRC 100397 / JF-1) ribK gene Proteins 0.000 description 1
- 101100369197 Methanospirillum hungatei JF-1 (strain ATCC 27890 / DSM 864 / NBRC 100397 / JF-1) tfe gene Proteins 0.000 description 1
- 101100080031 Methanothrix thermoacetophila (strain DSM 6194 / JCM 14653 / NBRC 101360 / PT) Mthe_0662 gene Proteins 0.000 description 1
- 101100480772 Methanothrix thermoacetophila (strain DSM 6194 / JCM 14653 / NBRC 101360 / PT) tbp gene Proteins 0.000 description 1
- 101100260197 Methanothrix thermoacetophila (strain DSM 6194 / JCM 14653 / NBRC 101360 / PT) tfb gene Proteins 0.000 description 1
- 101100206357 Methanothrix thermoacetophila (strain DSM 6194 / JCM 14653 / NBRC 101360 / PT) tfe gene Proteins 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 108010059724 Micrococcal Nuclease Proteins 0.000 description 1
- 241001148170 Microlunatus Species 0.000 description 1
- 101150082137 Mtrr gene Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 101100382264 Mus musculus Ca14 gene Proteins 0.000 description 1
- 101100112373 Mus musculus Ctsm gene Proteins 0.000 description 1
- 101100005318 Mus musculus Ctsr gene Proteins 0.000 description 1
- 101100011750 Mus musculus Hsp90b1 gene Proteins 0.000 description 1
- 101100518987 Mus musculus Pax1 gene Proteins 0.000 description 1
- 101100518997 Mus musculus Pax3 gene Proteins 0.000 description 1
- 101100310657 Mus musculus Sox1 gene Proteins 0.000 description 1
- 101100257363 Mus musculus Sox2 gene Proteins 0.000 description 1
- 101100257376 Mus musculus Sox3 gene Proteins 0.000 description 1
- 101100045406 Mus musculus Tap2 gene Proteins 0.000 description 1
- 101000635833 Mus musculus Tissue factor Proteins 0.000 description 1
- 101100425749 Mus musculus Tnfrsf18 gene Proteins 0.000 description 1
- 102100030372 Myelin regulatory factor Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 1
- 108091008729 NR1G1 Proteins 0.000 description 1
- 241001123225 Naumovozyma castellii Species 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 101100333320 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) end-3 gene Proteins 0.000 description 1
- 101100076157 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) mbf-1 gene Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 102100034408 Nuclear transcription factor Y subunit alpha Human genes 0.000 description 1
- 101710115878 Nuclear transcription factor Y subunit alpha Proteins 0.000 description 1
- 102100022201 Nuclear transcription factor Y subunit beta Human genes 0.000 description 1
- 101710205449 Nuclear transcription factor Y subunit beta Proteins 0.000 description 1
- 102100031719 Nuclear transcription factor Y subunit gamma Human genes 0.000 description 1
- 101710150472 Nuclear transcription factor Y subunit gamma Proteins 0.000 description 1
- 241000700124 Octodon degus Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 101150072055 PAL1 gene Proteins 0.000 description 1
- 101150025129 POP1 gene Proteins 0.000 description 1
- 241000235652 Pachysolen Species 0.000 description 1
- 241000178961 Paenibacillus alvei Species 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 241000881860 Paenibacillus mucilaginosus Species 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 241000193390 Parageobacillus thermoglucosidasius Species 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 241001660097 Pedobacter Species 0.000 description 1
- 229930195708 Penicillin V Natural products 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 241000199264 Phaseolus carteri Species 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101100486031 Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) PAE1627 gene Proteins 0.000 description 1
- 101100256793 Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) sfsA gene Proteins 0.000 description 1
- 101100206145 Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) tbp gene Proteins 0.000 description 1
- 101100260203 Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) tfb gene Proteins 0.000 description 1
- 101100206362 Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) tfe gene Proteins 0.000 description 1
- 101100256794 Pyrobaculum arsenaticum (strain DSM 13514 / JCM 11321 / PZ6) sfsA gene Proteins 0.000 description 1
- 101100260204 Pyrobaculum arsenaticum (strain DSM 13514 / JCM 11321 / PZ6) tfb gene Proteins 0.000 description 1
- 101100206363 Pyrobaculum arsenaticum (strain DSM 13514 / JCM 11321 / PZ6) tfe gene Proteins 0.000 description 1
- 101100014833 Pyrobaculum calidifontis (strain DSM 21063 / JCM 11548 / VA1) Pcal_1032 gene Proteins 0.000 description 1
- 101100256795 Pyrobaculum calidifontis (strain DSM 21063 / JCM 11548 / VA1) sfsA gene Proteins 0.000 description 1
- 101100206146 Pyrobaculum calidifontis (strain DSM 21063 / JCM 11548 / VA1) tbp gene Proteins 0.000 description 1
- 101100206364 Pyrobaculum calidifontis (strain DSM 21063 / JCM 11548 / VA1) tfe gene Proteins 0.000 description 1
- 101100256797 Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3) sfsA gene Proteins 0.000 description 1
- 101100206149 Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3) tbp gene Proteins 0.000 description 1
- 101100152769 Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3) tfb gene Proteins 0.000 description 1
- 101100206367 Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3) tfe gene Proteins 0.000 description 1
- 101100412389 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB00550 gene Proteins 0.000 description 1
- 101100412395 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB00690 gene Proteins 0.000 description 1
- 101100301515 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB01370 gene Proteins 0.000 description 1
- 101100177167 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB03470 gene Proteins 0.000 description 1
- 101100319045 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB03670 gene Proteins 0.000 description 1
- 101100177178 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB04720 gene Proteins 0.000 description 1
- 101100247955 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB04820 gene Proteins 0.000 description 1
- 101100210905 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB13000 gene Proteins 0.000 description 1
- 101100157495 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB14350 gene Proteins 0.000 description 1
- 101100080038 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB14420 gene Proteins 0.000 description 1
- 101100247958 Pyrococcus abyssi (strain GE5 / Orsay) PYRAB16920 gene Proteins 0.000 description 1
- 101100301526 Pyrococcus abyssi (strain GE5 / Orsay) fl11 gene Proteins 0.000 description 1
- 101100301529 Pyrococcus abyssi (strain GE5 / Orsay) lrpA gene Proteins 0.000 description 1
- 101100034121 Pyrococcus abyssi (strain GE5 / Orsay) ribK gene Proteins 0.000 description 1
- 101100206144 Pyrococcus abyssi (strain GE5 / Orsay) tbp gene Proteins 0.000 description 1
- 101100260202 Pyrococcus abyssi (strain GE5 / Orsay) tfb gene Proteins 0.000 description 1
- 101100206361 Pyrococcus abyssi (strain GE5 / Orsay) tfe gene Proteins 0.000 description 1
- 101100104970 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) PF0535 gene Proteins 0.000 description 1
- 101100034125 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) ribK gene Proteins 0.000 description 1
- 101100256796 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) sfsA gene Proteins 0.000 description 1
- 101100206147 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) tbp gene Proteins 0.000 description 1
- 101100260205 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) tfb gene Proteins 0.000 description 1
- 101100206365 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) tfe gene Proteins 0.000 description 1
- 101100425643 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) trmBL2 gene Proteins 0.000 description 1
- 101100177169 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) PH1782.1 gene Proteins 0.000 description 1
- 101100034126 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) ribK gene Proteins 0.000 description 1
- 101100206148 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) tbp gene Proteins 0.000 description 1
- 101100152768 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) tfb gene Proteins 0.000 description 1
- 101100206366 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) tfe gene Proteins 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 101100172720 Rattus norvegicus Ces1e gene Proteins 0.000 description 1
- 101100372762 Rattus norvegicus Flt1 gene Proteins 0.000 description 1
- 101100337058 Rattus norvegicus Glp1r gene Proteins 0.000 description 1
- 101100240886 Rattus norvegicus Nptx2 gene Proteins 0.000 description 1
- 101100083855 Rattus norvegicus Pou2f3 gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000242743 Renilla reniformis Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000191025 Rhodobacter Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
- 101150081243 STA1 gene Proteins 0.000 description 1
- 101100080045 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) SSO0659 gene Proteins 0.000 description 1
- 101100212633 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) SSO0942 gene Proteins 0.000 description 1
- 101100231659 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) SSO0977 gene Proteins 0.000 description 1
- 101100182526 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) lrs14 gene Proteins 0.000 description 1
- 101100400215 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) lysM gene Proteins 0.000 description 1
- 101100256808 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) sfsA gene Proteins 0.000 description 1
- 101100206153 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tbp gene Proteins 0.000 description 1
- 101100369153 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tfbA gene Proteins 0.000 description 1
- 101100369160 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tfbB gene Proteins 0.000 description 1
- 101100206369 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tfe gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100273994 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CFT2 gene Proteins 0.000 description 1
- 101100496466 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CMR3 gene Proteins 0.000 description 1
- 101100152661 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TDA9 gene Proteins 0.000 description 1
- 101100370026 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TOG1 gene Proteins 0.000 description 1
- 101100263680 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) VHR2 gene Proteins 0.000 description 1
- 101100106006 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YER130C gene Proteins 0.000 description 1
- 101100376565 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YKL222C gene Proteins 0.000 description 1
- 101100320750 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YLL054C gene Proteins 0.000 description 1
- 101100267497 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YLR278C gene Proteins 0.000 description 1
- 101100376725 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YNR063W gene Proteins 0.000 description 1
- 101100320971 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YPR015C gene Proteins 0.000 description 1
- 101100320973 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YPR022C gene Proteins 0.000 description 1
- 101100267719 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YPR196W gene Proteins 0.000 description 1
- 101100094962 Salmo salar salarin gene Proteins 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000235060 Scheffersomyces stipitis Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 241000015473 Schizothorax griseus Species 0.000 description 1
- 102100021119 Serine protease HTRA1 Human genes 0.000 description 1
- 102100027864 Serine/threonine-protein phosphatase 4 regulatory subunit 3A Human genes 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241001135312 Sinorhizobium Species 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000221948 Sordaria Species 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 101100206370 Staphylothermus marinus (strain ATCC 43588 / DSM 3639 / JCM 9404 / F1) tfe gene Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 101000901034 Streptococcus gordonii Accessory Sec system protein Asp2 Proteins 0.000 description 1
- 241000913727 Streptomyces alboniger Species 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 241000187433 Streptomyces clavuligerus Species 0.000 description 1
- 241000958215 Streptomyces filamentosus Species 0.000 description 1
- 241000187438 Streptomyces fradiae Species 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241000187399 Streptomyces lincolnensis Species 0.000 description 1
- 241000970906 Streptomyces natalensis Species 0.000 description 1
- 241000122969 Streptomyces nodosus Species 0.000 description 1
- 241000187310 Streptomyces noursei Species 0.000 description 1
- 241000187419 Streptomyces rimosus Species 0.000 description 1
- 241000531819 Streptomyces venezuelae Species 0.000 description 1
- 241001147844 Streptomyces verticillus Species 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 101100231660 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) Saci_1304 gene Proteins 0.000 description 1
- 101100318036 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) Saci_1344 gene Proteins 0.000 description 1
- 101100056431 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) arnR gene Proteins 0.000 description 1
- 101100056430 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) arnR1 gene Proteins 0.000 description 1
- 101100421404 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) sfsA gene Proteins 0.000 description 1
- 101100098939 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) tbp gene Proteins 0.000 description 1
- 101100152777 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) tfb gene Proteins 0.000 description 1
- 101100206371 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) tfe gene Proteins 0.000 description 1
- 241000160715 Sulfolobus tokodaii Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 241000388430 Tara Species 0.000 description 1
- 108010053950 Teicoplanin Proteins 0.000 description 1
- 241000405713 Tetraselmis suecica Species 0.000 description 1
- 101100194809 Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1) ribK gene Proteins 0.000 description 1
- 101100098943 Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1) tbp gene Proteins 0.000 description 1
- 101100480998 Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1) tfe gene Proteins 0.000 description 1
- 101100480999 Thermofilum pendens (strain DSM 2475 / Hrk 5) tfe gene Proteins 0.000 description 1
- 101100194808 Thermoplasma acidophilum (strain ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165) ribK gene Proteins 0.000 description 1
- 101100203120 Thermoplasma acidophilum (strain ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165) sfsA gene Proteins 0.000 description 1
- 101100098941 Thermoplasma acidophilum (strain ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165) tbp gene Proteins 0.000 description 1
- 241000204666 Thermotoga maritima Species 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
- 108091028113 Trans-activating crRNA Proteins 0.000 description 1
- 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000607265 Vibrio vulnificus Species 0.000 description 1
- 241000193396 Virgibacillus pantothenticus Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- 102100028610 Zinc finger protein 1 homolog Human genes 0.000 description 1
- 101710144834 Zinc finger protein 1 homolog Proteins 0.000 description 1
- UGEVDEPHPZWGPI-KEWYIRBNSA-N [(2R,3S,4R,5R)-6-acetyl-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate Chemical compound P(=O)(O)(O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O)(O1)C(C)=O)N)O)O UGEVDEPHPZWGPI-KEWYIRBNSA-N 0.000 description 1
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 241000193761 [Bacillus] caldolyticus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 229940003446 arsphenamine Drugs 0.000 description 1
- VLAXZGHHBIJLAD-UHFFFAOYSA-N arsphenamine Chemical compound [Cl-].[Cl-].C1=C(O)C([NH3+])=CC([As]=[As]C=2C=C([NH3+])C(O)=CC=2)=C1 VLAXZGHHBIJLAD-UHFFFAOYSA-N 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000007845 assembly PCR Methods 0.000 description 1
- 229960002379 avibactam Drugs 0.000 description 1
- NDCUAPJVLWFHHB-UHNVWZDZSA-N avibactam Chemical compound C1N2[C@H](C(N)=O)CC[C@@]1([H])N(OS(O)(=O)=O)C2=O NDCUAPJVLWFHHB-UHNVWZDZSA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960003623 azlocillin Drugs 0.000 description 1
- JTWOMNBEOCYFNV-NFFDBFGFSA-N azlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCNC1=O JTWOMNBEOCYFNV-NFFDBFGFSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- PPKJUHVNTMYXOD-PZGPJMECSA-N c49ws9n75l Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O PPKJUHVNTMYXOD-PZGPJMECSA-N 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- JSVCEVCSANKFDY-SFYZADRCSA-N carbacephem Chemical compound C1CC(C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)C)[C@H]21 JSVCEVCSANKFDY-SFYZADRCSA-N 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- UIMOJFJSJSIGLV-JNHMLNOCSA-N carumonam Chemical compound O=C1N(S(O)(=O)=O)[C@H](COC(=O)N)[C@@H]1NC(=O)C(=N/OCC(O)=O)\C1=CSC(N)=N1 UIMOJFJSJSIGLV-JNHMLNOCSA-N 0.000 description 1
- 229960000662 carumonam Drugs 0.000 description 1
- 101150091502 ced-6 gene Proteins 0.000 description 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
- 229960005361 cefaclor Drugs 0.000 description 1
- 229960004841 cefadroxil Drugs 0.000 description 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 description 1
- 229960003012 cefamandole Drugs 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960003719 cefdinir Drugs 0.000 description 1
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 description 1
- 229960004069 cefditoren Drugs 0.000 description 1
- KMIPKYQIOVAHOP-YLGJWRNMSA-N cefditoren Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1\C=C/C=1SC=NC=1C KMIPKYQIOVAHOP-YLGJWRNMSA-N 0.000 description 1
- 229960002100 cefepime Drugs 0.000 description 1
- HVFLCNVBZFFHBT-ZKDACBOMSA-N cefepime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-N 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960003391 cefovecin Drugs 0.000 description 1
- ZJGQFXVQDVCVOK-MSUXKOGISA-N cefovecin Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1[C@@H]1CCCO1 ZJGQFXVQDVCVOK-MSUXKOGISA-N 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 description 1
- 229960005090 cefpodoxime Drugs 0.000 description 1
- WYUSVOMTXWRGEK-HBWVYFAYSA-N cefpodoxime Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(O)=O)C(=O)C(=N/OC)\C1=CSC(N)=N1 WYUSVOMTXWRGEK-HBWVYFAYSA-N 0.000 description 1
- 229960002580 cefprozil Drugs 0.000 description 1
- 229950009592 cefquinome Drugs 0.000 description 1
- 229960004828 ceftaroline fosamil Drugs 0.000 description 1
- ZCCUWMICIWSJIX-NQJJCJBVSA-N ceftaroline fosamil Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OCC)C=2N=C(NP(O)(O)=O)SN=2)CC=1SC(SC=1)=NC=1C1=CC=[N+](C)C=C1 ZCCUWMICIWSJIX-NQJJCJBVSA-N 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 description 1
- 229960004086 ceftibuten Drugs 0.000 description 1
- UNJFKXSSGBWRBZ-BJCIPQKHSA-N ceftibuten Chemical compound S1C(N)=NC(C(=C\CC(O)=O)\C(=O)N[C@@H]2C(N3C(=CCS[C@@H]32)C(O)=O)=O)=C1 UNJFKXSSGBWRBZ-BJCIPQKHSA-N 0.000 description 1
- 229960005229 ceftiofur Drugs 0.000 description 1
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 description 1
- 229960001991 ceftizoxime Drugs 0.000 description 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 description 1
- VOAZJEPQLGBXGO-SDAWRPRTSA-N ceftobiprole Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(\C=C/4C(N([C@H]5CNCC5)CC\4)=O)CS[C@@H]32)C(O)=O)=O)=N1 VOAZJEPQLGBXGO-SDAWRPRTSA-N 0.000 description 1
- 229950004259 ceftobiprole Drugs 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960001668 cefuroxime Drugs 0.000 description 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 1
- 101150031236 ceh-24 gene Proteins 0.000 description 1
- 101150051158 ceh-30 gene Proteins 0.000 description 1
- 101150089239 ceh-44 gene Proteins 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004656 cell transport Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 108091092259 cell-free RNA Proteins 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 239000011035 citrine Substances 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004287 clofazimine Drugs 0.000 description 1
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- ZIHHMGTYZOSFRC-UWWAPWIJSA-M cobamamide Chemical compound C1(/[C@](C)(CCC(=O)NC[C@H](C)OP(O)(=O)OC2[C@H]([C@H](O[C@@H]2CO)N2C3=CC(C)=C(C)C=C3N=C2)O)[C@@H](CC(N)=O)[C@]2(N1[Co+]C[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C3=NC=NC(N)=C3N=C1)O)[H])=C(C)\C([C@H](C/1(C)C)CCC(N)=O)=N\C\1=C/C([C@H]([C@@]\1(CC(N)=O)C)CCC(N)=O)=N/C/1=C(C)\C1=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O ZIHHMGTYZOSFRC-UWWAPWIJSA-M 0.000 description 1
- 235000006279 cobamamide Nutrition 0.000 description 1
- 239000011789 cobamamide Substances 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002488 dalbavancin Drugs 0.000 description 1
- 108700009376 dalbavancin Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- 229960005484 daptomycin Drugs 0.000 description 1
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 229960002398 demeclocycline Drugs 0.000 description 1
- 229960001585 dicloxacillin Drugs 0.000 description 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 description 1
- 102000004419 dihydrofolate reductase Human genes 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229960004100 dirithromycin Drugs 0.000 description 1
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 1
- 229960000895 doripenem Drugs 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 101150019229 dpy-20 gene Proteins 0.000 description 1
- 101150028817 dpy-22 gene Proteins 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002549 enoxacin Drugs 0.000 description 1
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 229960002770 ertapenem Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- 229960002001 ethionamide Drugs 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 229960000379 faropenem Drugs 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- QTQAWLPCGQOSGP-GBTDJJJQSA-N geldanamycin Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(OC)C(=O)C=C1C2=O QTQAWLPCGQOSGP-GBTDJJJQSA-N 0.000 description 1
- 229960003170 gemifloxacin Drugs 0.000 description 1
- ZRCVYEYHRGVLOC-HYARGMPZSA-N gemifloxacin Chemical compound C1C(CN)C(=N/OC)/CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1CC1 ZRCVYEYHRGVLOC-HYARGMPZSA-N 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 210000005256 gram-negative cell Anatomy 0.000 description 1
- 210000005255 gram-positive cell Anatomy 0.000 description 1
- 229960000642 grepafloxacin Drugs 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- MCAHMSDENAOJFZ-BVXDHVRPSA-N herbimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](OC)[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C1C2=O MCAHMSDENAOJFZ-BVXDHVRPSA-N 0.000 description 1
- 229930193320 herbimycin Natural products 0.000 description 1
- 101150064902 hlh-1 gene Proteins 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- QJPWUUJVYOJNMH-UHFFFAOYSA-N homoserine lactone Chemical compound NC1CCOC1=O QJPWUUJVYOJNMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 101150111214 lin-28 gene Proteins 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229940041028 lincosamides Drugs 0.000 description 1
- 229960003907 linezolid Drugs 0.000 description 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
- ULXTYUPMJXVUHQ-OVTFQNCVSA-N lipid II Chemical compound OC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]1[C@@H](NC(C)=O)[C@@H](OP(O)(=O)OP(O)(=O)OC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(\C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ULXTYUPMJXVUHQ-OVTFQNCVSA-N 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229960002422 lomefloxacin Drugs 0.000 description 1
- ZEKZLJVOYLTDKK-UHFFFAOYSA-N lomefloxacin Chemical compound FC1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1 ZEKZLJVOYLTDKK-UHFFFAOYSA-N 0.000 description 1
- 229960001977 loracarbef Drugs 0.000 description 1
- JAPHQRWPEGVNBT-UTUOFQBUSA-M loracarbef anion Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)N)=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-M 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229960003640 mafenide Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000000723 mammalian artificial chromosome Anatomy 0.000 description 1
- 101150016833 mec-3 gene Proteins 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960002260 meropenem Drugs 0.000 description 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000198 mezlocillin Drugs 0.000 description 1
- YPBATNHYBCGSSN-VWPFQQQWSA-N mezlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O YPBATNHYBCGSSN-VWPFQQQWSA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012737 microarray-based gene expression Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
- 229960003128 mupirocin Drugs 0.000 description 1
- 229930187697 mupirocin Natural products 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
- 229960000515 nafcillin Drugs 0.000 description 1
- GPXLMGHLHQJAGZ-JTDSTZFVSA-N nafcillin Chemical compound C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C(O)=O)=O)C(OCC)=CC=C21 GPXLMGHLHQJAGZ-JTDSTZFVSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 101150009274 nhr-1 gene Proteins 0.000 description 1
- 101150024084 nhr-28 gene Proteins 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960000564 nitrofurantoin Drugs 0.000 description 1
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- CTNZOGJNVIFEBA-UPSUJEDGSA-N nocardicin A Chemical compound C1=CC(OCC[C@@H](N)C(O)=O)=CC=C1C(=N\O)\C(=O)N[C@@H]1C(=O)N([C@@H](C(O)=O)C=2C=CC(O)=CC=2)C1 CTNZOGJNVIFEBA-UPSUJEDGSA-N 0.000 description 1
- CTNZOGJNVIFEBA-SCTDSRPQSA-N nocardicin A Natural products N[C@@H](CCOc1ccc(cc1)C(=NO)C(=O)N[C@@H]2CN([C@H](C(=O)O)c3ccc(O)cc3)C2=O)C(=O)O CTNZOGJNVIFEBA-SCTDSRPQSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000009437 off-target effect Effects 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- XDUHQPOXLUAVEE-BPMMELMSSA-N oleoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC\C=C/CCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XDUHQPOXLUAVEE-BPMMELMSSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- VHFGEBVPHAGQPI-MYYQHNLBSA-N oritavancin Chemical compound O([C@@H]1C2=CC=C(C(=C2)Cl)OC=2C=C3C=C(C=2O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@@](C)(NCC=4C=CC(=CC=4)C=4C=CC(Cl)=CC=4)C2)OC2=CC=C(C=C2Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]2C(=O)N[C@@H]1C(N[C@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1 VHFGEBVPHAGQPI-MYYQHNLBSA-N 0.000 description 1
- 229960001607 oritavancin Drugs 0.000 description 1
- 108010006945 oritavancin Proteins 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
- 229940056367 penicillin v Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 108700010839 phage proteins Proteins 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- CSOMAHTTWTVBFL-OFBLZTNGSA-N platensimycin Chemical compound C([C@]1([C@@H]2[C@@H]3C[C@@H]4C[C@@]2(C=CC1=O)C[C@@]4(O3)C)C)CC(=O)NC1=C(O)C=CC(C(O)=O)=C1O CSOMAHTTWTVBFL-OFBLZTNGSA-N 0.000 description 1
- CSOMAHTTWTVBFL-UHFFFAOYSA-N platensimycin Natural products O1C2(C)CC3(C=CC4=O)CC2CC1C3C4(C)CCC(=O)NC1=C(O)C=CC(C(O)=O)=C1O CSOMAHTTWTVBFL-UHFFFAOYSA-N 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 229950004447 posizolid Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- ABBQGOCHXSPKHJ-WUKNDPDISA-N prontosil Chemical compound NC1=CC(N)=CC=C1\N=N\C1=CC=C(S(N)(=O)=O)C=C1 ABBQGOCHXSPKHJ-WUKNDPDISA-N 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 229940052337 quinupristin/dalfopristin Drugs 0.000 description 1
- 229950009965 radezolid Drugs 0.000 description 1
- BTTNOGHPGJANSW-IBGZPJMESA-N radezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(C=2C=CC(CNCC=3NN=NC=3)=CC=2)C(F)=C1 BTTNOGHPGJANSW-IBGZPJMESA-N 0.000 description 1
- 238000007420 radioactive assay Methods 0.000 description 1
- 101150069431 rbr-2 gene Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 108091008020 response regulators Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- ATEBXHFBFRCZMA-VXTBVIBXSA-N rifabutin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC(=C2N3)C(=O)C=4C(O)=C5C)C)OC)C5=C1C=4C2=NC13CCN(CC(C)C)CC1 ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 description 1
- 229960002599 rifapentine Drugs 0.000 description 1
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- IKQNRQOUOZJHTR-UWBRJAPDSA-N ritipenem Chemical compound S1C(COC(N)=O)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 IKQNRQOUOZJHTR-UWBRJAPDSA-N 0.000 description 1
- 229950004286 ritipenem Drugs 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960004954 sparfloxacin Drugs 0.000 description 1
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 1
- 229960005256 sulbactam Drugs 0.000 description 1
- 229960002673 sulfacetamide Drugs 0.000 description 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 description 1
- 229960000973 sulfadimethoxine Drugs 0.000 description 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229960005158 sulfamethizole Drugs 0.000 description 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 229950008188 sulfamidochrysoidine Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 1
- 229960003865 tazobactam Drugs 0.000 description 1
- XFALPSLJIHVRKE-GFCCVEGCSA-N tedizolid Chemical compound CN1N=NC(C=2N=CC(=CC=2)C=2C(=CC(=CC=2)N2C(O[C@@H](CO)C2)=O)F)=N1 XFALPSLJIHVRKE-GFCCVEGCSA-N 0.000 description 1
- 229960001608 teicoplanin Drugs 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 108010041283 teixobactin Proteins 0.000 description 1
- ONUMZHGUFYIKPM-MXNFEBESSA-N telavancin Chemical compound O1[C@@H](C)[C@@H](O)[C@](NCCNCCCCCCCCCC)(C)C[C@@H]1O[C@H]1[C@H](OC=2C3=CC=4[C@H](C(N[C@H]5C(=O)N[C@H](C(N[C@@H](C6=CC(O)=C(CNCP(O)(O)=O)C(O)=C6C=6C(O)=CC=C5C=6)C(O)=O)=O)[C@H](O)C5=CC=C(C(=C5)Cl)O3)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C3=CC=C(C(=C3)Cl)OC=2C=4)O[C@H](CO)[C@@H](O)[C@@H]1O ONUMZHGUFYIKPM-MXNFEBESSA-N 0.000 description 1
- 229960005240 telavancin Drugs 0.000 description 1
- 108010089019 telavancin Proteins 0.000 description 1
- 229960003250 telithromycin Drugs 0.000 description 1
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 description 1
- 229960004576 temafloxacin Drugs 0.000 description 1
- 229960001114 temocillin Drugs 0.000 description 1
- BVCKFLJARNKCSS-DWPRYXJFSA-N temocillin Chemical compound N([C@]1(OC)C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C=1C=CSC=1 BVCKFLJARNKCSS-DWPRYXJFSA-N 0.000 description 1
- 229940081330 tena Drugs 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 1
- 229960003053 thiamphenicol Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229960004089 tigecycline Drugs 0.000 description 1
- 229950010206 tigemonam Drugs 0.000 description 1
- VAMSVIZLXJOLHZ-QWFSEIHXSA-N tigemonam Chemical compound O=C1N(OS(O)(=O)=O)C(C)(C)[C@@H]1NC(=O)C(=N/OCC(O)=O)\C1=CSC(N)=N1 VAMSVIZLXJOLHZ-QWFSEIHXSA-N 0.000 description 1
- 229960005053 tinidazole Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 101150117196 tra-1 gene Proteins 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 229960005041 troleandomycin Drugs 0.000 description 1
- LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 description 1
- 229960000497 trovafloxacin Drugs 0.000 description 1
- WVPSKSLAZQPAKQ-CDMJZVDBSA-N trovafloxacin Chemical compound C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-CDMJZVDBSA-N 0.000 description 1
- 101150057095 ttgR gene Proteins 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 101150096625 unc-4 gene Proteins 0.000 description 1
- 101150109253 unc-62 gene Proteins 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 101150022879 vab-15 gene Proteins 0.000 description 1
- 229950007158 vaborbactam Drugs 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 101150047957 yfiR gene Proteins 0.000 description 1
- KGPGQDLTDHGEGT-JCIKCJKQSA-N zeven Chemical compound C=1C([C@@H]2C(=O)N[C@H](C(N[C@H](C3=CC(O)=C4)C(=O)NCCCN(C)C)=O)[C@H](O)C5=CC=C(C(=C5)Cl)OC=5C=C6C=C(C=5O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@H](O5)C(O)=O)NC(=O)CCCCCCCCC(C)C)OC5=CC=C(C=C5)C[C@@H]5C(=O)N[C@H](C(N[C@H]6C(=O)N2)=O)C=2C(Cl)=C(O)C=C(C=2)OC=2C(O)=CC=C(C=2)[C@H](C(N5)=O)NC)=CC=C(O)C=1C3=C4O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O KGPGQDLTDHGEGT-JCIKCJKQSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
- G16B35/20—Screening of libraries
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
Definitions
- the present described inventions relate, inter alia, to methods and compositions that provide for a cell-free system for engineering and deploying allosteric sensor proteins.
- a key objective of synthetic biology is the efficient production of high value target molecules. But, a significant unsolved bottleneck in the bioengineering design-build-test cycle is in the test phase due to screening limitations.
- One possible solution to this bottleneck is the use of molecular sensors. Indeed, sensors that recognize industrially important molecules are rapidly becoming part of metabolic engineering strategies to improve enzymatic bioproduction and detection. However, coupling a response to the detection of a specific target is an engineering challenge in itself.
- allosteric proteins single proteins that directly couple the recognition of a molecule of interest to a response has been proposed. Allostery is a common feature of proteins, in which the behavior at an ‘active’ site is altered by binding of an effector to a second or ‘allosteric’ site, often quite distant from the first (about 10 A or more). The altered behavior can either directly or indirectly lead to a change in the protein's activity and thereby elicit a detectable response.
- aTFs bacterial allosteric transcription factors
- circulary permuted reporter proteins about the active site of a second conformationally dynamic effector protein presents an alternative method for directly coupling the recognition of a molecule to a response.
- the protein's conformational change caused by effector binding results in a shift in protein structure that can be repurposed to switch a reporter protein from an inactive to active state or vice versa.
- This response can either be positive or negative as well as stoichiometric or amplifiable.
- the circular permutation of GFP about the binding site of a protein has resulted in a fluorescent state that is directly coupled to the binding of a small molecule effector. Since one protein may bind a specific number of molecules based on its structure and relative affinity, the result leads to a stoichiometric fluorescent signal directly correlated to the amount of ligand-bound protein present.
- Permutation of an enzyme about the active site results in signal amplification as a single effector molecule leads to multiple functional turnovers for the reporter enzyme. Further, effector modulated presentation of a degradation tag results in the selective reduction in a protein that may either have a beneficial or derogatory effect on cellular state.
- One of the challenges of engineering sensor proteins—such as aTFs, circularly permuted reporter-binders, and allosterically controlled degradation tags—to recognize target molecules is that the host cell in which the molecular biology is conducted may not permit sufficiently adjustable concentrations of the target molecule to allow a measurable on/off response of the engineered protein. Simple introduction of the target molecule into the growth medium exogenously or through bioproduction may not be a suitable approach because the target molecule may be excluded from, transported out of, toxic to, or chemically altered by the cell or the target molecule's concentration is actively controlled by the cell. These active or passive mechanisms modulating the effective concentration of the ligand convolutes the sensor's ability to respond to the true concentration of the ligand being added or produced.
- proteins are often sensitive to deviations in their environmental conditions—such as buffer compositions, metabolite profiles, temperature, etc.—that may lead to deviations in protein activity. Allosteric proteins also suffer to various degrees to this phenomenon. As a result, their phenotypic sensitivity to cellular environment when used as a biological sensor system has the potential to skew results as the environmental conditions are artificially or biologically adjusted.
- intermediate steps may demonstrate off-target effects by binding to unknown and unpredictable locations leading to unwarranted changes in cellular state. Therefore, intermediate steps for engineering operator sites may be required to be performed in an acellular environment.
- FIG. 1 shows a schematic of the methods/systems of non-limiting embodiments of the invention. Specifically, panel A shows a strategy for temporal control in the reporter assays using a orthogonal sensor for engineered tetR sensors in the case where the engineered sensor is non-functional and panel B shows a strategy for temporal control in the reporter assays using a orthogonal sensor for engineered tetR sensors in the case where the engineered sensor is functional.
- FIG. 2 shows an illustrative overview of the cell-free transcription factor screening strategy using bulk emulsions.
- panel A shows a pool of allosteric transcription factors (aTF) expressed in E. coli and encapsulated in water-in-oil droplets generated in bulk. Each droplet contains the effector of interest, the polymerase reporter DNA under negative control through the aTF operator, primers specific to the aTF gene, and a chemical or enzymatic lytic agent.
- Panel B shows a more detailed view of the reporter strategy.
- aTFs that respond to the effector result in production of Kod polymerase that is then utilized to amplify the aTF genotype by PCR. Enriched amplicons are recovered from the emulsion and then cloned back into their expression vectors for subsequent rounds of screening.
- FIG. 3 shows an overview of the cell-free transcription factor screening strategy using microfluidically generated emulsions.
- panel A shows a pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets generated microfluidically. The effector, polymerase reporter gene, primers, and lytic agent are introduced through a second internal aqueous inlet.
- aTFs are enriched using the strategy presented in Figure (panel b)
- panel B and C show photographs of the droplet production chips from Dolomite Microfluidics for reference, but any microfluidic chip may be used.
- Panel D shows schematic of the flow focusing junction producing water-in-oil droplets.
- Panel E shows photograph of water-in-oil droplet formation.
- the channel width is 14 ⁇ m for scale
- panel F shows water-in-oil droplets are stable for more than 1 week at 37° C. and are monodisperse with a size of ⁇ 15 ⁇ 1 ⁇ m.
- FIG. 4 shows an illustrative overview of the cell-free RNA transcription-based reporter strategy.
- a pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets either microfluidically or in bulk. The effector, IVT reagents, and lytic agent re-introduced separately. After encapsulation, the droplets are incubated at 37° C. to promote lysis releasing the aTFs. aTFs that respond to the effector result in RNA transcription that is then utilized to amplify the aTF genotype by RT-PCR. Enriched amplicons are recovered from the emulsion and then cloned back into their expression vectors for subsequent rounds of screening. This strategy may replace the DNA polymerase strategy in FIG. 2 and FIG. 3 .
- FIG. 5 shows an overview of the cell-free transcription factor screening strategy using microfluidically generated double emulsions.
- panel A shows a pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets generated in bulk. Each droplet contains the effector of interest, the enzyme reporter DNA under negative control through the aTF operator, a fluorogenic substrate, and a chemical or enzymatic lytic agent. After encapsulation, the droplets are incubated at 37° C. to promote lysis releasing the aTFs. aTFs that respond to the effector result in production of the reporter enzyme.
- the single emulsions are then converted into a water-in-oil double emulsion and sorted by FACS
- panel B shows the water-in-oil emulsions either receive no E. coli, receive an E. coli expressing an unresponsive aTF, or an E. coli containing a responsive aTF resulting in the production of fluorescent signal
- panel C shows photograph of double emulsion formation.
- the channel width is 14 pm for scale
- panel D shows photograph of water-in-oil-in-water droplets that are stable for more than 1 week at 24° C. and are monodisperse with a size of ⁇ 20 ⁇ 2.2 ⁇ m
- panel E shows Schematic of the second emulsion.
- d Photograph of double emulsion formation.
- FIG. 6 shows single chip water-in-oil-in-water formation for cell-free transcription factor screening.
- panel A shows a schematic representation of the chip design
- panel B shows a photograph of the single chip design in PDMS producing double emulsions in one step.
- channel width is 50 ⁇ m for scale.
- FIG. 7 shows sensitivity and dynamic range of beta-glucosidase fluorogenic reporter substrate.
- FIG. 8 shows sensitivity and dynamic range of Antarctic phosphatase (AP) fluorogenic reporter substrate.
- FIG. 9 shows aTF-dependent control of T7 transcription in vitro.
- FIG. 10 shows the dose response of 4 TetR sensors engineered to detect the target molecule nootkatone (CE3, GF1, GA3, and CG5) and wild type TetR (p523) to nootkatone and ATc.
- FIG. 11 shows flow cytometry data of p1174 plasmid causing loss of the p1057 target plasmid
- FIG. 12 shows dilutions of cultures on selective media for either p1174 or p1057 to estimate loss of carb plasmid.
- engineered sensors are not limited to their utility within the environment in which they were derived, i.e. cellularly derived sensors may also be deployed in acellular environments and vice versa.
- the present invention provides compositions and methods that allow for the detection and/or production of target molecules and can be produced in manners that are independent of limiting processes of a cell and therefore not contingent on, for example, retention of the target molecule within a cell, e.g. a healthy cell.
- the present invention is not necessarily limited by an inherent toxicity of the target molecules to a cell, the ability of any target molecule to enter or remain inside screening strain cells, or the ability of any target molecule to be unaltered by cellular machinery. Further, the present invention is not limited by the sensing of molecules either small or large, but may be extended to cellular states such as redox potential and charge. Further, the present invention is not limited to the utility of allosteric transcription factors that directly bind to a DNA operator, but may use effector domains that propagate though protein cascades such as two component systems. Accordingly, the present methods and compositions allow for measurable on/off response of the engineered protein that is not limited by the ability of a cell to withstand or maintain measurable concentrations.
- the present invention relates to compositions and methods for making an engineered protein sensor and/or switch, e.g. from an allosteric protein, e.g. a transcription factor, that binds to and allows detection of a target molecule, wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened either cellularly or acellularly.
- an allosteric protein e.g. a transcription factor
- an allosteric sensor and/or switch that binds controllably to a ligand different from that of the wild type ligand.
- the engineered sensor and/or switch binds to and allows detection of the target molecule through a detectable response wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- an allosteric sensor and/or switch that binds controllably to an engineered DNA sequence different from that of the wild type sequence in response to the binding of a target molecule.
- the engineered sensor and/or switch binds to and allows detection of a target molecule through binding to an engineered DNA sequence wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- the allosteric sensor and or switch may be engineered to recognize both a new ligand as well as a new DNA binding site simultaneously.
- the present invention relates to compositions and methods for deploying sensors and/or switches to detect the production of target molecules.
- the engineered sensor and/or switch developed acellularly may be used either in a cellular or acellular environment.
- an engineered sensor and/or switched developed cellularly may be used in an acellular environment.
- the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule.
- the method comprises steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield a candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind a target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding a reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate alloster
- the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- the target molecule is an antibiotic.
- step (a) comprises mutating an allosteric protein.
- the nucleic acid is provided to the host cell by one or more of electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- the host cell is selected from a eukaryotic or prokaryotic cell, selected from a bacterial, yeast, algal, plant, insect, mammalian cells, and immortalized cell.
- the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- the IVT or IVTT mixture comprises a coupled or linked system.
- the reporterresponse is a direct amplification of the genotype of the allosteric protein.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- the method further comprises a step of (e): isolating the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule.
- the method comprises steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield a DNA-binding protein sensor and/or switch which has an ability to bind a target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding a reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding
- the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- the target molecule is an antibiotic.
- step (a) comprises mutating an allosteric protein.
- the nucleic acid is provided to the host cell by one or more of electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- the host cell is selected from a eukaryotic or prokaryotic cell, selected from a bacterial, yeast, algal, plant, insect, mammalian cells, and immortalized cell.
- the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- the IVT or IVTT mixture comprises a coupled or linked system.
- the reporter response is a direct amplification of the genotype of the allosteric protein.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- the method further comprises a step of (e): isolating the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule.
- the method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind a target molecule; (b) contacting a solid support with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and selecting for a solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch; (c) isolating nucleic acids from the solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch and contacting the isolated nu
- the solid support is a nanoparticle and a microparticle, a bead, a nanobead, a microbead, or an array.
- the candidate allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- the target molecule is an antibiotic.
- step (a) comprises mutating an allosteric protein.
- the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- the IVT or IVTT mixture comprises a coupled or linked system.
- the reporter response is a direct amplification of the genotype of the allosteric protein.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch comprises a synthetic DNA, amplified DNA, or amplified RNA.
- the method further comprises a step of (e): isolating the nucleic acid encoding the allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- the present invention relates to a method for making a target molecule in a biological cell.
- the method comprises steps of (a) engineering the biological cell to produce the target molecule; (b) introducing an allosteric DNA-binding protein sensor and/or switch which binds to the target molecule in the biological cell;
- the biological cell is engineered to produce the target molecule by a multiplex genome engineering technique and/or a method involving a double-strand break (DSB) or single-strand break or nick.
- DSB double-strand break
- nick single-strand break
- the allosteric DNA-binding protein sensor and/or switch which binds to the target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind the target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding the reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein
- the allosteric DNA-binding protein sensor and/or switch which binds to the target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch which has an ability to bind the target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter
- the allosteric DNA-binding protein sensor and/or switch which binds to a target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind the target molecule; (b) contacting a solid support with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and selecting for a solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch; (c) isolating nucleic acids from the solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch and contacting the isolated nucleic acids with
- the solid support is a nanoparticle and a microparticle, a nanobead, a microbead, or an array.
- the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- the screening for target molecule comprises a positive or negative screen.
- the allosteric DNA-binding protein sensor and/or switch is one or more of those of Table 1 and has about 1, or 2, or 3, or 4, or 5, or 10 mutations.
- the present invention is based, in part, on the surprising discovery that engineered protein sensors and/or switches, such as aTFs, can be designed to not require cellular-based target molecule interaction and therefore not be constrained by properties of a host cell (e.g. cell viability when contacted with a target molecule, cell transport of a target molecule, etc.). Accordingly, the present acellular methods allow for the development of engineered protein sensors and/or switches and the interrogation of a wide variety of target molecules that are not otherwise available using strictly cell-based approaches.
- the present invention is not necessarily limited by an inherent toxicity of the target molecules to a cell, the ability of any target molecule to enter or remain inside screening strain cells, or the ability of any target molecule to be unaltered by cellular machinery. Further, the present invention is not limited by the sensing of molecules either small or large, but may be extended to cellular states such as redox potential and charge. Further, the present invention is not limited to the utility of allosteric transcription factors that directly bind to a DNA operator, but may use effector domains that propagate though protein cascades such as two component systems. Accordingly, the present methods and compositions allow for measurable on/off response of the engineered protein that is not limited by the ability of a cell to withstand or maintain measurable concentrations.
- the present invention relates to compositions and methods for making an engineered protein sensor and/or switch, e.g. from an allosteric protein, e.g. a transcription factor, that binds to and allows detection of a target molecule, wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened either cellularly or acellularly.
- an allosteric protein e.g. a transcription factor
- an allosteric sensor and/or switch that binds controllably to a ligand different from that of the wild type ligand.
- the engineered sensor and/or switch binds to and allows detection of the target molecule through an elicited detectable response wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- an allosteric sensor and/or switch that binds controllably to an engineered DNA sequence different from that of the wild type sequence in response to the binding of a target molecule.
- the engineered sensor and/or switch binds to and allows detection of a target molecule through binding to an engineered DNA sequence wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- the allosteric sensor and or switch may be engineered to recognize both a new ligand as well as a new DNA binding site simultaneously.
- a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system and selecting for cells comprising a candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system; (c) isolating nucleic acids from the cells comprising a candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system and contacting the isolated nucleic acids with an in vitro transcription and translation (IVTT) mixture, the IVTT mixture comprising a target molecule and a detection reagent; and (d) interrog
- the engineered protein sensor and/or switch e.g. transcription factor, library members and reporter gene system reside on a single plasmid.
- a host organism such as E. coli or the others described herein, it is grown as single colonies each of which harbors a clonal library member.
- the reporter gene and protein sensor and/or switch library members are then purified as plasmids and individual plasmids are introduced into an IVTT mixture (see Zubay. Ann. Rev. Genet. 1973.7:267-287, the entire contents of which are hereby incorporated by reference in their entirety) to which has been added the target molecule and other detection reagents. After a suitable incubation period to allow expression of the reporter gene, the solution is interrogated for reporter response.
- a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) attaching the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch to a solid support; (c) contacting the isolated nucleic acids with an in vitro transcription and translation (IVTT) mixture, the IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVTT mixture for sensor and/or switch activity in the presence and absence of target ligand.
- the interrogation is not necessarily limited to the methods described above.
- a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) generating DNA encoding the allosteric sensor and/or switch in vitro; (c) introducing the DNA into a display system—for example but not limited to ribosome display, mRNA display, phage display, cell display—(d) interrogating the displayed sensors for DNA binding in the presence and absence of ligand. The interrogation being indicative of activity.
- a display system for example but not limited to ribosome display, mRNA display, phage display, cell display
- This reporter-free strategy to evaluate sensors is facilitated by coupling the sensor protein to the mRNA transcript encoding its translation, either by association with stalled ribosomes as in ribosome display (see Hanes, et al. PNAS. 1997; 94(10):4937-4942.) or through covalent linkage as in mRNA display (see Wilson et al. PNAS. 2001; 98(7):3750-5). Coupling of genetic sequence to the functional protein allows for faster identification of functional sensor sequences, and rapid cycles of in vitro selection, mutation and evolution of the sensor proteins.
- this strategy is further facilitated by creating a ‘dimeric’ single chain sensor with a linker sequence that allows proper folding (see Krueger et al. Nucleic Acids Research. 2003 31(12):3050-3056) from an initial mutant monomer sensor gene through PCR, ligation, transposon/transposase system, recombinase, CRISPR/Cas9, or combination of these methods.
- both dimers encode the same monomer sequence, as a single chain that would greatly favor homodimerization rather than heterodimerization of different mutants within a large mutant pool.
- the engineered monomer is coupled to a wild type monomer to create a heterodimeric single chain.
- sensors are assayed by their affinity for an operator DNA sequence, without a separate reporter being expressed, and/or by a change in this operator DNA affinity in the presence of a target chemical.
- this allows a pool of sensors to be evaluated initially for DNA binding capability in the absence of a target chemical by capture on immobilized DNA operator sequences (e.g. on beads, microarray chips, microfluidic device, flow cell, chromatography column), and then secondly evaluated for response to a target chemical by release from the immobilized DNA operator sequences.
- immobilized DNA operator sequences e.g. on beads, microarray chips, microfluidic device, flow cell, chromatography column
- This reporter-free strategy to evaluate sensors is facilitated by coupling the sensor protein to the mRNA transcript encoding its translation, either by association with stalled ribosomes as in ribosome display (see Hanes, et al. PNAS. 1997; 94(10):4937-4942.) or through covalent linkage as in mRNA display (see Wilson et al. PNAS.
- both dimers encode the same monomer sequence, as a single chain that would greatly favor homodimerization rather than heterodimerization of different mutants within a large mutant pool.
- the engineered monomer is coupled to a wild type monomer to create a heterodimeric single chain.
- the engineered protein sensor and/or switch such as an aTF, and nucleic acids comprising the aTF in addition to a candidate reporter gene system contacting an in vitro transcription and translation (IVTT) mixture and detection reagent results in the generation of a reporter protein upon ligand binding.
- the engineered protein sensor and/or switch such as an aTF
- a reporter is generated using an acellular method, e.g. IVTT.
- the reaction mixture can then be interrogated by the reporter response where the reporter response is indicative of target molecule binding to the allosteric DNA-binding protein sensor and/or switch.
- the present invention relates to compositions and methods for detecting a target molecule, optionally cellularly or acellularly, using an engineered protein sensor and/or switch, such as an aTF, which is produced with cellular or acellular methods, such as in vitro transcription and translation (IVTT) as described herein.
- the detection is acellularly, e.g. by employing methods such as in vitro transcription and translation (IVTT) to detect a reporter that is allosterically linked to the engineered protein sensor and/or switch, such as an aTF.
- the engineered protein sensor and/or switch, such as an aTF can optionally be produced acellularly or within the cell.
- the engineered protein sensor and/or switch, such as an aTF detects target molecule binding via acellular methods, for instance the production of a detectable reporter via an acellular method, e.g. IVTT.
- Useful reporters include proteins with unique spectral signatures, such as, without limitation, green fluorescent protein whose expression may be determined using a microtiter plate fluorimeter, visual inspection, or a fluorescence activated cell sorter (FACS). Reporters also include, without limitation, spectral signatures based on absorbance, physical properties such as magnetism and impedance, changes in redox state, assayable enzymatic activities, such as a phosphatase, beta-galactosidase, peroxidase, luciferase, or gas generating enzymes. Alternatively, a linear single or double stranded DNA that encodes the reporter and transcription factor library member may be used as a reporter in cases not limited to amplification by polymerases.
- proteins with unique spectral signatures such as, without limitation, green fluorescent protein whose expression may be determined using a microtiter plate fluorimeter, visual inspection, or a fluorescence activated cell sorter (FACS). Reporters also include, without limitation,
- the present invention includes a reporter gene system, which comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- Illustrative reporter systems detection methods include, but are not limited to, those using chemiluminescent or fluorescent proteins, such as, for example, green fluorescent protein (GFP), enhanced green fluorescent protein (EGFP), Renilla Reniformis green fluorescent protein, GFPmut2, GFPuv4, yellow fluorescent protein (YFP), enhanced yellow fluorescent protein (EYFP), cyan fluorescent protein (CFP), enhanced cyan fluorescent protein (ECFP), enhanced blue fluorescent protein (EBFP), chromoproteins, citrine and red fluorescent protein from discosoma (dsRED), infrared fluorescent proteins, luciferase, umbelliferone, rhodamine, fluorescein, dichlorotriazinylamine fluorescein, dansyl chloride, phycoerythrin, and the like.
- detectable bioluminescent proteins include, but are not limited to, luciferase (e.g., bacterial, firefly, click beetle and the like), luciferin, aequorin and the like.
- detectable enzyme systems include, but are not limited to, galactosidases, glucorinidases, phosphatases, peroxidases, cholinesterases, proteases, and the like.
- the reporter systems detection methods include an enzyme.
- the detectable marker is a non-essential gene that can be assayed rapidly for genetic variation by qPCR.
- the detectable marker is a drug resistance marker that can be readily assessed for functionality by reverse selection.
- the detectable marker is a nutritional marker, e.g. production of a required metabolite in an auxotrophic strain, ability to grow on a sole carbon source, or any other growth selection strategy known in the art.
- the reporter is composed of two or more components which when present together produce the functional reporter.
- examples include split GFPs, and enzymes such as luciferase, beta galactosidase, beta lactamase, and dihydrofolate reductase.
- One or more components of a split reporter may be introduced exogenously allowing detection of cellular production of fewer components.
- the split reporter may be can be used to detect split reporter-fused to another protein allowing detection either inside the cell, outside the cell, or both.
- a split GFP fusion protein may be excreted by a cell encapsulated with the complementing reporter component such that the producing cell does not have the capacity to produce a functional reporter until encapsulated with its complement.
- One or more components of such a split systems may be produced independently and added as a detection reagent to the cells being assayed.
- beta-glucosidase and Antarctic phosphatase may be used as reporter systems with their corresponding fluorogenic substrates fluorescein di-(p-D-glucopyranoside) and fluorescein diphosphate ( FIG. 7 , FIG. 8 ).
- the binding event of the aTF itself is utilized to present a physical readout of aTF state through either optical or nonoptical methods in an acellular environment.
- the aTF is linked to a fluorescent protein and the DNA binding site is linked to a quencher molecule. Fluorescent readout is possible only when the aTF is released from the DNA binding site itself. This method allows for a direct readout of aTF binding events. This strategy is not limited to fluorophore quencher pairs, but may also employ other read outs such as split proteins.
- the binding event may be used to physically separate functional proteins from non-functional proteins in the case of protein display methods.
- the engineered protein sensor and/or switch detects target molecule binding via acellular methods, for instance by controlling the activity of a polymerase that directly amplifies the genotype of the functional sensor and/or switch.
- the polymerase may either be a DNA or RNA polymerase that either amplifies the RNA and/or DNA versions of the genotype ( FIG. 2 , FIG. 3 , FIG. 4 ).
- the present methods include various detection techniques, e.g. for reporter signal.
- detection techniques may involve a microscope, a spectrophotometer, a fluorometer, a tube luminometer or plate luminometer, x-ray film, magnetic fields, a scintillator, a fluorescence activated cell sorting (FACS) apparatus, a microbial colony picker (e.g., QPix), a microfluidics apparatus, a bead-based apparatus or the like.
- strains engineered for protein secretion may be assayed for secretion by fusing a split reporter, such as GFP, to the secreted protein and assaying in cell-free compartments.
- a split reporter such as GFP
- Useful cell-free compartments include without limitation standard growth fermenters, flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, microdroplets generated either in bulk ( FIG. 2 ) or microfluidically ( FIG. 3 and FIG. 4 ).
- Bulk emulsions may be formed without limitation using the BioRad droplet oil for supermixes or a suitable such as mineral oil and span 80 or fluorinated oils such as HFE7500 and a fluorinated surfactant ( FIG. 2 , panel a). Droplet diameters may range from 1 um to 500 um without limitation. Microfluidic emulsions may be formed without limitation using commercial fluorophilic chips or house-made PDMS chips with a hydrophobic surface with the HFE7500 fluorinated oil and Dolomite's proprietary PicoSurf surfactant ( FIG. 3 ). Other commercially available chips, oils, and surfactants may be used as well as noncommercial chips and oil-surfactant mixes.
- a single commercial Dolomite chip can produce droplets at a rate of ⁇ 20 kHz allowing the production of up to 576, 000, 000 droplets from a single chip in a single workday.
- This assay is amenable to parallel droplet formation for improved throughput.
- Microfluidically generated water-in-oil emulsions are monodisperse and stable for >7 days at 37° C.
- Droplet diameters may range from 1 um to 500 um without limitation. Droplets may also be generated inside of tubes using an air interface to separate droplets. In this strategy, both pressures and atmospheric compositions may be controlled inside of the droplets.
- water-in-oil droplets may be utilized to compartmentalize a single E. coli cell overexpressing a unique aTF ( FIG. 2 , panel a, FIG. 3 , panel a, and FIG. 5 , panel a).
- the library diversity in other words the number of unique E. coli capable of being screened—is limited to the number of droplets produced.
- Each compartment also contains the effector (ligand) of interest regulating aTF activity, a polymerase reporter gene or promoter upstream of the aTF gene under the control of the aTF operator site, IVT or IVTT reagents as needed, as well as a chemical or enzymatic lytic agent.
- a pool of E. coli containing a library of engineered aTFs are encapsulated and the E. coli cells are lysed releasing the aTFs.
- aTFs bound to the operator site directly upstream a reporter DNA polymerase gene that prevents IVTT of the reporter polymerase. Any DNA polymerase may be used.
- aTFs responsive to the effector of interest release the DNA allowing IVTT of the polymerase.
- aTFs unresponsive to the effector of interest repress IVTT and therefore production of the polymerase ( FIG. 4 ).
- droplets are immediately amplified by PCR using aTF specific primers. Functional aTFs that produce more polymerase are enriched over their non-functional counterparts ( FIG.
- Amplicons are cloned into the correponding expression vector, transformed back into the E. coli strain, and plated on solid support. Colonies may be scraped from the solid support and grown in liquid for subsequent rounds of enrichment or colonies or picked as isolates for screening. Unique colonies containing functional aTF genes picked from plates may be tested for activity. Activity is tested with lysate in 96 or 384 well blocks using fluorescent assays or using microfluidic droplet-based assays.
- a pool of E. coli containing a library of engineered aTFs are encapsulated and the E. coli cells are lysed releasing the aTFs.
- aTFs bound to the operator site directly upstream of the aTF gene prevent transcription by an RNA polymerase. Any RNA polymerase may be used.
- aTFs responsive to the effector of interest release the DNA allowing RNA transcription of the aTF gene.
- aTFs unresponsive to the effector of interest repress transcription and therefore amplification of the aTF genotype ( FIG. 4 ).
- Subsequent breaking of the droplets and recovery of the RNA followed by RT-PCR with aTF specific primers rapidly amplifies the genotype of functional aTFs.
- Amplicons are cloned into the correponding expression vector, transformed back into the E. coli strain, and plated on solid support. Colonies may be scraped from the solid support and grown in liquid for subsequent rounds of enrichment or colonies or picked as isolates for screening. Unique colonies containing functional aTF genes picked from plates may be tested for activity. Activity is tested with lysate in 96 or 384 well blocks using fluorescent assays or using microfluidic droplet-based assays.
- a method of the invention comprises microencapsulating an individual cell, e.g. a bacterium, hosting the library plasmid with lysis reagent, IVTT mixture, the target molecule, and, if using a reporter enzyme system, substrate using one or more microfluidic devices (see Zinchenko, et al. Analytical Chem. 2014.86:2526-2533 and A. Fallah-Araghi, et al. Lab Chip. 2012. 12: 882-891, the contents of which are hereby incorporated by reference in their entireties). Following conditions suitable for cell lysis the microdroplets are incubated at conditions suitable for IVTT. They are then incubated for the appropriate time to develop the reporter protein.
- library members which produce a desired response are isolated from those that do not using a microfluidic device or FACS ( FIG. 5 , panels a and b).
- the plasmids of the positive responders are purified from the microdroplets, amplified and re-transformed into host bacterium for sequencing and clonal functional testing as described herein.
- sensors and/or switches may be screened for a desired activity inside of water-in-oil-in-water emulsions.
- the water-in-oil emulsions are formed microfluidically.
- Microfluidic double emulsions may be formed using Dolomite commercial chips or house-made PDMS chips with the HFE7500 fluorinated oil and Dolomite's proprietary PicoSurf surfactant ( FIG. 5 , panels c-e).
- Dolomite commercial chips or house-made PDMS chips with the HFE7500 fluorinated oil and Dolomite's proprietary PicoSurf surfactant ( FIG. 5 , panels c-e).
- Other commercially available chips, oils, and surfactants may be used as well as noncommercial chips and oil-surfactant mixes.
- Double emulsions may be formed in two steps ( FIG. 5 , panels c-e).
- the first emulsion is made using a Domolomite commercial fluorophilic chip and the second is with a hydrophilic chip.
- PDMS chips sufficiently oxidized to have a hydrophobic surface may supplement the first Dolomite chip while a newly plasma treated chip with a hydrophilic coating may replace the second chip.
- the PDMS chip may be treated with PVA or an alternative reagent to bear a semi-permanent hydrophilic surface.
- a single commercial Dolomite chip can produce droplets at a rate of ⁇ 20 kHz allowing the production of 576, 000, 000 droplets from a single chip in a single workday.
- Microfluidically generated water-in-oil emulsions are monodisperse and stable for >7 days at 37° C.
- the second emulsification takes place at half the rate to prevent droplet shearing.
- Double emulsions are stable for >7 days at 37° C.
- Double emulsions may also be produced in a single step using custom PDMS chips ( FIG. 6 ).
- the first emulsion directly precedes the formation of the second emulsions on the same chip. This process circumvents the need to produce two independent emulsions but proceeds at a rate 25% that of the single emulsion step.
- water-in-oil-in-water droplets are utilized to compartmentalize a single E. coli cell overexpressing a unique aTF ( FIG. 5 , panel a).
- the number of unique E. coli capable of being screened is limited to the amount of unique droplets being made.
- Inside of each compartment is also the effector (ligand) of interest regulating aTF activity, a reporter enzyme gene under the control of the aTF operator site, a fluorogenic substrate as described above, additional lysate as needed, as well as a chemical or enzymatic lytic agent.
- the E. coli cells are lysed releasing the aTFs.
- aTFs bind to the operator site preventing the expression of the reporter enzyme.
- aTFs responsive to the effector of interest release the DNA allowing expression of the reporter enzyme.
- aTFs unresponsive to the effector of interest repress reporter enzyme expression.
- the enzyme converts the substrate from a non-detectable to a detectable state ( FIG. 5 , panel b).
- Droplets containing functional aTFs will allow for the production of sufficient signal to enable separation using a suitable method. Once sorted, plasmids encoding the functional aTFs are transformed into the desired E. coli strain and plated. Colonies are scraped from the plate and grown in liquid for subsequent rounds of screening.
- a lytic plasmid contains a replication origin (e.g. ColE1), selectable marker (e.g. AMP), an IVTT transcribable (e.g. T7) reporter gene (e.g. alkaline phosphatase, AP) under control of the design aTF operator (e.g. TetO), Lacl, lacO controlled lytic system (e.g. T4 holin and T4 lysozyme), and the design aTF (e.g. TetR).
- aTF operator e.g. TetO
- Lacl e.g. T4 holin and T4 lysozyme
- T4 lysozyme e.g. TetR
- a library of aTF designs is created and transformed into an E. coli strain which has no IVTT (e.g. T7) polymerase and in which alkaline phosphatase is deleted from the genome.
- a growing culture of these bacteria is washed in a buffer and passed through a microfluidic device at conditions which encapsulated a reagent stream and, on average, about one bacterium per microdroplet.
- the reagent stream includes IPTG (without wishing to be bound by theory, to induce self lysis by the lytic system), IVTT reagents, the target molecule against which the aTF is designed, and the AP substrate fluorescein diphosphate (FDP).
- the microdroplets are encapsulated in a second microfluidic device to produce a population of water stable double emulsion microdroplets.
- microdroplets are then incubated to allow bacterial lysis, transcription and translation of AP if the TetR library member recognizes target molecule, and development of fluorescein from the FDP.
- Bright (positive) microdroplets are sorted from dim microdroplets using a FACS machine.
- the pool of positive droplets is dissolved with an organic solvent to release the contents of the positive droplets and the mixture of positive TetR genes are amplified using PCR.
- the positive TetR mixture is then cloned back into the plasmid backbone and retransformed into the host E. coli strain, and grown under selection. This positive library is then put through the process again to confirm the results, with the possibility to alter the concentration of the target molecule to identify more or less sensitive library members ( FIG. 5 ).
- Recovered confirmed positive plasmids are then again amplified, cloned, and transformed into the host strain and grown clonally.
- Clonal sensor plasmids are then characterized once again, for instance by repetition of the present microencapsulation system or other techniques (e.g. to measure in bulk), by looking at their response to a range of concentrations of the target molecule.
- the sequence of TetR clones with the desired properties are then determined.
- the target sensor can then be cloned into its working context for strain optimization or genome engineering or other downstream use.
- lysis may also be effected using an inducible cell lytic system encoded on the host cell genome, a separate plasmid, or encoded on the library plasmid itself (Morita, et al. Biotechnol. Prog. 2001. 17(3):573-6, the entire contents of which are hereby incorporated by reference).
- the lysis inducer is included with the IVTT mixture, target molecule, and other required substrates depending on the reporter system being used.
- Inducible lytic systems often include one or more phage proteins such as, for example, psi X174 E protein (Henrich Mol. Gen. Genet. 1982. 185(3)493-7, the entire contents of which are hereby incorporated by reference or T4 holin and lysozyme.
- Microfluidic chip designs are not limited to those presented above.
- double emulsions are generated in one step ( FIG. 6 ).
- chips made with PDMS and external aqueous phase channels treated with 1% PVA may be used to form double emulsion droplets in a single step with the HFE7500 and fluorinated surfactant.
- Other oil and surfactant combinations may be utilized.
- the internal aqueous phase is coflowed with 2 streams of oil-surfactant in which they are encapsulated by the external aqueous phase.
- This chip design results in both droplets being formed in a single pinch-flow interface.
- individual sensors might be assayed by enclosing each one in emulsion-type droplets. For example, this may be facilitated by merging two or more droplets or types of droplets (e.g. containing different DNA sequences or enzymes or chemicals) in a microfluidic device. Droplets may also be assessed and sorted on-chip using techniques like but not limited fluorescence activated droplet sorting (FADS) or absorbance activated droplet sorting (AADS).
- FFADS fluorescence activated droplet sorting
- AADS absorbance activated droplet sorting
- a cell or cells hosting the cellularly or acellularly derived sensor system is coencaspulated with a metabolically engineered cell or cells, or “producing strain, ” having been engineered by one or more of the methods described herein, designed to produce the target molecule capable of being detected by the sensor system.
- a metabolically engineered cell or cells, or “producing strain, ” having been engineered by one or more of the methods described herein, designed to produce the target molecule capable of being detected by the sensor system.
- the producing strain constitutively exports the sensed molecule into its growth medium creating the case where a high producing and low producing strain both have the same intracellular concentration of the molecule of interest but the medium of the high producing strain has a greater concentration.
- the detector strain may be used to discern high from low producers.
- the present invention includes the use of multiple droplets containing whole or lysed cells from different hosts.
- a first droplet comprises whole or lysed cells with an engineered sensor while a second droplet comprises whole or lysed cells, “producer strains”, with the target molecule (e.g. host cells that are engineered to produce a target molecule as described elsewhere herein).
- the first droplet comprising whole or lysed cells with an engineered sensor is used to detect production of a target molecule in a different host (in the form of whole or lysed cells in a droplet). As such, inter a/ia, this permits detection of the target molecule at levels that are beyond what could be undertaken if the engineered sensor were present solely in the host cells that are engineered to produce a target molecule.
- transcription/translation of the sensor and/or the reporter it controls are driven by in vitro transcription and translation (IVTT), as described in Zubay. Ann. Rev. Genet. 1973.7:267-287, the entire contents of which are hereby incorporated by reference in their entirety or TX-TL as described in Shin and Noireaux, J Biol. Eng. 4, 8 (2010) and US Patent Publication No. 2016/0002611, the entire contents of which are hereby incorporated by reference in their entireties.
- Microencapsulation of single producers, either harboring the sensor machinery or coencapsulated with sensor cells is also a useful technique in cases where the molecule is highly diffusible across the cell membrane, making screening in batch liquid culture impossible.
- cells are lysed in one microdroplet which is then merged with a second microdroplet containing the reagents required for IVT or IVTT.
- DNA encoding a single sensor library member is captured on a bead and encapsulated in a microdroplet (see Dressman, et al. PNAS 2003 100(15):8817-8822), such that it may be amplified and/or expressed through IVTT.
- the droplet is then merged with reporter reagents for response interrogation. This may be beneficial when the aTF is not expressible and/or expressed in a functional state in suitable screening systems.
- DNA encoding a reporter gene is captured on a bead and encapsulated in a microdroplet, such that it may be amplified and/or expressed through IVTT.
- the droplet is then merged with reporter reagents for response interrogation.
- the transcription factor library resides on one plasmid while the reporter gene system resides on a second plasmid.
- the effective concentration of reporter gene to sensor library members may be adjusted to facilitate identification of active library members. This is useful where simply using higher versus lower promoter strength is not enough control, for instance.
- the reporter system is encoded in the host genome.
- the DNA encoding the reporter is present only in the droplet containing the reagents required for IVT or IVTT, and the DNA encoding the sensor is present in the other droplet.
- the DNA encoding the sensor is present only in the droplet containing the reagents required for IVT or IVTT, and the DNA encoding the reporter is present in the other droplet.
- the present invention includes the use of multiple droplets containing whole or lysed cells from different hosts.
- a first droplet comprises whole or lysed cells with an engineered sensor while a second droplet comprises whole or lysed cells with the target molecule (e.g. host cells that are engineered to produce a target molecule as described elsewhere herein).
- the first droplet comprising whole or lysed cells with an engineered sensor is used to detect production of a target molecule in a different host (in the form of whole or lysed cells in a droplet). As such, inter alia, this permits detection of the target molecule at levels that are beyond what could be undertaken if the engineered sensor were present in the host cells that are engineered to produce a target molecule.
- the present methods are designed to delay the creation of the reporter message relative to the designed aTF; an approach which enables concentrations of the designed aTF protein to reach the level required to repress transcription of the reporter.
- the reporter transcription is controlled by two repressors which recognize separate operator sites on the reporter gene's promoter region. The reporter transcription is thus suppressed in the IVTT system until both transcription factors bind an inducing molecule. This permits, inter a/ia, delaying transcription of the reporter message until a sufficient concentration of the engineered aTF is built up in the IVTT mix to allow detection of its response to its non-cognate target ligand.
- a library of TetR designs is produced with candidate designs to alter ligand specificity from, e.g., tetracycline to a target molecule, such as curcumin.
- the TetR gene is driven by a promoter recognized by the IVTT but not the host cell, such as T7.
- the reporter gene is similarly driven by a promoter recognized by the IVTT and modulated by both Tetracyline and Lacl operators (TetO and LacO in FIG. 1 ).
- TetO and LacO Tetracyline and Lacl operators
- the present methods are extended to include any substrate that is changed into an inducing molecule, for example IPTG in the case of Lacl, whose concentration is gradually increased through an enzymatic activity.
- IPTG in the case of Lacl
- One advantage of this approach is that a single mixture containing the non-cognate target ligand, substrate, IVTT, and lysis system reduces the number of components that need to be combined. In its final state, the multiple repressor system only allows the creation of reporter message and thus reporter protein when the engineered protein candidate is modulated by the non-cognate target ligand.
- the effective concentration of the non-engineered repressor may be lowered by targeted degradation, by, for example, proteases.
- the non-engineered repressor may be sensitive to additional treatments. For example, it may denature or become inactive when, for example, one or more of temperature, pH, ionic strength, and charge, is altered (e.g. raised or lowered). Additionally or alternatively, in various embodiments, the non-engineered repressor may be sensitive to additional treatments, such that it denatures or becomes inactive when in the presence of light.
- the reporter message may be made to be unstable in the absence of a stabilizing agent, whereupon the stabilizing reagent is added either together with or subsequent to the addition of the IVTT and/or lysis reagents.
- a rapidly degrading reporter can be utilized to enhance the distinction between the response range of sensors that are responding to the target molecule.
- the present invention relates to compositions and methods for detecting, optionally acellularly, a target molecule using an engineered protein sensor and/or switch, such as an aTF, which is optionally detected for the desired functionality with acellular methods, such as in vitro transcription (IVT) or in vitro transcription and translation (IVTT) as described herein.
- IVTT in vitro transcription
- IVTT in vitro transcription and translation
- the detection of a target molecule is in a cell, such as any of those described herein, which has been manipulated to produce the target molecule.
- the present invention allows for engineering or use of a protein sensor and/or switch for which the protein sensor and/or switch's natural promoter and/or operator does not function suitably in a host cell.
- the invention provides transfer of a functional operator site from one organism to another. For instance, such transfer is applicable to the present cell-free senor engineering as described herein and the use of an engineered sensor in a host cell (e.g. to detect production of a target molecule).
- the present invention allows for the introduction of protein sensors and/or switches, e.g. aTFs, from a variety of organisms and the operation of the present sensing in a variety of host organisms, including those particularly desired for metabolic engineering, such as any of the host cells described herein.
- An illustrative method to transfer a functional operator site from one organism to another, such organisms may be selected from the cells described herein, is to clone the intergenic region immediately upstream of a gene regulated by the protein sensor and/or switch, e.g. aTF, of interest immediately upstream of reporter gene that is carried in the desired host organism.
- a gene regulated by the protein sensor and/or switch e.g. aTF
- This na ⁇ ve approach assumes that the transcriptional promoter will also function in the host organism. Assuming no host repressors recognize the exogenous operator site once cloned, the reporter will be constitutively on until expression of the regulator protein in a mode to bind its operator and repress the reporter signal.
- the basic approach has the advantage of, among others, not needing any information about the actual DNA sequence of the operator site but may suffer from the fact that the intergenic region cloned may have a promoter region incompatible with the new host organism.
- an operator sequence may be cloned into a promoter region known to function in the host organism between the transcriptional promoter and ribosome binding site.
- operator sequences are longer than the allowable sequence space between the promoter and RBS sites. In such cases the operator may be placed 5′ or 3′ to the promoter site.
- the operator consists of two regions of DNA separated by some number of bases. In such cases, it may be advantageous to flank either or both the promoter and/or RBS site with the operator binding sequence.
- multiple sets of operator sites may by introduced in the promoter RBS region to increase the number of binding aTFs to more than 1.
- synthetic promoter/operators allow the aTF to function in any organism for which the promoter/RBS paradigm is maintained, including eukaryotes such as yeast.
- the aTF may be expressed as a fusion with a nuclear localization signal.
- the synthetic promoter/operators also function in the context of IVTT so long as the promoter and RBS are recognized by the IVTT system. RBS may be replaced by internal ribosome entry sites for translation initiation.
- the present invention allows for engineering a host cell to produce a target molecule and the target molecule is detected or detectable using one or more of the engineered protein sensor and/or switch.
- cells are engineered with a multiplex genome engineering technique (e.g.
- a method involving a double-strand break (DSB) or single-strand break or nick which can be created by a site-specific nuclease such as a zinc-finger nuclease (ZFN) or TAL effector domain nuclease (TALEN) or BurrH binding domain (BuD)-derived nucleases, or CRISPR/Cas9 system with an engineered crRNA/tracrRNA (or synthetic guide RNA) to guide specific cleavage (see, e.g., U.S.
- a site-specific nuclease such as a zinc-finger nuclease (ZFN) or TAL effector domain nuclease (TALEN) or BurrH binding domain (BuD)-derived nucleases
- ZFN zinc-finger nuclease
- TALEN TAL effector domain nuclease
- BuD BurrH binding domain
- ssDNA recombinase system which may include a single-stranded annealing protein (SSAP), such as the A Red recombineering system (e.g., Beta protein) or RecET system (e.g., recT), or homologous system, including Rad52-like (of which A Red Beta, Sak, and Erf are members), Rad51-like (e.g., Sak4), and Gp2.5-like, each with distinct sequence profiles and folds.
- SSAP single-stranded annealing protein
- a Red recombineering system e.g., Beta protein
- RecET system e.g., recT
- homologous system including Rad52-like (of which A Red Beta, Sak, and Erf are members), Rad51-like (e.g., Sak4), and Gp2.5-like, each with distinct sequence profiles and folds.
- the engineered protein sensor and/or switch is an aTF, for instance a eukaryotic aTF.
- engineered protein sensor and/or switch is an engineered version of a prokaryotic transcriptional regulator family such as a member of the LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp families.
- engineered protein sensor and/or switch is an engineered version of a prokaryotic transcriptional regulator family such as a member of the AbrB, AlpA, AraC, ArgR, ArsR, AsnC, BetR, Bhl, CitT, CodY, ComK, Crl, Crp, CsoR, CtsR, DeoR, DnaA, DtxR, Ecf, FaeA, Fe_dep_repress, FeoC, Fis, FlhC, FlhD, Fur, GntR, GutM, Hns, HrcA, HxIR, IcIR, KorB, Lacl, LexA, Lsr2, LuxR, LysR, LytTR, MarR, MerR, MetJ, Mga, Mor, MtIR, NarL, NtrC, OmpR, PadR, Prd, PrrA, PucR, PuR, Rok, Ros_MucR, RpiR, RpoD, R
- engineered protein sensor and/or switch is an engineered version of a member of the TetR family of receptors, such as AcrR, ActIl, AmeR AmrR, ArpR, BpeR, EnvR E, EthR, HydR, IfeR, LanK, LfrR, LmrA, MtrR, Pip, PqrA, QacR, RifQ, RmrR, SimReg, SmeT, SrpR, TcmR, TetR, TtgR, TtgW, UrdK, VarR, YdeS, ArpA, Aur1B, BarA, CalR1, CprB, FarA, JadR, JadR2, MphB, NonG, PhIF, TyIQ, VanT, TarA, TyIP, BM1P1, Bm1P1, Bm3R1, ButR, CampR, CamR, CymR, DhaR, KstR, LexA-like, Acn
- the engineered protein sensor and/or switch may be an engineered version of a two-component or hybrid two-component system that directly bind both a ligand and DNA or work through a protein cascade.
- the engineered protein sensor and/or switch is an aTF, for instance a eukaryotic aTF.
- engineered protein sensor and/or switch is an engineered version of RovM ( Yersinia pseudotuberculosis ), HcaR ( Acinetobacter ), BIcR ( Agrobacterium tumefaciens ), HetR (Anabaena spp.), HetR (Anabaena spp.), DesR ( B.
- Bacillus subtilis HyllIR ( Bacillus cereus ), PlcR ( Bacillus cereus ), CcpA ( Bacillus megaterium ), YvoA ( Bacillus subtilis ), AhrR ( Bacillus subtilis ), MntR ( Bacillus subtilis ), GabR ( Bacillus subtilis ), SinR ( Bacillus subtilis ), CggR ( Bacillus subtilis ), FapR ( Bacillus subtilis ), OhrR ( Bacillus subtilis ), PurR ( Bacillus subtilis ), Rrf2 ( Bacillus subtilis ), BmrR ( Bacillus subtilis ), CcpN repressor ( Bacillus subtilis ), TreR ( Bacillus subtilis ), CodY ( Bacillus subtilis ), yfiR ( Bacillus subtilis ), OhrR ( Bacillus subtilis ), Rex ( Bacillus subtilis, Thermus thermophilus, Thermus aquaticus ), NprR ( Bacillus
- engineered protein sensor and/or switch is an engineered version of MphR, AlkS, AlkR, CdaR, BenM, RUNX1, MarR, AphA, Pex, CatM, AtzR, CatR, ClcR, CbbR, CysB, CbnR, OxyR, OccR, and CrgA.
- engineered protein sensor and/or switch is an engineered version of aN E. coli TF, such as ArcA, AtoC, BaeR, BasR, CitB, CpxR, CreB, CusR, DcuR, DpiA, EvgA, KdpE, NarL, NarP, OmpR, PhoB,
- aN E. coli TF such as ArcA, AtoC, BaeR, BasR, CitB, CpxR, CreB, CusR, DcuR, DpiA, EvgA, KdpE, NarL, NarP, OmpR, PhoB,
- the engineered protein sensor and/or switch is an engineered version of a plant transcriptional regulator family such as a member of the AP2, C2H2, Dof, LATA, HD-ZIP, M-type, NF-YA, S1Fa-like, TCP, YABBY, ARF, C3H, E2F/DP, GRAS, HRT-like, MIKC, NF-YB, SAP, Trihelix, ZF-HD, ARR-B, CAMTA, EIL, GRF, HSF, MYB, NF-YC, SBP, VOZ, bHLH, B3, CO-like, ERF, GeBP, LBD, MYB _related, NZZ/SPL, SRS, WOX, bZIP, BBR-BPC, CPP, FAR1, HB-PHD, LFY, NAC, Nin-like, STAT, WRKY, BES1, DBB, G2-like, HB-other, LSD, NF
- the engineered protein sensor and/or switch is an engineered version of a yeast TF, such as Abf1p, Abf2p, Aca1p, Ace2p, Adr1p, Aft1p, Aft2p, Arg80p, Arg81p, Aro80p, Arr1p, Asg1p, Ash1p, Azf1p, Bas1p, Cad1p, Cat8p, Cbf1p, Cep3p, Cha4p, Cin5p, Crz1p, Cst6p, Cup2p, Cup9p, DaI80p, DaI81p, Dai82p, Dot6p, Ecm22p, Ecm23p, Eds1p, Ert1p, Fhl1p, Fkh1p, Fkh2p, Flo8p, Fzf1p, Gai4p, Gat1p, Gat3p, Gat4p, Gcn4p, Gcr1p, Gis1p, G
- the engineered protein sensor and/or switch is an engineered version of a nematode TF, such as ada-2, aha-1, ahr-1, alr-1, ast-1, atf-2, atf-5, atf-6, atf-7, athp-1, blmp-1, bra-2, brc-1, cbp-1, ccr-4, cdk-9, ced-6, ceh-1, ceh-10, ceh-12, ceh-13, ceh-14, ceh-16, ceh-17, ceh-18, ceh-19, ceh-2, ceh-20, ceh-21, ceh-22, ceh-23, ceh-24, ceh-26, ceh-27, ceh-28, ceh-30, ceh-31, ceh-32, ceh-33, ceh-34, ceh-36, ceh-37, ceh-38, ceh-39, ceh-40, ceh-41, ceh-43, ceh-44, ceh-
- the engineered protein sensor and/or switch is an engineered version of a B. subtilis TF, such as Abh, AbrB, AcoR, AdaA, AhrC, AlaR, AIsR, AnsR, AraR, ArfM, ArsR, AzIB, BirA, BkdR, BItR, BmrR, CcpA, CcpB, CcpC, CggR, CheB, CheV, CheY, CitR, CitT, CodY, ComA, ComK, ComZ, CssR, CtsR, DctR, DegA, DegU, DeoR, DnaA, ExuR, FNR, FruR, Fur, GabR, GerE, GIcK, GIcR, GIcT, GInR, GIpP, GItC, GItR, GntR, GutR, Hbs, Hpr, HrcA, HtrA, Hut
- the engineered protein sensor and/or switch is an engineered version of a Arabidopsis thaliana TF, such as AT1G01060, AT1G01380, AT1G01530, AT1G02340, AT1G04370, AT1G06160, AT1G07640, AT1G09530, AT1G09770, AT1G10170, AT1G12610, AT1G12860, AT1G12980, AT1G13960, AT1G14350, AT1G14920, AT1G15360, AT1G16490, AT1G18570, AT1G19220, AT1G19350, AT1G19850, AT1G21970, AT1G22070, AT1G23420, AT1G24260, AT1G24590, AT1G25560, AT1G26310, AT1G26870, AT1G26945, AT1G27730, AT1G28300, AT1G30210, AT1G30330, AT1G
- the engineered protein sensor and/or switch is an engineered version of a Drosophila melanogaster TF, such as CG10325, CG11648, CG6093, CG3796, CG9151, CG15845, CG3935, CG3166, CG8376, CG3258, CG6677, CG3629, CG1034, CG3578, CG11491, CG12653, CG1759, CG6384, CG11924, CG4881, CG8367, CG17894, CG8669, CG2714, CG5893, CG9745, CG5102, CG2189, CG33183, CG9908, CG10798, CG1897, CG11094, CG2711, CG10604, CG32346, CG5714, CG1765, CG7383, CG32180, CG8127, CG1007, CG2988, CG9015, CG14941
- the engineered protein sensor and/or switch is an engineered version of a mouse TF, such as mouse loci 11538, 11568, 11569, 11614, 11622, 11624, 11632, 11634, 11694, 11695, 11733, 11736, 11819, 11835, 11859, 11863, 11864, 11865, 11878, 11906, 11908, 11909, 11910, 11911, 11920, 11921, 11922, 11923, 11924, 11925, 11991, 12013, 12014, 12020, 12021, 12022, 12023, 12029, 12051, 12053, 12142, 12151, 12173, 12180, 12189, 12192, 12224, 12265, 12326, 12355, 12387, 12393, 12394, 12395, 12399, 12400, 12416, 12417, 12418, 12454, 124
- Protein sensor and/or switch amino acid sequences upon which engineering is to occur may, in various embodiments, be selected by sequence homology using one or more of BLASTP, PSI-BLAST, DELTA-BLAST, OR HMMER, JackHMMER, or the corresponding nucleotide sequences selected by sequence homology search.
- mutagenesis that alters the binding activity of an allosteric protein, e.g. making the allosteric protein suitable for binding the target molecule at the expense of the allosteric proteins cognate ligand (i.e. the ligand that binds to the wild type allosteric protein).
- mutagenesis comprises introducing one or more amino acid mutations, e.g. independently selected from substitutions, insertions, deletions, and truncations.
- the amino acid mutations are amino acid substitutions, and may include conservative and/or non-conservative substitutions.
- “Conservative substitutions” may be made, for instance, on the basis of similarity in polarity, charge, size, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the amino acid residues involved.
- the 20 naturally occurring amino acids can be grouped into the following six standard amino acid groups: (1) hydrophobic: Met, Ala, Val, Leu, Ile; (2) neutral hydrophilic: Cys, Ser, Thr; Asn, Gln; (3) acidic: Asp, Glu; (4) basic: His, Lys, Arg; (5) residues that influence chain orientation: Gly, Pro; and (6) aromatic: Trp, Tyr, Phe.
- “conservative substitutions” are defined as exchanges of an amino acid by another amino acid listed within the same group of the six standard amino acid groups shown above. For example, the exchange of Asp by Glu retains one negative charge in the so modified polypeptide.
- glycine and proline may be substituted for one another based on their ability to disrupt ⁇ -helices.
- non-conservative substitutions are defined as exchanges of an amino acid by another amino acid listed in a different group of the six standard amino acid groups (1) to (6) shown above.
- the substitutions may also include non-classical amino acids (e.g. selenocysteine, pyrrolysine, N-formylmethionine ⁇ -alanine, GABA and ⁇ -Aminolevulinic acid, 4-aminobenzoic acid (PABA), D-isomers of the common amino acids, 2,4-diaminobutyric acid, ⁇ -amino isobutyric acid, 4-aminobutyric acid, Abu, 2-amino butyric acid, ⁇ -Abu, ⁇ -Ahx, 6-amino hexanoic acid, Aib, 2-amino isobutyric acid, 3-amino propionic acid, ornithine, norleucine, norvaline, hydroxyproline, sarcosme, citrulline, homocitrulline, cysteic acid, t-butylglycine, t-butylalanine, phenylglycine,
- the present invention pertains to various target molecules, for which a protein sensor and/or switch may be engineered.
- Illustrative target molecules include one or more of the compounds described in WO 2015/017866, e.g. at paragraphs [00107]-[00112], the entire contents of which are hereby incorporated by reference in its entirety.
- the various target molecules of the invention are toxic to a cell and/or cannot be readily bind or interact with a protein sensor and/or switch in a detectable manner in a cellular environment.
- the protein sensor and/or switch is selected based on its cognate ligand identity and any commonality the cognate ligand may have with a target molecules.
- a shared chemical group between a cognate ligand and a target molecule may direct one to the protein sensor and/or switch which binds to the cognate ligand and lead to the engineering of the protein sensor and/or switch so it can bind to the target molecule.
- the present invention relates to antibiotics.
- various resistance mechanisms may be introduced into a producing cell. Without limitation, these may include enzymes which degrade or chemically render the antibiotic less toxic to the producing cell. Resistance to the antibiotics mechanism of action may be conferred by alterations introduced into the cellular context of the producing cell. For instance, the ribosome may be altered to avoid antibiotic binding and relieve inhibition of protein synthesis. A cell wall biosynthetic enzyme may be mutated to ablate antibiotic binding and relieve inhibition of cell wall biosynthesis. A pump which lowers the intracellular concentration may be expressed. A specific antibiotic binding protein may be expressed.
- the target molecule is an antibiotic (e.g. one which is lethal to a host cell).
- the antibiotic is a beta-lactam antibiotic, such as a penicillin, e.g., Penicillin, Amoxicillin, Ampicillin, Azlocillin, Carbenicillin, Cloxacillin, Dicloxacillin, Flucloxacillin, Mezlocillin, Methicillin, Nafcillin, Oxacillin, Penicillin G, Penicillin V, Piperacillin, Penicillin G, Temocillin, Ticarcillin.
- a penicillin e.g., Penicillin, Amoxicillin, Ampicillin, Azlocillin, Carbenicillin, Cloxacillin, Dicloxacillin, Flucloxacillin, Mezlocillin, Methicillin, Nafcillin, Oxacillin, Penicillin G, Penicillin V, Piperacillin, Penicillin G, Temocillin, Ticarcillin.
- the antibiotic is an Aminoglycoside, e.g., Amikacin, Gentamicin, Kanamycin, Neomycin, Netilmicin, Tobramycin, Paromomycin, Streptomycin, or Spectinomycin.
- the antibiotic is an Ansamycin, e.g., Geldanamycin, Herbimycin, or Rifaximin.
- the antibiotic is a penem such as faropenem or Ritipenem; or a Carbacephem such as Loracarbef; or a carbapenem such as Ertapenem, Doripenem, Imipenem/Cilastatin, or Meropenem.
- the antibiotic is an Cephalosporin, e.g., Cefadroxil, Cefazolin, Cefalotin or Cefalothin, Cefalexin (or cephalexin), Cefaclor, Cefamandole, Cefoxitin, Cefprozil, Cefuroxime, Cefixime, Cefdinir, Cefditoren, Cefoperazone, Cefotaxime, Cefpodoxime, Ceftazidime, Ceftibuten, Ceftizoxime, Ceftriaxone (IV and IM), Cefepime, Ceftaroline fosamil, Ceftobiprole, Ceftiofur, Cefquinome, or Cefovecin.
- Cefadroxil Cefazolin
- Cefalotin or Cefalothin Cefalexin (or cephalexin)
- Cefaclor Cefamandole
- Cefoxitin Cefprozi
- the antibiotic is a polypeptide, such as Bacitracin, Colistin, or Polymyxin B.
- the antibiotic is a Quinolone or Fluoroquinolone such as, e.g., Ciprofloxacin, Enoxacin, Gatifloxacin, Gemifloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Nalidixic acid, Norfloxacin, Ofloxacin, Trovafloxacin, Grepafloxacin, Sparfloxacin, or Temafloxacin.
- the antibiotic is a sulfonamide such as Mafenide, Sulfacetamide, Sulfadiazine, Silver sulfadiazine, Sulfadimethoxine, Sulfamethizole, Sulfamethoxazole, Sulfanilimide (archaic), Sulfasalazine, Sulfisoxazole, Trimethoprim, Trimethoprim-Sulfamethoxazole(Co-trimoxazole) (TMP-SMX), or Sulfonamidochrysoidine.
- a sulfonamide such as Mafenide, Sulfacetamide, Sulfadiazine, Silver sulfadiazine, Sulfadimethoxine, Sulfamethizole, Sulfamethoxazole, Sulfanilimide (archaic), Sulfasalazine, Sulfisoxazole, Trime
- the antibiotic is a Tetracycline, e.g., Demeclocycline, Doxycycline, Minocycline, Oxytetracycline, or Tetracycline.
- the antibiotic is a drug against mycobacteria, such as Clofazimine, Dapsone, Capreomycin, Cycloserine, Ethambutol(Bs), Ethionamide, Isoniazid, Pyrazinamide, Rifampicin (Rifampin in US), Rifabutin, Rifapentine, Streptomycin.
- the antibiotic is Arsphenamine, Chloramphenicol(Bs), Fosfomycin, Fusidic acid, Metronidazole, Mupirocin, Platensimycin, Quinupristin/Dalfopristin, Thiamphenicol, Tigecycline(Bs), Tinidazole.
- the antibiotic is teixobactin, or related molecules in this new class of antibiotics, which harm bacteria by binding lipid II and/or lipid III, which are important cell wall precursors.
- the protein sensor and/or switch is an engineered using design from existing allosteric proteins, e.g. aTFs.
- the designing comprises in silico design. Illustrative design principles are found in US 2016/0063177, the entire contents of which are hereby incorporated by reference in their entirety.
- molecular modeling is used to predict mutations in an allosteric protein which may render the allosteric protein able to bind one or more target molecules.
- reference to an experimentally derived three-dimensional protein structure typically obtained through experimental methods including, but not limited to, x-ray crystallography, nuclear magnetic resonance (NMR), scattering, or diffraction techniques, is employed to model and/or predict mutations in an allosteric protein which may render the allosteric protein able to bind one or more target molecule.
- the ROSETTA software suite is employed to assist with modelling (see Kaufmann et al. Biochemistry. 2010 Apr.
- a homology modeling algorithm such as ROBETTA, TASSER, I-TASSER, HHpred, HHsearch, or MODELLER, or SWISS-MODEL can be used.
- a homology modeling algorithm can be used to build the sequence homology models.
- one or more sequence or structural homologs have less than 90% amino acid sequence identity, less than 85% amino acid sequence identity, less than 80% amino acid sequence identity, less than 75% amino acid sequence identity, less than 70% amino acid sequence identity, less than 65% amino acid sequence identity, less than 60% amino acid sequence identity, less than 55% amino acid sequence identity, less than 50% amino acid sequence identity, less than 45% amino acid sequence identity, less than 40% amino acid sequence identity, less than 35% amino acid sequence identity, less than 30% amino acid sequence identity, less than 25% amino acid sequence identity, or less amino acid sequence identity to the amino acid sequence of the three-dimensional protein structure.
- Illustrative homology modelling methods and principles are found in US 2016/0063177, e.g. at paragraphs [0085]-[0093], the entire contents of which are hereby incorporated by reference in its entirety.
- a structure of an allosteric protein is evaluated for alterations which may render the allosteric protein able to bind one or more target molecules (e.g. by docking a one or more target molecules into the structure of an allosteric protein).
- Illustrative docking methods and principles are found in US 2016/0063177, e.g. at paragraphs [0095]-[0101], the entire contents of which are hereby incorporated by reference in its entirety.
- libraries of potential mutations to the allosteric protein are made and selection, positive or negative, is used to screen desired mutants.
- engineering may use the technique of computational protein design (as disclosed in U.S. Pat. No. 7,574,306 and U.S. Pat. No. 8,340,951, which are hereby incorporated by reference in their entirety) directed evolution techniques, rational mutagenesis, or any suitable combination thereof.
- mutation techniques such as gene shuffling, homologous recombination, domain swapping, deep mutation scanning, and/or random mutagenesis may be employed.
- Bacillus subtilis 2YAL, 3QQ6 peptides and proteins EthR something Mycobacterium 1T56 c4-c20 hydrophobic hydrophobic tuberculosis .
- the amino acids targeted for mutation or in silico design are those within about 3, or about 5, or about 7, or about 10, or about 12 Angstroms (e.g. between about 3 to about 12 Angstroms, or between about 5 to about 12 Angstroms, or between about 7 to about 12 Angstroms, or between about 10 to about 12 Angstroms, or between about 3 to about 5 Angstroms, or between about 3 to about 7 Angstroms, or between about 3 to about 10 Angstroms) of a ligand modeled into a binding pocket either through docking or by experimental methods such as X-ray crystallography.
- a ligand modeled into a binding pocket either through docking or by experimental methods such as X-ray crystallography.
- Mutated allosteric proteins that may be protein sensors and/or switches able to bind one or more target molecules can be screen using standard binding assays (e.g. fluorescent, radioactive assays, etc.).
- the protein sensor and/or switch is engineered as described in Taylor, et al. Nat. Methods 13(2): 177, the entire contents of which are hereby incorporated by reference in its entirety.
- the host cells of the present invention include eukaryotic and/or prokaryotic cells, including bacterial, yeast, algal, plant, insect, mammalian cells (human or non-human), and immortal cell lines.
- the host cell may be Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Saccharomyces castellii, Kluyveromyces lactis, Pichia stipitis, Schizosaccharomyces pombe, Chlamydomonas reinhardtii, Arabidopsis thaliana, or Caenorhabditis elegans.
- the host cell is a bacterial cell, such as Escherichia spp., Streptomyces spp., Zymonas spp., Acetobacter spp., Citrobacter spp., Synechocystis spp., Rhizobium spp., Clostridium spp., Corynebacterium spp., Streptococcus spp., Xanthomonas spp., Lactobacillus spp., Lactococcus spp., Bacillus spp., Pedobacter spp., Bacteroides spp., Alcaligenes spp., Pseudomonas spp., Aeromonas spp., Azotobacter spp., Comamonas spp., Mycobacterium spp., Rhodococcus spp., Gluconobacter spp., Rals
- the cell is a fungal cell such as a yeast cell, e.g., Saccharomyces spp., Schizosaccharomyces spp., Pichia spp., Paffia spp., Kluyveromyces spp., Candida spp., Talaromyces spp., Brettanomyces spp., Pachysolen spp., Debaryomyces spp., Yarrowia spp., and industrial polyploid yeast strains.
- yeast strain is a S. cerevisiae strain or a Yarrowia spp. strain.
- fungi include Aspergillus spp., Pennicilium spp., Fusarium spp., Rhizopus spp., Acremonium spp., Neurospora spp., Sordaria spp., Magnaporthe spp., Allomyces spp., Ustilago spp., Botrytis spp., and Trichoderma spp.
- Target cells can include transgenic and recombinant cell lines.
- heterologous cell lines can be used, such as Chinese Hamster Ovary cells (CHO).
- the host cell is an Actinomycetes spp. cell.
- Actinomycetes are a heterogeneous collection of bacteria that form branching filaments which include, for example, Actinomyces, Actinomadura, Nocardia, Streptomyces and related genera.
- Actinomyces comprise Streptomyces.
- the Actinomycetes spp. cell is a Streptomyces cell. (e.g. S. coelicolor ). Streptomyces include, by way of non-limiting example, S. noursei, S. nodosus, S. natalensis, S. venezuelae, S. roseosporus, S.
- the host cell is a Bacillus spp. cell.
- Bacillus spp. cell is selected from B. alcalophilus, B. alvei, B. aminovorans, B. amyloliquefaciens, B. aneurinolyticus, B. anthracis, B. aquaemaris, B. atrophaeus, B. boroniphilus, B. brevis, B. caldolyticus, B. centrosporus, B. cereus, B. circulans, B. coagulans, B. firmus, B. flavothermus, B. fusiformis, B. galliciensis, B. globigii, B. infernus, B. larvae, B.
- laterosporus B. lentus, B. licheniformis, B. megaterium, B. mesentericus, B. mucilaginosus, B. mycoides, B. natto, B. pantothenticus, B. polymyxa, B. pseudoanthracis, B. pumilus, B. schlegelii, B. sphaericus, B. sporothermodurans, B. stearothermophilus, B. subtilis, B. thermoglucosidasius, B. thuringiensis, B. vulgatis, and B. weihenstephanensis.
- the nucleic acid is provided to host cell by one or more of by electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- the polymerase traverses the template strand and uses base pairing with the DNA to synthesize a complementary RNA strand (using uracil in the place of thymine).
- the RNA polymerase travels from the 3 ⁇ 5′ end of the DNA template strand, to produce an RNA molecule in the 5 ⁇ 3′ direction. Further details are available in Rio, et al. RNA: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2011, 205-220, the contents of which are hereby incorporated by reference in their entirety.
- the most frequently used in vitro or cell-free translation systems consist of extracts from a biological source, e.g. rabbit reticulocytes, wheat germ, HeLa, and E. coli. All are typically prepared as crude extracts containing all the macromolecular components (e.g. 70 S or 80 S ribosomes, tRNAs, aminoacyl-tRNA synthetases, initiation, elongation and termination factors, etc.) required for translation of exogenous RNA. Extracts may be supplemented with amino acids, energy sources (e.g. ATP, GTP), energy regenerating systems (e.g.
- energy sources e.g. ATP, GTP
- energy regenerating systems e.g.
- the present invention employs “coupled” or “linked” IVTT. In various embodiments, the present invention employs IVTT in which the transcription and translation are not coupled, i.e. separate.
- RNA or DNA There are two approaches to in vitro protein synthesis based on the starting genetic material i.e. RNA or DNA.
- Standard translation systems such as reticulocyte lysates and wheat germ extracts, use RNA as a template; whereas “coupled” and “linked” systems start with DNA templates, which are transcribed into RNA then translated. Either is suitable for use in the invention described herein.
- Rabbit reticulocyte lysate is a highly efficient in vitro eukaryotic protein synthesis system used for translation of exogenous RNAs (either natural or generated in vitro).
- reticulocytes are highly specialized cells primarily responsible for the synthesis of hemoglobin and these immature red cells have adequate mRNA, as well as complete translation machinery, for extensive globin synthesis.
- the endogenous globin mRNA is eliminated by incubation with a nuclease, e.g. a Cat 2+ dependent micrococcal nuclease, which is later inactivated, e.g. by chelation of the Cat 2+ by, for example, EGTA.
- Untreated reticulocyte lysate translates endogenous globin mRNA, exogenous RNAs, or both. This type of lysate is typically used for studying the translation machinery, e.g. studying the effects of inhibitors on globin translation. Both the untreated and treated rabbit reticulocyte lysates have low nuclease activity and are capable of synthesizing a large amount of full-length product. Both lysates are appropriate for the synthesis of larger proteins from either capped or uncapped RNAs.
- Wheat germ extract has low background incorporation due to its low level of endogenous mRNA.
- Wheat germ lysate efficiently translates exogenous RNA from a variety of different organisms.
- Both reticulocyte and wheat germ extracts translate RNA isolated from cells and tissue or those generated by in vitro transcription.
- RNA synthesized in vitro the presence of a 5′ cap structure may enhance translational activity.
- translation by wheat germ extract is more cap-dependent than translation by reticulocyte extracts. If capping of the RNA is impossible and the protein yield from an uncapped mRNA is low, the coding sequence can be subcloned into a prokaryotic vector and expressed directly from a DNA template in an E. coli cell-free system.
- E. coli cell-free systems consist of a crude extract that is rich in endogenous mRNA. The extract is incubated during preparation so that this endogenous mRNA is translated and subsequently degraded. Because the levels of endogenous mRNA in the prepared lysate is low, the exogenous product is easily identified. In comparison to eukaryotic systems, the E. coli extract has a relatively simple translational apparatus with less complicated control at the initiation level, allowing this system to be very efficient in protein synthesis. E. coli are particularly suited for coupled transcription:translation from DNA templates.
- RNA is used as a template for translation.
- Linked or coupled systems use DNA as a template. RNA is transcribed from the DNA and subsequently translated without any purification. Such systems typically combine a prokaryotic phage RNA polymerase and promoter (T7, T3, or SP6) with eukaryotic or prokaryotic extracts to synthesize proteins from exogenous DNA templates. DNA templates for IVT or IVTT reactions may be cloned into plasmid vectors or generated by PCR.
- the linked or coupled system is a two-step reaction, based on transcription with a bacteriophage polymerase followed by translation in the rabbit reticulocyte lysate or wheat germ lysate. Because the transcription and translation reactions are separate, each can be optimized to ensure that both are functioning at their full potential.
- E. coli Unlike eukaryotic systems where transcription and translation occur sequentially, in E. coli, transcription and translation occur simultaneously within the cell. In vitro E. coli translation systems are thus performed the same way, coupled, in the same tube under the same reaction conditions. During transcription, the 5′ end of the RNA becomes available for ribosomal binding and undergoes translation while its 3′ end is still being transcribed. This early binding of ribosomes to the RNA maintains transcript stability and promotes efficient translation. This bacterial translation system gives efficient expression of either prokaryotic or eukaryotic gene products in a short amount of time.
- E. coli S30 extract system allows expression from DNA vectors containing natural E. coli promoter sequences (such as lac or tac).
- the present methods employ a bactenophage promoter (e.g., without limitation, T7, T3, or SP6).
- the present methods employ the TX-TL system as described in Shin and Noireaux, J Biol. Eng. 4,8 (2010) and US Patent PL:blication No. 2016/0002611, the entire contents of which are hereby incorporated by reference in their entireties.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system comprises a single nucleic acid vector.
- the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system comprises two nucleic acid vectors.
- the protein sensor and/or switch e.g. transcription factor library
- the reporter gene system resides on a second plasmid.
- a highly sensitive plasmid required for initial strain improvement may saturate as the strain or strain library is improved. Rapidly swapping the sensitive sensor plasmid for another harboring a less sensitive plasmid facilitates further strain improvement. Another instance could be that the desired molecule to be sensed for further strain improvement may change.
- a sensor plasmid may additionally express a method directing the restriction of another sensor plasmid. By having three or more unique targets it allow at will restriction of any plasmid for another, i.e. Type A restriction targets Type B, Type B restriction targets Type C, and Type C targets Type A.
- a vector refers to discrete elements that are used to, for example, introduce heterologous nucleic acid into cells for expression or replication thereof.
- the vectors can remain episomal or can be designed to effect integration of a gene or portion thereof into a chromosome of the genome.
- vectors that are artificial chromosomes such as yeast artificial chromosomes and mammalian artificial chromosomes. Selection and use of such vehicles are well known to those of skill in the art.
- vectors capable of expressing DNA that is operatively linked with regulatory sequences, such as promoter regions, that are capable of effecting expression of such DNA fragments e.g. expression vectors).
- a vector refers to a recombinant DNA or RNA construct, such as a plasmid, a phage, recombinant virus or other vector that, upon introduction into an appropriate host cell, results in expression of the DNA.
- a recombinant DNA or RNA construct such as a plasmid, a phage, recombinant virus or other vector that, upon introduction into an appropriate host cell, results in expression of the DNA.
- Appropriate vectors are well known to those of skill in the art and include those that are replicable in eukaryotic cells and/or prokaryotic cells and those that remain episomal or those that integrate into the host cell genome.
- the present compositions and methods can include vectors based and/or generated using commercially available expression constructs, which can optionally be adapted or optimized for use in certain species and/or cell types.
- expression constructs include the GATEWAY cloning vector available from INVITROGEN, which is available for multiple species.
- Examples of other expression constructs suitable for use in various species are known in the art.
- expression constructs suitable for use in, for example, Pichia pastoris include, for example, pAO815, pGAPZ, pGAPZa, pHIL-D2, pHIL-S1, pPIC3.5K, pPIC9K, pPICZ, and pPICZa.
- expression constructs suitable for episomal maintenance in for example, Kluyveromyces lactis include, for example, pKD1.
- Expression constructs suitable for integration in Kluyveromyces lactis include, for example, pGB-HSb20 vector (Swinkels et al. Antonie van Leeuwenhoek, 64:187-201 (1993); Bergkamp et al., Current Genetics, 21(4-5):365-370 (1992); Rossolini et al. Gene, 21; 119(1):75-81 (1992); Dominguez et al., the Official Journal of the Spanish Society for Microbiology, 1:131-142 (1998)), pKLAC1 or pKLAC2 (Paul A. Colussi and Christopher H. Taron, Appl Environ Microbiol. 71(11): 7092-7098 (2005)).
- phage vectors plasmid vectors, phagemid vectors, phasmid vectors, cosmid vectors, virus vectors and YAC vectors may be used in the present invention.
- cloning methods which are known in the art and include, by way of non-limiting example, fusion PCR and assembly PCR see, e.g. Stemmer et al. Gene 164(1): 49-53 (1995), inverse fusion PCR see, e.g. Spiliotis et al. PLoS ONE 7(4): 35407 (2012), site directed mutagenesis see, e.g. Ruvkun et al. Nature 289(5793): 85-88 (1981), Gibson assembly (see, e.g. Gibson et al.
- FDG fluorescein di-(beta-D-glucopyranoside)
- FDP fluorescein diphosphate
- the tetR gene was cloned into the pET28a(+) E. coli expression plasmid with a C-terminal 6 ⁇ his tag.
- the plasmid was cloned into BL21(DE3) cells inoculated into expression medium (LB+kanamycin) at a starting OD600 of 0.05 and grown to mid log phase. Cells were induced with 1 mM IPTG and protein expression occurred for 4 hours. After 4 hours, cells were pelleted at 5, 000 rpm for 10 min, the supernatant was aspirated, and the cells were resuspended in TGN500 buffer [10 mM tris pH 7.5, 10% glycerol, 500 mM NaCl].
- the T7 RNA polymerase gene was cloned into the pET28a(+) E. coli expression plasmid with a C-terminal 6 ⁇ his tag.
- the plasmid was cloned into BL21(DE3) cells inoculated into expression medium (LB+kanamycin) at a starting OD600 of 0.05 and grown to mid log phase. Cells were induced with 1 mM IPTG and protein expression occurred for 4 hours. After 4 hours, cells were pelleted at 5, 000 rpm for 10 min, the supernatant was aspirated, and the cells were resuspended in TGN500 buffer [10 mM tris pH 7.5, 10% glycerol, 500 mM NaCI].
- a plasmid was constructed containing a T7 reporter construct [T7 promoter upstream of a tetR operator followed by a tetR expression cassette and a T7 terminator]. This reporter construct allows for tetR controlled of T7 amplification of the tetR gene.
- T7 transcription in 2 ⁇ IVT mix [100 mM tris-HCI pH 7.5, 30 mM MgCl 2 , 10 mM DTT, 4 mM spermidine, 5 mM each NTP, 4 U/uL RNase inhibitor, 4 U/uL T7 RNA polymerase] and diluted to lx with 100 nM final reporter plasmid as described above, and a titration of purified tetR from 2 uM to 0 uM. The reactions were incubated at 37° C. for 4 hours.
- Transcripts were denatured in 2x RNA loading dye and run on a 1% agarose gel for 1 hr at 90V constant, stained with SYBR Safe, and imaged on a gel doc. Effective transcription repression was seen with a stoichiometric amount of tetR as plasmid, in this case 100 nM plasmid and 100 nM tetR ( FIG. 4 , FIG. 7 ). This data demonstrates the ability of tetR to repress T7 RNA polymerase activity in vitro.
- T7 transcription reactions were set up as described above with the inclusion of a titrating amount of anhydrotetracycline (ATC), the native ligand for tetR.
- ATC anhydrotetracycline
- the ATC titration ranged from 2 uM to 0 uM.
- the IVT transcripts were analyzed by gel as described above. At low ATC concentrations, there was no generation of RNA transcripts suggesting complete repression of transcription by tetR in vitro.
- RNA band was generated similar to that when no tetR in included in the reaction suggesting full depression of the tetR gene by the ligand in vitro ( FIG. 9 ).
- titrated amounts of ATC show a titratable amount of RNA produced demonstrating the potential of a range of ligand binding affinities to produce differential amounts of RNA product ( FIG. 4 , FIG. 7 ). This titratable response is a requirement when working with engineered sensors cell-free to enrich a population for those members with improved ligand binding function in the pool.
- This strategy may be used in microfluidically generated emulsions as shown in ( FIG. 4 ) or bulk emulsions and shown in ( FIG. 2 ) for the screening of engineered sensor activity in a cell-free context.
- FIG. 10 shows the dose response of 4 TetR sensors engineered to detect the target molecule nootkatone (CE3, GF1, GA3, and CG5) and wild type TetR (p523) to nootkatone and ATc.
- nootkatone CE3, GF1, GA3, and CG5
- TetR wild type TetR
- a population of cells was generated with a primary sensor plasmid harboring a single I-Scel restriction enzyme cut site and an ampicillin selection marker and expressing GFP (p1057).
- a secondary sensor plasmid was generated containing an expression cassette for the I-Scel enzyme and a kanamycin resistance cassette and RFP (p1174). Removal of the ampicillin from the selective medium did not result in a stochastic removal of the primary sensor plasmid. Based on flow cytometry, no difference was observed between a clean background strain transformed only with p1174 and the strain harboring the p1057 plasmid. However, introduction of the secondary sensor plasmid and subsequent growth on kanamycin selective medium resulted in a 200, 000-fold reduction in cells harboring the primary plasmid in the population ( FIGS. 11 and 12 ).
- any numerical range recited herein is intended to include all sub-ranges subsumed therein.
- a range of “1 to 10” is intended to include all sub-ranges between (and including) the recited minimum value of 1 and the recited maximum value of 10, that is, having a minimum value equal to or greater than 1 and a maximum value of equal to or less than 10.
- the terms “one, ” “a, ” or “an” as used herein are intended to include “at least one” or “one or more, ” unless otherwise indicated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Toxicology (AREA)
- Library & Information Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
Abstract
Description
- This application claims the benefit of U.S. Provisional Application Nos. 62/375,305, filed Aug. 15, 2016; 62/375,301, filed Aug. 15, 2016; 62/378,999, filed Aug. 24, 2016; and 62/379, 002, filed August 24, 2016, the contents of which are hereby incorporated by reference herein in their entirety.
- The present described inventions relate, inter alia, to methods and compositions that provide for a cell-free system for engineering and deploying allosteric sensor proteins.
- A key objective of synthetic biology is the efficient production of high value target molecules. But, a significant unsolved bottleneck in the bioengineering design-build-test cycle is in the test phase due to screening limitations. One possible solution to this bottleneck is the use of molecular sensors. Indeed, sensors that recognize industrially important molecules are rapidly becoming part of metabolic engineering strategies to improve enzymatic bioproduction and detection. However, coupling a response to the detection of a specific target is an engineering challenge in itself.
- The use of allosteric proteins—single proteins that directly couple the recognition of a molecule of interest to a response has been proposed. Allostery is a common feature of proteins, in which the behavior at an ‘active’ site is altered by binding of an effector to a second or ‘allosteric’ site, often quite distant from the first (about 10A or more). The altered behavior can either directly or indirectly lead to a change in the protein's activity and thereby elicit a detectable response.
- The use of bacterial allosteric transcription factors (aTFs)—single proteins that directly couple the recognition of a small molecule to a transcriptional output—has been proposed (Taylor, et al. Nat. Methods 13(2): 177). The protein's conformational change caused by effector binding modulates its affinity for a specific operator DNA sequence, which alters gene expression by up to 5000-fold. Any strategy to engineer aTF sensors for new molecular recognition engineers both the sensing and actuation functions that are needed for a sensing device to operate. This makes aTF sensors an exciting paradigm to address the sense-and-respond challenge that is central to many applications of synthetic biology.
- The use of circulary permuted reporter proteins about the active site of a second conformationally dynamic effector protein presents an alternative method for directly coupling the recognition of a molecule to a response.
- The protein's conformational change caused by effector binding results in a shift in protein structure that can be repurposed to switch a reporter protein from an inactive to active state or vice versa. This response can either be positive or negative as well as stoichiometric or amplifiable. For example, the circular permutation of GFP about the binding site of a protein has resulted in a fluorescent state that is directly coupled to the binding of a small molecule effector. Since one protein may bind a specific number of molecules based on its structure and relative affinity, the result leads to a stoichiometric fluorescent signal directly correlated to the amount of ligand-bound protein present. Permutation of an enzyme about the active site on the other hand results in signal amplification as a single effector molecule leads to multiple functional turnovers for the reporter enzyme. Further, effector modulated presentation of a degradation tag results in the selective reduction in a protein that may either have a beneficial or derogatory effect on cellular state.
- One of the challenges of engineering sensor proteins—such as aTFs, circularly permuted reporter-binders, and allosterically controlled degradation tags—to recognize target molecules is that the host cell in which the molecular biology is conducted may not permit sufficiently adjustable concentrations of the target molecule to allow a measurable on/off response of the engineered protein. Simple introduction of the target molecule into the growth medium exogenously or through bioproduction may not be a suitable approach because the target molecule may be excluded from, transported out of, toxic to, or chemically altered by the cell or the target molecule's concentration is actively controlled by the cell. These active or passive mechanisms modulating the effective concentration of the ligand convolutes the sensor's ability to respond to the true concentration of the ligand being added or produced.
- Furthermore, proteins are often sensitive to deviations in their environmental conditions—such as buffer compositions, metabolite profiles, temperature, etc.—that may lead to deviations in protein activity. Allosteric proteins also suffer to various degrees to this phenomenon. As a result, their phenotypic sensitivity to cellular environment when used as a biological sensor system has the potential to skew results as the environmental conditions are artificially or biologically adjusted.
- Further, protein engineering usually occurs through discrete steps in function from wild type to desired activity. In the case of ligand binding, both affinity and specificity for a target molecule is usually gained in incremental steps that tend to weaken affinity and broaden specificity before the wild-type activity is lost. This phenomenon presents a specific challenge for engineering biosensors within cells where the natural ligands will likely be present and therefore generate a detectable sensor response that may convolute the desired response. This interference may obstruct identification of sensors with low to medium activity for the desired ligand as the response to the wild type ligand may be greater than the response to the targeted ligand. This interference may also present itself when deploying engineered sensors as the wild type ligand response may obstruct the response to the desired metabolite. Therefore, depending on the ubiquity of the native ligand, there is a need to separate the sensor system from the wild-type environment in the beginning steps of the sensor engineering process as well as in their deployment.
- This same challenge presents itself when engineering a sensor's DNA binding sites to recognize a new DNA sequence for allosteric transcription factors and their response regulators for multiple-component systems. In order to substantially change the DNA binding site (operator site) specificity to a completely novel and foreign site often requires iterative steps that transition in specificity from wild-type, to broad specificity, to new target.
- Additionally, these intermediate steps may demonstrate off-target effects by binding to unknown and unpredictable locations leading to unwarranted changes in cellular state. Therefore, intermediate steps for engineering operator sites may be required to be performed in an acellular environment.
- As a result, there is a need for improved compositions and methods for both developing engineered allosteric sensor proteins as well as deploying them for sensing target molecules in a manner not limited by the cellular environment.
-
FIG. 1 shows a schematic of the methods/systems of non-limiting embodiments of the invention. Specifically, panel A shows a strategy for temporal control in the reporter assays using a orthogonal sensor for engineered tetR sensors in the case where the engineered sensor is non-functional and panel B shows a strategy for temporal control in the reporter assays using a orthogonal sensor for engineered tetR sensors in the case where the engineered sensor is functional. -
FIG. 2 shows an illustrative overview of the cell-free transcription factor screening strategy using bulk emulsions. Specifically, panel A shows a pool of allosteric transcription factors (aTF) expressed in E. coli and encapsulated in water-in-oil droplets generated in bulk. Each droplet contains the effector of interest, the polymerase reporter DNA under negative control through the aTF operator, primers specific to the aTF gene, and a chemical or enzymatic lytic agent. Panel B shows a more detailed view of the reporter strategy. aTFs that respond to the effector result in production of Kod polymerase that is then utilized to amplify the aTF genotype by PCR. Enriched amplicons are recovered from the emulsion and then cloned back into their expression vectors for subsequent rounds of screening. -
FIG. 3 shows an overview of the cell-free transcription factor screening strategy using microfluidically generated emulsions. Specifically, panel A shows a pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets generated microfluidically. The effector, polymerase reporter gene, primers, and lytic agent are introduced through a second internal aqueous inlet. aTFs are enriched using the strategy presented in Figure (panel b), panel B and C show photographs of the droplet production chips from Dolomite Microfluidics for reference, but any microfluidic chip may be used. Panel D shows schematic of the flow focusing junction producing water-in-oil droplets. Panel E shows photograph of water-in-oil droplet formation. The channel width is 14 μm for scale, and panel F shows water-in-oil droplets are stable for more than 1 week at 37° C. and are monodisperse with a size of ˜15±1 μm. -
FIG. 4 shows an illustrative overview of the cell-free RNA transcription-based reporter strategy. A pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets either microfluidically or in bulk. The effector, IVT reagents, and lytic agent re-introduced separately. After encapsulation, the droplets are incubated at 37° C. to promote lysis releasing the aTFs. aTFs that respond to the effector result in RNA transcription that is then utilized to amplify the aTF genotype by RT-PCR. Enriched amplicons are recovered from the emulsion and then cloned back into their expression vectors for subsequent rounds of screening. This strategy may replace the DNA polymerase strategy inFIG. 2 andFIG. 3 . -
FIG. 5 shows an overview of the cell-free transcription factor screening strategy using microfluidically generated double emulsions. Specifically, panel A shows a pool of allosteric transcription factors (aTF) are expressed in E. coli and encapsulated in water in oil droplets generated in bulk. Each droplet contains the effector of interest, the enzyme reporter DNA under negative control through the aTF operator, a fluorogenic substrate, and a chemical or enzymatic lytic agent. After encapsulation, the droplets are incubated at 37° C. to promote lysis releasing the aTFs. aTFs that respond to the effector result in production of the reporter enzyme. The single emulsions are then converted into a water-in-oil double emulsion and sorted by FACS, panel B shows the water-in-oil emulsions either receive no E. coli, receive an E. coli expressing an unresponsive aTF, or an E. coli containing a responsive aTF resulting in the production of fluorescent signal, panel C shows photograph of double emulsion formation. The channel width is 14 pm for scale, panel D shows photograph of water-in-oil-in-water droplets that are stable for more than 1 week at 24° C. and are monodisperse with a size of ˜20±2.2 μm, and panel E shows Schematic of the second emulsion. d, Photograph of double emulsion formation. -
FIG. 6 shows single chip water-in-oil-in-water formation for cell-free transcription factor screening. Specifically, panel A shows a schematic representation of the chip design, and panel B shows a photograph of the single chip design in PDMS producing double emulsions in one step. channel width is 50 μm for scale. -
FIG. 7 shows sensitivity and dynamic range of beta-glucosidase fluorogenic reporter substrate. -
FIG. 8 shows sensitivity and dynamic range of Antarctic phosphatase (AP) fluorogenic reporter substrate. -
FIG. 9 shows aTF-dependent control of T7 transcription in vitro. -
FIG. 10 shows the dose response of 4 TetR sensors engineered to detect the target molecule nootkatone (CE3, GF1, GA3, and CG5) and wild type TetR (p523) to nootkatone and ATc. -
FIG. 11 shows flow cytometry data of p1174 plasmid causing loss of the p1057 target plasmid -
FIG. 12 shows dilutions of cultures on selective media for either p1174 or p1057 to estimate loss of carb plasmid. - Accordingly, in general, methods and compositions that improve the development of engineered, allosteric sensor proteins, such as engineered aTFs, as wells their utility in detection and/or production of target molecules in cell-free environments are provided. Furthermore, engineered sensors are not limited to their utility within the environment in which they were derived, i.e. cellularly derived sensors may also be deployed in acellular environments and vice versa. Accordingly, the present invention provides compositions and methods that allow for the detection and/or production of target molecules and can be produced in manners that are independent of limiting processes of a cell and therefore not contingent on, for example, retention of the target molecule within a cell, e.g. a healthy cell.
- In various embodiments, the present invention is not necessarily limited by an inherent toxicity of the target molecules to a cell, the ability of any target molecule to enter or remain inside screening strain cells, or the ability of any target molecule to be unaltered by cellular machinery. Further, the present invention is not limited by the sensing of molecules either small or large, but may be extended to cellular states such as redox potential and charge. Further, the present invention is not limited to the utility of allosteric transcription factors that directly bind to a DNA operator, but may use effector domains that propagate though protein cascades such as two component systems. Accordingly, the present methods and compositions allow for measurable on/off response of the engineered protein that is not limited by the ability of a cell to withstand or maintain measurable concentrations.
- In one aspect, the present invention relates to compositions and methods for making an engineered protein sensor and/or switch, e.g. from an allosteric protein, e.g. a transcription factor, that binds to and allows detection of a target molecule, wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened either cellularly or acellularly.
- In one embodiment, there is a provided method of making an allosteric sensor and/or switch that binds controllably to a ligand different from that of the wild type ligand. The engineered sensor and/or switch binds to and allows detection of the target molecule through a detectable response wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- In a further embodiment, there is a provided method of making an allosteric sensor and/or switch that binds controllably to an engineered DNA sequence different from that of the wild type sequence in response to the binding of a target molecule. The engineered sensor and/or switch binds to and allows detection of a target molecule through binding to an engineered DNA sequence wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- In various embodiments, the allosteric sensor and or switch may be engineered to recognize both a new ligand as well as a new DNA binding site simultaneously.
- In another aspect, the present invention relates to compositions and methods for deploying sensors and/or switches to detect the production of target molecules. In various embodiments, the engineered sensor and/or switch developed acellularly may be used either in a cellular or acellular environment. In further embodiments, an engineered sensor and/or switched developed cellularly may be used in an acellular environment.
- In various aspects, the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule. The method comprises steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield a candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind a target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding a reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture, the IVT or IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVT or IVTT mixture for reporter response, the reporter response being indicative of target molecule binding to the candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- In various embodiments, the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the target molecule is an antibiotic.
- In various embodiments, step (a) comprises mutating an allosteric protein.
- In various embodiments, the nucleic acid is provided to the host cell by one or more of electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- In various embodiments, the host cell is selected from a eukaryotic or prokaryotic cell, selected from a bacterial, yeast, algal, plant, insect, mammalian cells, and immortalized cell.
- In various embodiments, the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- In various embodiments, the IVT or IVTT mixture comprises a coupled or linked system.
- In various embodiments, the reporterresponse is a direct amplification of the genotype of the allosteric protein.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- In various embodiments, the method further comprises a step of (e): isolating the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- In various aspects, the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule. The method comprises steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield a DNA-binding protein sensor and/or switch which has an ability to bind a target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding a reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture, the IVT or IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVT or IVTT mixture by nucleic acid sequencing before and after selection to determine those molecules that have become functionally enriched.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- In various embodiments, the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the target molecule is an antibiotic.
- In various embodiments, step (a) comprises mutating an allosteric protein.
- In various embodiments, the nucleic acid is provided to the host cell by one or more of electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- In various embodiments, the host cell is selected from a eukaryotic or prokaryotic cell, selected from a bacterial, yeast, algal, plant, insect, mammalian cells, and immortalized cell.
- In various embodiments, the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- In various embodiments, the IVT or IVTT mixture comprises a coupled or linked system.
- In various embodiments, the reporter response is a direct amplification of the genotype of the allosteric protein.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- In various embodiments, the method further comprises a step of (e): isolating the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- In various aspects, the present invention relates to a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule. The method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a DNA-binding protein sensor and/or switch for an ability to bind a target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind a target molecule; (b) contacting a solid support with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and selecting for a solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch; (c) isolating nucleic acids from the solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture; (d) introducing a reporter gene system, detection reagent, and target molecule, and interrogating the mixture for a reporter response, the reporter response being indicative of the target molecule binding to the candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the solid support is a nanoparticle and a microparticle, a bead, a nanobead, a microbead, or an array.
- In various embodiments, the candidate allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- In various embodiments, the target molecule is a small molecule that is not a native ligand of the wild type candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the target molecule is an antibiotic.
- In various embodiments, step (a) comprises mutating an allosteric protein.
- In various embodiments, the reporter gene system comprises a protein having a unique spectral signature and/or assayable enzymatic activity.
- In various embodiments, the IVT or IVTT mixture comprises a coupled or linked system.
- In various embodiments, the reporter response is a direct amplification of the genotype of the allosteric protein.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises a single nucleic acid vector.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the nucleic acid encoding the reporter gene system comprises two nucleic acid vectors.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch comprises a synthetic DNA, amplified DNA, or amplified RNA.
- In various embodiments, the method further comprises a step of (e): isolating the nucleic acid encoding the allosteric DNA-binding protein sensor and/or switch, e.g., comprising use of flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, or microdroplets generated either in bulk or microfluidically.
- In various aspects, the present invention relates to a method for making a target molecule in a biological cell. The method comprises steps of (a) engineering the biological cell to produce the target molecule; (b) introducing an allosteric DNA-binding protein sensor and/or switch which binds to the target molecule in the biological cell;
- and (c) screening for target molecule production.
- In embodiments, the biological cell is engineered to produce the target molecule by a multiplex genome engineering technique and/or a method involving a double-strand break (DSB) or single-strand break or nick.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch which binds to the target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind the target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a nucleic acid encoding the reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture, the IVT or IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVT or IVTT mixture for reporter response, the reporter response being indicative of target molecule binding to the allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch which binds to the target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch which has an ability to bind the target molecule; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and selecting for a cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system; (c) isolating nucleic acids from the cell comprising the candidate allosteric DNA-binding protein sensor and/or switch and the reporter gene system and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture, the IVT or IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVT or IVTT mixture by nucleic acid sequencing before and after selection to determine those molecules that have become functionally enriched.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch which binds to a target molecule is produced by a method comprising steps of (a) constructing a candidate allosteric DNA-binding protein sensor and/or switch, the constructing comprising (i) designing a candidate allosteric DNA-binding protein sensor and/or switch for an ability to bind the target molecule, the designing optionally being in silico or (ii) undertaking directed or random mutagenesis to yield the candidate allosteric DNA-binding protein sensor and/or switch having an ability to bind the target molecule; (b) contacting a solid support with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and selecting for a solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch; (c) isolating nucleic acids from the solid support comprising the candidate allosteric DNA-binding protein sensor and/or switch and contacting the isolated nucleic acids with an in vitro transcription (IVT) or an in vitro transcription and translation (IVTT) mixture; (d) introducing a reporter gene system, detection reagent, and target molecule, and interrogating the mixture for a reporter response, the reporter response being indicative of target molecule binding to the candidate allosteric DNA-binding protein sensor and/or switch.
- In various embodiments, the solid support is a nanoparticle and a microparticle, a nanobead, a microbead, or an array.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch is an engineered prokaryotic transcriptional regulator family member optionally selected from a LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp family member.
- In various embodiments, the screening for target molecule comprises a positive or negative screen.
- In various embodiments, the allosteric DNA-binding protein sensor and/or switch is one or more of those of Table 1 and has about 1, or 2, or 3, or 4, or 5, or 10 mutations.
- Any aspect or embodiment disclosed herein can be combined with any other aspect or embodiment as disclosed herein.
- The present invention is based, in part, on the surprising discovery that engineered protein sensors and/or switches, such as aTFs, can be designed to not require cellular-based target molecule interaction and therefore not be constrained by properties of a host cell (e.g. cell viability when contacted with a target molecule, cell transport of a target molecule, etc.). Accordingly, the present acellular methods allow for the development of engineered protein sensors and/or switches and the interrogation of a wide variety of target molecules that are not otherwise available using strictly cell-based approaches.
- In various embodiments, the present invention is not necessarily limited by an inherent toxicity of the target molecules to a cell, the ability of any target molecule to enter or remain inside screening strain cells, or the ability of any target molecule to be unaltered by cellular machinery. Further, the present invention is not limited by the sensing of molecules either small or large, but may be extended to cellular states such as redox potential and charge. Further, the present invention is not limited to the utility of allosteric transcription factors that directly bind to a DNA operator, but may use effector domains that propagate though protein cascades such as two component systems. Accordingly, the present methods and compositions allow for measurable on/off response of the engineered protein that is not limited by the ability of a cell to withstand or maintain measurable concentrations.
- In one aspect, the present invention relates to compositions and methods for making an engineered protein sensor and/or switch, e.g. from an allosteric protein, e.g. a transcription factor, that binds to and allows detection of a target molecule, wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened either cellularly or acellularly.
- In one embodiment, there is a provided method of making an allosteric sensor and/or switch that binds controllably to a ligand different from that of the wild type ligand. The engineered sensor and/or switch binds to and allows detection of the target molecule through an elicited detectable response wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- In a further embodiment, there is a provided method of making an allosteric sensor and/or switch that binds controllably to an engineered DNA sequence different from that of the wild type sequence in response to the binding of a target molecule. The engineered sensor and/or switch binds to and allows detection of a target molecule through binding to an engineered DNA sequence wherein the engineered protein sensor and/or switch is produced and screened at least in part, acellularly, and/or allows target molecules to be screened acellularly not limited to methods as described above.
- In various embodiments, the allosteric sensor and or switch may be engineered to recognize both a new ligand as well as a new DNA binding site simultaneously.
- In various embodiments, there is provided a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule, comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) providing a host cell with a nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system and selecting for cells comprising a candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system; (c) isolating nucleic acids from the cells comprising a candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system and contacting the isolated nucleic acids with an in vitro transcription and translation (IVTT) mixture, the IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVTT mixture for reporter response, the reporter response being indicative of target molecule binding to the allosteric DNA-binding protein sensor and/or switch.
- In some embodiments, the engineered protein sensor and/or switch, e.g. transcription factor, library members and reporter gene system reside on a single plasmid. When the plasmid is carried in a host organism, such as E. coli or the others described herein, it is grown as single colonies each of which harbors a clonal library member. The reporter gene and protein sensor and/or switch library members are then purified as plasmids and individual plasmids are introduced into an IVTT mixture (see Zubay. Ann. Rev. Genet. 1973.7:267-287, the entire contents of which are hereby incorporated by reference in their entirety) to which has been added the target molecule and other detection reagents. After a suitable incubation period to allow expression of the reporter gene, the solution is interrogated for reporter response.
- In some embodiments, there is provided a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule, comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) attaching the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch to a solid support; (c) contacting the isolated nucleic acids with an in vitro transcription and translation (IVTT) mixture, the IVTT mixture comprising a target molecule and a detection reagent; and (d) interrogating the IVTT mixture for sensor and/or switch activity in the presence and absence of target ligand. The interrogation is not necessarily limited to the methods described above.
- In some embodiments, there is provided a method of making an allosteric DNA-binding protein sensor and/or switch which binds to a target molecule, comprising (a) designing a candidate allosteric DNA-binding protein sensor and/or switch, the DNA-binding protein sensor and/or switch being designed for an ability to bind a target molecule and the designing optionally being in silico; (b) generating DNA encoding the allosteric sensor and/or switch in vitro; (c) introducing the DNA into a display system—for example but not limited to ribosome display, mRNA display, phage display, cell display—(d) interrogating the displayed sensors for DNA binding in the presence and absence of ligand. The interrogation being indicative of activity. This reporter-free strategy to evaluate sensors is facilitated by coupling the sensor protein to the mRNA transcript encoding its translation, either by association with stalled ribosomes as in ribosome display (see Hanes, et al. PNAS. 1997; 94(10):4937-4942.) or through covalent linkage as in mRNA display (see Wilson et al. PNAS. 2001; 98(7):3750-5). Coupling of genetic sequence to the functional protein allows for faster identification of functional sensor sequences, and rapid cycles of in vitro selection, mutation and evolution of the sensor proteins. Because many aTF sensors operate as obligate homodimers, this strategy is further facilitated by creating a ‘dimeric’ single chain sensor with a linker sequence that allows proper folding (see Krueger et al. Nucleic Acids Research. 2003 31(12):3050-3056) from an initial mutant monomer sensor gene through PCR, ligation, transposon/transposase system, recombinase, CRISPR/Cas9, or combination of these methods. In this way, both dimers encode the same monomer sequence, as a single chain that would greatly favor homodimerization rather than heterodimerization of different mutants within a large mutant pool. In some embodiments, the engineered monomer is coupled to a wild type monomer to create a heterodimeric single chain.
- In other embodiments, sensors are assayed by their affinity for an operator DNA sequence, without a separate reporter being expressed, and/or by a change in this operator DNA affinity in the presence of a target chemical.
- For example, this allows a pool of sensors to be evaluated initially for DNA binding capability in the absence of a target chemical by capture on immobilized DNA operator sequences (e.g. on beads, microarray chips, microfluidic device, flow cell, chromatography column), and then secondly evaluated for response to a target chemical by release from the immobilized DNA operator sequences. This reporter-free strategy to evaluate sensors is facilitated by coupling the sensor protein to the mRNA transcript encoding its translation, either by association with stalled ribosomes as in ribosome display (see Hanes, et al. PNAS. 1997; 94(10):4937-4942.) or through covalent linkage as in mRNA display (see Wilson et al. PNAS. 2001; 98(7):3750-5). Coupling of genetic sequence to the functional protein allows for faster identification of functional sensor sequences, and rapid cycles of in vitro selection, mutation and evolution of the sensor proteins. Because many aTF sensors operate as obligate homodimers, this strategy is further facilitated by creating a ‘dimeric’ single chain sensor with a linker sequence that allows proper folding (see Krueger et al. Nucleic Acids Research. 2003 31(12):3050-3056) from an initial mutant monomer sensor gene through PCR, ligation, transposon/transposase system, recombinase, CRISPR/Cas9, or combination of these methods. In this way, both dimers encode the same monomer sequence, as a single chain that would greatly favor homodimerization rather than heterodimerization of different mutants within a large mutant pool. In some embodiments, the engineered monomer is coupled to a wild type monomer to create a heterodimeric single chain. In some embodiments, the engineered protein sensor and/or switch, such as an aTF, and nucleic acids comprising the aTF in addition to a candidate reporter gene system contacting an in vitro transcription and translation (IVTT) mixture and detection reagent results in the generation of a reporter protein upon ligand binding. For example, in some embodiments, the engineered protein sensor and/or switch, such as an aTF, is contacted with a target molecule and a reporter is generated using an acellular method, e.g. IVTT. The reaction mixture can then be interrogated by the reporter response where the reporter response is indicative of target molecule binding to the allosteric DNA-binding protein sensor and/or switch.
- In another aspect, the present invention relates to compositions and methods for detecting a target molecule, optionally cellularly or acellularly, using an engineered protein sensor and/or switch, such as an aTF, which is produced with cellular or acellular methods, such as in vitro transcription and translation (IVTT) as described herein. In various embodiments, the detection is acellularly, e.g. by employing methods such as in vitro transcription and translation (IVTT) to detect a reporter that is allosterically linked to the engineered protein sensor and/or switch, such as an aTF. In some embodiments, the engineered protein sensor and/or switch, such as an aTF, can optionally be produced acellularly or within the cell. In some embodiments, the engineered protein sensor and/or switch, such as an aTF, detects target molecule binding via acellular methods, for instance the production of a detectable reporter via an acellular method, e.g. IVTT.
- Useful reporters include proteins with unique spectral signatures, such as, without limitation, green fluorescent protein whose expression may be determined using a microtiter plate fluorimeter, visual inspection, or a fluorescence activated cell sorter (FACS). Reporters also include, without limitation, spectral signatures based on absorbance, physical properties such as magnetism and impedance, changes in redox state, assayable enzymatic activities, such as a phosphatase, beta-galactosidase, peroxidase, luciferase, or gas generating enzymes. Alternatively, a linear single or double stranded DNA that encodes the reporter and transcription factor library member may be used as a reporter in cases not limited to amplification by polymerases.
- The present invention includes a reporter gene system, which comprises a protein having a unique spectral signature and/or assayable enzymatic activity. Illustrative reporter systems detection methods include, but are not limited to, those using chemiluminescent or fluorescent proteins, such as, for example, green fluorescent protein (GFP), enhanced green fluorescent protein (EGFP), Renilla Reniformis green fluorescent protein, GFPmut2, GFPuv4, yellow fluorescent protein (YFP), enhanced yellow fluorescent protein (EYFP), cyan fluorescent protein (CFP), enhanced cyan fluorescent protein (ECFP), enhanced blue fluorescent protein (EBFP), chromoproteins, citrine and red fluorescent protein from discosoma (dsRED), infrared fluorescent proteins, luciferase, umbelliferone, rhodamine, fluorescein, dichlorotriazinylamine fluorescein, dansyl chloride, phycoerythrin, and the like. Examples of detectable bioluminescent proteins include, but are not limited to, luciferase (e.g., bacterial, firefly, click beetle and the like), luciferin, aequorin and the like. Examples of detectable enzyme systems include, but are not limited to, galactosidases, glucorinidases, phosphatases, peroxidases, cholinesterases, proteases, and the like. In certain other embodiments, the reporter systems detection methods include an enzyme. In certain other embodiments, the detectable marker is a non-essential gene that can be assayed rapidly for genetic variation by qPCR. In certain other embodiments, the detectable marker is a drug resistance marker that can be readily assessed for functionality by reverse selection. In some embodiments, the detectable marker is a nutritional marker, e.g. production of a required metabolite in an auxotrophic strain, ability to grow on a sole carbon source, or any other growth selection strategy known in the art.
- In certain embodiments, the reporter is composed of two or more components which when present together produce the functional reporter. Examples include split GFPs, and enzymes such as luciferase, beta galactosidase, beta lactamase, and dihydrofolate reductase. One or more components of a split reporter may be introduced exogenously allowing detection of cellular production of fewer components. The split reporter may be can be used to detect split reporter-fused to another protein allowing detection either inside the cell, outside the cell, or both. For instance, a split GFP fusion protein may be excreted by a cell encapsulated with the complementing reporter component such that the producing cell does not have the capacity to produce a functional reporter until encapsulated with its complement. One or more components of such a split systems may be produced independently and added as a detection reagent to the cells being assayed.
- For example, beta-glucosidase and Antarctic phosphatase may be used as reporter systems with their corresponding fluorogenic substrates fluorescein di-(p-D-glucopyranoside) and fluorescein diphosphate (
FIG. 7 ,FIG. 8 ). - In some embodiments, the binding event of the aTF itself is utilized to present a physical readout of aTF state through either optical or nonoptical methods in an acellular environment. For example in a non-limiting manner, the aTF is linked to a fluorescent protein and the DNA binding site is linked to a quencher molecule. Fluorescent readout is possible only when the aTF is released from the DNA binding site itself. This method allows for a direct readout of aTF binding events. This strategy is not limited to fluorophore quencher pairs, but may also employ other read outs such as split proteins. Additionally, the binding event may be used to physically separate functional proteins from non-functional proteins in the case of protein display methods.
- In some embodiments, the engineered protein sensor and/or switch, such as an aTF, detects target molecule binding via acellular methods, for instance by controlling the activity of a polymerase that directly amplifies the genotype of the functional sensor and/or switch. The polymerase may either be a DNA or RNA polymerase that either amplifies the RNA and/or DNA versions of the genotype (
FIG. 2 ,FIG. 3 ,FIG. 4 ). - In various embodiments, the present methods include various detection techniques, e.g. for reporter signal. Such detection techniques may involve a microscope, a spectrophotometer, a fluorometer, a tube luminometer or plate luminometer, x-ray film, magnetic fields, a scintillator, a fluorescence activated cell sorting (FACS) apparatus, a microbial colony picker (e.g., QPix), a microfluidics apparatus, a bead-based apparatus or the like.
- In some embodiments, strains engineered for protein secretion may be assayed for secretion by fusing a split reporter, such as GFP, to the secreted protein and assaying in cell-free compartments.
- Useful cell-free compartments include without limitation standard growth fermenters, flasks, culture tubes, and plastic ware, microliter plates, patterned microwells, microdroplets generated either in bulk (
FIG. 2 ) or microfluidically (FIG. 3 andFIG. 4 ). - Bulk emulsions may be formed without limitation using the BioRad droplet oil for supermixes or a suitable such as mineral oil and span 80 or fluorinated oils such as HFE7500 and a fluorinated surfactant (
FIG. 2 , panel a). Droplet diameters may range from 1 um to 500 um without limitation. Microfluidic emulsions may be formed without limitation using commercial fluorophilic chips or house-made PDMS chips with a hydrophobic surface with the HFE7500 fluorinated oil and Dolomite's proprietary PicoSurf surfactant (FIG. 3 ). Other commercially available chips, oils, and surfactants may be used as well as noncommercial chips and oil-surfactant mixes. A single commercial Dolomite chip can produce droplets at a rate of <20 kHz allowing the production of up to 576, 000, 000 droplets from a single chip in a single workday. This assay is amenable to parallel droplet formation for improved throughput. Microfluidically generated water-in-oil emulsions are monodisperse and stable for >7 days at 37° C. Droplet diameters may range from 1 um to 500 um without limitation. Droplets may also be generated inside of tubes using an air interface to separate droplets. In this strategy, both pressures and atmospheric compositions may be controlled inside of the droplets. - In some embodiments, water-in-oil droplets may be utilized to compartmentalize a single E. coli cell overexpressing a unique aTF (
FIG. 2 , panel a,FIG. 3 , panel a, andFIG. 5 , panel a). The library diversity—in other words the number of unique E. coli capable of being screened—is limited to the number of droplets produced. Each compartment also contains the effector (ligand) of interest regulating aTF activity, a polymerase reporter gene or promoter upstream of the aTF gene under the control of the aTF operator site, IVT or IVTT reagents as needed, as well as a chemical or enzymatic lytic agent. - In one embodiment, a pool of E. coli containing a library of engineered aTFs are encapsulated and the E. coli cells are lysed releasing the aTFs. aTFs bound to the operator site directly upstream a reporter DNA polymerase gene that prevents IVTT of the reporter polymerase. Any DNA polymerase may be used. aTFs responsive to the effector of interest release the DNA allowing IVTT of the polymerase. aTFs unresponsive to the effector of interest repress IVTT and therefore production of the polymerase (
FIG. 4 ). Afterwards, droplets are immediately amplified by PCR using aTF specific primers. Functional aTFs that produce more polymerase are enriched over their non-functional counterparts (FIG. 2 , panel b). Amplicons are cloned into the correponding expression vector, transformed back into the E. coli strain, and plated on solid support. Colonies may be scraped from the solid support and grown in liquid for subsequent rounds of enrichment or colonies or picked as isolates for screening. Unique colonies containing functional aTF genes picked from plates may be tested for activity. Activity is tested with lysate in 96 or 384 well blocks using fluorescent assays or using microfluidic droplet-based assays. - In a second embodiment, a pool of E. coli containing a library of engineered aTFs are encapsulated and the E. coli cells are lysed releasing the aTFs. aTFs bound to the operator site directly upstream of the aTF gene prevent transcription by an RNA polymerase. Any RNA polymerase may be used. aTFs responsive to the effector of interest release the DNA allowing RNA transcription of the aTF gene. aTFs unresponsive to the effector of interest repress transcription and therefore amplification of the aTF genotype (
FIG. 4 ). Subsequent breaking of the droplets and recovery of the RNA followed by RT-PCR with aTF specific primers rapidly amplifies the genotype of functional aTFs. Amplicons are cloned into the correponding expression vector, transformed back into the E. coli strain, and plated on solid support. Colonies may be scraped from the solid support and grown in liquid for subsequent rounds of enrichment or colonies or picked as isolates for screening. Unique colonies containing functional aTF genes picked from plates may be tested for activity. Activity is tested with lysate in 96 or 384 well blocks using fluorescent assays or using microfluidic droplet-based assays. - In some embodiments, a method of the invention comprises microencapsulating an individual cell, e.g. a bacterium, hosting the library plasmid with lysis reagent, IVTT mixture, the target molecule, and, if using a reporter enzyme system, substrate using one or more microfluidic devices (see Zinchenko, et al. Analytical Chem. 2014.86:2526-2533 and A. Fallah-Araghi, et al. Lab Chip. 2012. 12: 882-891, the contents of which are hereby incorporated by reference in their entireties). Following conditions suitable for cell lysis the microdroplets are incubated at conditions suitable for IVTT. They are then incubated for the appropriate time to develop the reporter protein. Finally, library members which produce a desired response are isolated from those that do not using a microfluidic device or FACS (
FIG. 5 , panels a and b). The plasmids of the positive responders are purified from the microdroplets, amplified and re-transformed into host bacterium for sequencing and clonal functional testing as described herein. - In various embodiments sensors and/or switches may be screened for a desired activity inside of water-in-oil-in-water emulsions. The water-in-oil emulsions are formed microfluidically.
- Microfluidic double emulsions may be formed using Dolomite commercial chips or house-made PDMS chips with the HFE7500 fluorinated oil and Dolomite's proprietary PicoSurf surfactant (
FIG. 5 , panels c-e). Other commercially available chips, oils, and surfactants may be used as well as noncommercial chips and oil-surfactant mixes. - Double emulsions may be formed in two steps (
FIG. 5 , panels c-e). The first emulsion is made using a Domolomite commercial fluorophilic chip and the second is with a hydrophilic chip. Alternatively PDMS chips sufficiently oxidized to have a hydrophobic surface may supplement the first Dolomite chip while a newly plasma treated chip with a hydrophilic coating may replace the second chip. Alternatively, the PDMS chip may be treated with PVA or an alternative reagent to bear a semi-permanent hydrophilic surface. A single commercial Dolomite chip can produce droplets at a rate of <20 kHz allowing the production of 576, 000, 000 droplets from a single chip in a single workday. This assay is amenable to parallel droplet formation. Microfluidically generated water-in-oil emulsions are monodisperse and stable for >7 days at 37° C. The second emulsification takes place at half the rate to prevent droplet shearing. Double emulsions are stable for >7 days at 37° C. - Double emulsions may also be produced in a single step using custom PDMS chips (
FIG. 6 ). In this aspect, the first emulsion directly precedes the formation of the second emulsions on the same chip. This process circumvents the need to produce two independent emulsions but proceeds at a rate 25% that of the single emulsion step. - In both of these cases, water-in-oil-in-water droplets are utilized to compartmentalize a single E. coli cell overexpressing a unique aTF (
FIG. 5 , panel a). The number of unique E. coli capable of being screened is limited to the amount of unique droplets being made. Inside of each compartment is also the effector (ligand) of interest regulating aTF activity, a reporter enzyme gene under the control of the aTF operator site, a fluorogenic substrate as described above, additional lysate as needed, as well as a chemical or enzymatic lytic agent. - Once encapsulated, the E. coli cells are lysed releasing the aTFs. aTFs bind to the operator site preventing the expression of the reporter enzyme. aTFs responsive to the effector of interest release the DNA allowing expression of the reporter enzyme. aTFs unresponsive to the effector of interest repress reporter enzyme expression. As the reporter enzyme is expressed, the enzyme converts the substrate from a non-detectable to a detectable state (
FIG. 5 , panel b). - Droplets containing functional aTFs will allow for the production of sufficient signal to enable separation using a suitable method. Once sorted, plasmids encoding the functional aTFs are transformed into the desired E. coli strain and plated. Colonies are scraped from the plate and grown in liquid for subsequent rounds of screening.
- Unique colonies containing functional aTF genes may be picked from plates and tested for activity. Activity is tested with lysate in 96 or 384 well blocks using fluorescent assays or using microfluidically-based assays.
- As an example, in some embodiments, a lytic plasmid contains a replication origin (e.g. ColE1), selectable marker (e.g. AMP), an IVTT transcribable (e.g. T7) reporter gene (e.g. alkaline phosphatase, AP) under control of the design aTF operator (e.g. TetO), Lacl, lacO controlled lytic system (e.g. T4 holin and T4 lysozyme), and the design aTF (e.g. TetR). A library of aTF designs is created and transformed into an E. coli strain which has no IVTT (e.g. T7) polymerase and in which alkaline phosphatase is deleted from the genome. A growing culture of these bacteria is washed in a buffer and passed through a microfluidic device at conditions which encapsulated a reagent stream and, on average, about one bacterium per microdroplet. The reagent stream includes IPTG (without wishing to be bound by theory, to induce self lysis by the lytic system), IVTT reagents, the target molecule against which the aTF is designed, and the AP substrate fluorescein diphosphate (FDP). After microencapsulation, the microdroplets are encapsulated in a second microfluidic device to produce a population of water stable double emulsion microdroplets. The microdroplets are then incubated to allow bacterial lysis, transcription and translation of AP if the TetR library member recognizes target molecule, and development of fluorescein from the FDP. Bright (positive) microdroplets are sorted from dim microdroplets using a FACS machine. The pool of positive droplets is dissolved with an organic solvent to release the contents of the positive droplets and the mixture of positive TetR genes are amplified using PCR. The positive TetR mixture is then cloned back into the plasmid backbone and retransformed into the host E. coli strain, and grown under selection. This positive library is then put through the process again to confirm the results, with the possibility to alter the concentration of the target molecule to identify more or less sensitive library members (
FIG. 5 ). Recovered confirmed positive plasmids are then again amplified, cloned, and transformed into the host strain and grown clonally. Clonal sensor plasmids are then characterized once again, for instance by repetition of the present microencapsulation system or other techniques (e.g. to measure in bulk), by looking at their response to a range of concentrations of the target molecule. The sequence of TetR clones with the desired properties are then determined. The target sensor can then be cloned into its working context for strain optimization or genome engineering or other downstream use. - In various embodiments, lysis may also be effected using an inducible cell lytic system encoded on the host cell genome, a separate plasmid, or encoded on the library plasmid itself (Morita, et al. Biotechnol. Prog. 2001. 17(3):573-6, the entire contents of which are hereby incorporated by reference). In such a system, the lysis inducer is included with the IVTT mixture, target molecule, and other required substrates depending on the reporter system being used. Inducible lytic systems often include one or more phage proteins such as, for example, psi X174 E protein (Henrich Mol. Gen. Genet. 1982. 185(3)493-7, the entire contents of which are hereby incorporated by reference or T4 holin and lysozyme.
- Microfluidic chip designs are not limited to those presented above. In some embodiments, double emulsions are generated in one step (
FIG. 6 ). For example, chips made with PDMS and external aqueous phase channels treated with 1% PVA, may be used to form double emulsion droplets in a single step with the HFE7500 and fluorinated surfactant. Other oil and surfactant combinations may be utilized. In this previously published chip design [Nie Joumal of the American Chemical Society 2005. 127. 8058-63], the internal aqueous phase is coflowed with 2 streams of oil-surfactant in which they are encapsulated by the external aqueous phase. This chip design results in both droplets being formed in a single pinch-flow interface. In some embodiments, individual sensors might be assayed by enclosing each one in emulsion-type droplets. For example, this may be facilitated by merging two or more droplets or types of droplets (e.g. containing different DNA sequences or enzymes or chemicals) in a microfluidic device. Droplets may also be assessed and sorted on-chip using techniques like but not limited fluorescence activated droplet sorting (FADS) or absorbance activated droplet sorting (AADS). - In some embodiments, a cell or cells hosting the cellularly or acellularly derived sensor system is coencaspulated with a metabolically engineered cell or cells, or “producing strain, ” having been engineered by one or more of the methods described herein, designed to produce the target molecule capable of being detected by the sensor system. This is useful, inter a/ia, if the producing strain constitutively exports the sensed molecule into its growth medium creating the case where a high producing and low producing strain both have the same intracellular concentration of the molecule of interest but the medium of the high producing strain has a greater concentration. In such cases, the detector strain may be used to discern high from low producers. In other embodiments, the present invention includes the use of multiple droplets containing whole or lysed cells from different hosts. For instance, in some embodiments, a first droplet comprises whole or lysed cells with an engineered sensor while a second droplet comprises whole or lysed cells, “producer strains”, with the target molecule (e.g. host cells that are engineered to produce a target molecule as described elsewhere herein). For example, in some embodiments, the first droplet comprising whole or lysed cells with an engineered sensor is used to detect production of a target molecule in a different host (in the form of whole or lysed cells in a droplet). As such, inter a/ia, this permits detection of the target molecule at levels that are beyond what could be undertaken if the engineered sensor were present solely in the host cells that are engineered to produce a target molecule. In some embodiments transcription/translation of the sensor and/or the reporter it controls are driven by in vitro transcription and translation (IVTT), as described in Zubay. Ann. Rev. Genet. 1973.7:267-287, the entire contents of which are hereby incorporated by reference in their entirety or TX-TL as described in Shin and Noireaux, J Biol. Eng. 4, 8 (2010) and US Patent Publication No. 2016/0002611, the entire contents of which are hereby incorporated by reference in their entireties. Microencapsulation of single producers, either harboring the sensor machinery or coencapsulated with sensor cells, is also a useful technique in cases where the molecule is highly diffusible across the cell membrane, making screening in batch liquid culture impossible.
- In other embodiments, cells are lysed in one microdroplet which is then merged with a second microdroplet containing the reagents required for IVT or IVTT.
- In another embodiment, DNA encoding a single sensor library member is captured on a bead and encapsulated in a microdroplet (see Dressman, et al. PNAS 2003 100(15):8817-8822), such that it may be amplified and/or expressed through IVTT. The droplet is then merged with reporter reagents for response interrogation. This may be beneficial when the aTF is not expressible and/or expressed in a functional state in suitable screening systems.
- In another embodiment, DNA encoding a reporter gene is captured on a bead and encapsulated in a microdroplet, such that it may be amplified and/or expressed through IVTT. The droplet is then merged with reporter reagents for response interrogation.
- In another embodiment, the transcription factor library resides on one plasmid while the reporter gene system resides on a second plasmid. By having two separate plasmids, the effective concentration of reporter gene to sensor library members may be adjusted to facilitate identification of active library members. This is useful where simply using higher versus lower promoter strength is not enough control, for instance.
- In another embodiment, the reporter system is encoded in the host genome.
- In another embodiment, the DNA encoding the reporter is present only in the droplet containing the reagents required for IVT or IVTT, and the DNA encoding the sensor is present in the other droplet.
- In another embodiment, the DNA encoding the sensor is present only in the droplet containing the reagents required for IVT or IVTT, and the DNA encoding the reporter is present in the other droplet.
- In other embodiments, the present invention includes the use of multiple droplets containing whole or lysed cells from different hosts. For instance, in some embodiments, a first droplet comprises whole or lysed cells with an engineered sensor while a second droplet comprises whole or lysed cells with the target molecule (e.g. host cells that are engineered to produce a target molecule as described elsewhere herein). For example, in some embodiments, the first droplet comprising whole or lysed cells with an engineered sensor is used to detect production of a target molecule in a different host (in the form of whole or lysed cells in a droplet). As such, inter alia, this permits detection of the target molecule at levels that are beyond what could be undertaken if the engineered sensor were present in the host cells that are engineered to produce a target molecule.
- In some embodiments, the present methods are designed to delay the creation of the reporter message relative to the designed aTF; an approach which enables concentrations of the designed aTF protein to reach the level required to repress transcription of the reporter. For example, the reporter transcription is controlled by two repressors which recognize separate operator sites on the reporter gene's promoter region. The reporter transcription is thus suppressed in the IVTT system until both transcription factors bind an inducing molecule. This permits, inter a/ia, delaying transcription of the reporter message until a sufficient concentration of the engineered aTF is built up in the IVTT mix to allow detection of its response to its non-cognate target ligand. For instance, in some embodiments, a library of TetR designs is produced with candidate designs to alter ligand specificity from, e.g., tetracycline to a target molecule, such as curcumin. The TetR gene is driven by a promoter recognized by the IVTT but not the host cell, such as T7. The reporter gene is similarly driven by a promoter recognized by the IVTT and modulated by both Tetracyline and Lacl operators (TetO and LacO in
FIG. 1 ). When bacteria harboring such a system are lysed and mixed with the IVTT system, reporter transcription is halted, initially, by the wild type constitutively expressed Lacl only (“Initial State” inFIG. 1 ). As IVTT proceeds, concentrations of the engineered TetR increase to where it may also repress the reporter (“Intermediate State” inFIG. 1 ). At this time, an inducer molecule of Lacl may be added to interrogate if the curcumin has prevented engineered TetR binding its operator. This description is made by way of example and is equally applicable to other aTFs and target molecules. - In various embodiments, the present methods are extended to include any substrate that is changed into an inducing molecule, for example IPTG in the case of Lacl, whose concentration is gradually increased through an enzymatic activity. One advantage of this approach is that a single mixture containing the non-cognate target ligand, substrate, IVTT, and lysis system reduces the number of components that need to be combined. In its final state, the multiple repressor system only allows the creation of reporter message and thus reporter protein when the engineered protein candidate is modulated by the non-cognate target ligand.
- Similarly, the effective concentration of the non-engineered repressor may be lowered by targeted degradation, by, for example, proteases. Additionally or alternatively, in various embodiments, the non-engineered repressor may be sensitive to additional treatments. For example, it may denature or become inactive when, for example, one or more of temperature, pH, ionic strength, and charge, is altered (e.g. raised or lowered). Additionally or alternatively, in various embodiments, the non-engineered repressor may be sensitive to additional treatments, such that it denatures or becomes inactive when in the presence of light.
- In other embodiments, the reporter message may be made to be unstable in the absence of a stabilizing agent, whereupon the stabilizing reagent is added either together with or subsequent to the addition of the IVTT and/or lysis reagents.
- In other embodiments, a rapidly degrading reporter can be utilized to enhance the distinction between the response range of sensors that are responding to the target molecule.
- In another aspect, the present invention relates to compositions and methods for detecting, optionally acellularly, a target molecule using an engineered protein sensor and/or switch, such as an aTF, which is optionally detected for the desired functionality with acellular methods, such as in vitro transcription (IVT) or in vitro transcription and translation (IVTT) as described herein. For instance, in some embodiments, the detection of a target molecule is in a cell, such as any of those described herein, which has been manipulated to produce the target molecule.
- In some aspects, the present invention allows for engineering or use of a protein sensor and/or switch for which the protein sensor and/or switch's natural promoter and/or operator does not function suitably in a host cell. In some embodiments, the invention provides transfer of a functional operator site from one organism to another. For instance, such transfer is applicable to the present cell-free senor engineering as described herein and the use of an engineered sensor in a host cell (e.g. to detect production of a target molecule). In some embodiments, e.g. when deploying the present sensors (e.g. to detect production of a target molecule in a host cell), the present invention allows for the introduction of protein sensors and/or switches, e.g. aTFs, from a variety of organisms and the operation of the present sensing in a variety of host organisms, including those particularly desired for metabolic engineering, such as any of the host cells described herein.
- An illustrative method to transfer a functional operator site from one organism to another, such organisms may be selected from the cells described herein, is to clone the intergenic region immediately upstream of a gene regulated by the protein sensor and/or switch, e.g. aTF, of interest immediately upstream of reporter gene that is carried in the desired host organism. This naïve approach assumes that the transcriptional promoter will also function in the host organism. Assuming no host repressors recognize the exogenous operator site once cloned, the reporter will be constitutively on until expression of the regulator protein in a mode to bind its operator and repress the reporter signal. The basic approach has the advantage of, among others, not needing any information about the actual DNA sequence of the operator site but may suffer from the fact that the intergenic region cloned may have a promoter region incompatible with the new host organism.
- To circumvent the problem of the host cell not being able to utilize the foreign promoter, an operator sequence may be cloned into a promoter region known to function in the host organism between the transcriptional promoter and ribosome binding site. Sometimes operator sequences are longer than the allowable sequence space between the promoter and RBS sites. In such cases the operator may be placed 5′ or 3′ to the promoter site. In some cases, the operator consists of two regions of DNA separated by some number of bases. In such cases, it may be advantageous to flank either or both the promoter and/or RBS site with the operator binding sequence. In some cases, multiple sets of operator sites may by introduced in the promoter RBS region to increase the number of binding aTFs to more than 1.
- Construction of synthetic promoter/operators allow the aTF to function in any organism for which the promoter/RBS paradigm is maintained, including eukaryotes such as yeast. Optionally, in eukaryotes, the aTF may be expressed as a fusion with a nuclear localization signal. The synthetic promoter/operators also function in the context of IVTT so long as the promoter and RBS are recognized by the IVTT system. RBS may be replaced by internal ribosome entry sites for translation initiation.
- In various embodiments, the present invention allows for engineering a host cell to produce a target molecule and the target molecule is detected or detectable using one or more of the engineered protein sensor and/or switch. In various embodiments, cells are engineered with a multiplex genome engineering technique (e.g.
- Multiplexed Automated Genome Engineering (MAGE, see, e.g., Wang et al., Nature, 460:894-898 (2009); Church et al., U.S. Patent No. 8,153,432, the contents of which are hereby incorporated by reference in their entireties), conjugative assembly genome engineering (CAGE, see, e.g., Isaacs, F. J. et al. Science 333, 348-353, the contents of which are hereby incorporated by reference in their entireties), a method involving a double-strand break (DSB) or single-strand break or nick which can be created by a site-specific nuclease such as a zinc-finger nuclease (ZFN) or TAL effector domain nuclease (TALEN) or BurrH binding domain (BuD)-derived nucleases, or CRISPR/Cas9 system with an engineered crRNA/tracrRNA (or synthetic guide RNA) to guide specific cleavage (see, e.g., U.S. Patent Publications 2003/0232410; 2005/0208489; 2005/0026157; 2005/0064474; 2006/0188987; 2009/0263900; 2009/0117617; 2010/0047805; 2011/0207221; 2011/0301073 and International Patent Publication WO 2007/014275, and Gaj, et al. Trends in Biotechnology, 31(7), 397-405 (2013), the contents of which are hereby incorporated by reference in their entireties, or utilizes the organism's native CRISPR system together with a recombinase (e.g. ssDNA recombinase system, which may include a single-stranded annealing protein (SSAP), such as the A Red recombineering system (e.g., Beta protein) or RecET system (e.g., recT), or homologous system, including Rad52-like (of which A Red Beta, Sak, and Erf are members), Rad51-like (e.g., Sak4), and Gp2.5-like, each with distinct sequence profiles and folds. Datta et al., PNAS USA, 105:1626-31 (2008); Lopes, A., Nucleic Acids Research, 38(12), 3952-3962, which are hereby incorporated by reference in their entireties, see also International Patent Publication WO/2015/017866, the contents of which are hereby incorporated by reference in its entirety), the disclosures of which are incorporated by reference in their entireties for all purposes)).
- In various embodiments, the engineered protein sensor and/or switch is an aTF, for instance a eukaryotic aTF. In various embodiments, engineered protein sensor and/or switch is an engineered version of a prokaryotic transcriptional regulator family such as a member of the LysR, AraC/XylS, TetR, LuxR, Lacl, ArsR, MerR, AsnC, MarR, NtrC (EBP), OmpR, DeoR, Cold shock, GntR, and Crp families.
- In various embodiments, engineered protein sensor and/or switch is an engineered version of a prokaryotic transcriptional regulator family such as a member of the AbrB, AlpA, AraC, ArgR, ArsR, AsnC, BetR, Bhl, CitT, CodY, ComK, Crl, Crp, CsoR, CtsR, DeoR, DnaA, DtxR, Ecf, FaeA, Fe_dep_repress, FeoC, Fis, FlhC, FlhD, Fur, GntR, GutM, Hns, HrcA, HxIR, IcIR, KorB, Lacl, LexA, Lsr2, LuxR, LysR, LytTR, MarR, MerR, MetJ, Mga, Mor, MtIR, NarL, NtrC, OmpR, PadR, Prd, PrrA, PucR, PuR, Rok, Ros_MucR, RpiR, RpoD, RpoN, Rrf2, RtcR, Sarp, SfsA, SinR, SorC, Spo0A, TetR, TrmB, TrpR, WhiB, Xre, YcbB, and YesN families.
- In various embodiments, engineered protein sensor and/or switch is an engineered version of a member of the TetR family of receptors, such as AcrR, ActIl, AmeR AmrR, ArpR, BpeR, EnvR E, EthR, HydR, IfeR, LanK, LfrR, LmrA, MtrR, Pip, PqrA, QacR, RifQ, RmrR, SimReg, SmeT, SrpR, TcmR, TetR, TtgR, TtgW, UrdK, VarR, YdeS, ArpA, Aur1B, BarA, CalR1, CprB, FarA, JadR, JadR2, MphB, NonG, PhIF, TyIQ, VanT, TarA, TyIP, BM1P1, Bm1P1, Bm3R1, ButR, CampR, CamR, CymR, DhaR, KstR, LexA-like, AcnR, PaaR, Psbl, ThIR, UidR, YDH1, Betl, McbR, MphR, PhaD, Q9ZF45, TtK, Yhgd or YixD, CasR, IcaR, LitR, LuxR, LuxT, OpaR, Orf2, SmcR, HapR, Ef0113, HlylIR, BarB, ScbR, MmfR, AmtR, PsrA, and YjdC.
- The engineered protein sensor and/or switch may be an engineered version of a two-component or hybrid two-component system that directly bind both a ligand and DNA or work through a protein cascade.
- In various embodiments, the engineered protein sensor and/or switch is an aTF, for instance a eukaryotic aTF. In various embodiments, engineered protein sensor and/or switch is an engineered version of RovM (Yersinia pseudotuberculosis), HcaR (Acinetobacter), BIcR (Agrobacterium tumefaciens), HetR (Anabaena spp.), HetR (Anabaena spp.), DesR (B. subtilis), HyllIR (Bacillus cereus), PlcR (Bacillus cereus), CcpA (Bacillus megaterium), YvoA (Bacillus subtilis), AhrR (Bacillus subtilis), MntR (Bacillus subtilis), GabR (Bacillus subtilis), SinR (Bacillus subtilis), CggR (Bacillus subtilis), FapR (Bacillus subtilis), OhrR (Bacillus subtilis), PurR (Bacillus subtilis), Rrf2 (Bacillus subtilis), BmrR (Bacillus subtilis), CcpN repressor (Bacillus subtilis), TreR (Bacillus subtilis), CodY (Bacillus subtilis), yfiR (Bacillus subtilis), OhrR (Bacillus subtilis), Rex (Bacillus subtilis, Thermus thermophilus, Thermus aquaticus), NprR (Bacillus thuringiensis), BtAraR (Bacteriodes thetaiotaomicron), AraR (Bacteroides thetaiotaomicron VPI), DntR (Burkholderia cepacia), CmeR (Camplylobacter jejuni), CviR (Chromobacterium violaceum), TsaR (Comamonas testosteroni), CGL2612 (Corynebacterium glatamicum), CIgR (Corynebacterium glutamicum), LIdR (CGL2915) (Corynebacterium glutamicum), NtcA (Cyanobacterium Anabaena), HucR (Deinococcus radiodurans), Lacl (E. coli), PrgX (Enterococcus faecalis), NikR (Helobacter pylori), LmrR (Lactococcus lactis), CcpA (Lactococcus lactis), MtbCRP (Mycobacterium tuberculosis), EthR (Mycobacterium tuberculosis), MosR (Mycobacterium tuberculosis), PhoP (Mycobacterium tuberculosis), Rv1846c (Mycobacterium tuberculosis), EthR (Mycobacterium tuberculosis), LysR (Neisseria meningitdis), NMB0573/AsnC (Neisseria meningitidis), TetR-class H (Pasteurella multocida), MexR (Pseudomonas aeruginosa), DNR (Pseudomonas aeruginosa), PA01 (Pseudomonas aeruginosa), PA2196 (Pseudomonas aeruginosa), ttgR (Pseudomonas putida), Cra (Pseudomonas putida), QscR (Psudemonas aeruginosa), ActR (S. coelicolor), SCO0520 (S. coelicolor), CprB (S. coelicolor), SlyA (Salmonella enterica SlyA), FapR (Staphylococcus aureus), QacR (Staphylococcus aureus), SarZ (Staphylococcus aureus), IcaR (Staphylococcus aureus), LcaR (Staphylococcus epidermidis), SMET (Stenotrophomonas maltophilia), PcaV (SCO6704) (Streptomyces coelicolor), SCO4008 (Streptomyces coelicolor), NdgR (Streptomyces coelicolor), CprB (Streptomyces coelicolor), SCO0253 (Streptomyces coelicolor), TetR family (Streptomyces coelicolor), SCO0520 (Streptomyces coelicolor), SCO4942 (Streptomyces coelicolor), SCO4313 (Streptomyces coelicolor), TetR family (Streptomyces coelicolor), SCO7222 (Streptomyces coelicolor), SCO3205 (Streptomyces coelicolor), SCO3201 (Streptomyces coelicolor), ST1710 (Sulfolobus tokodaii ST1710), HrcA (Thermotoga maritima), TM1030 (Thermotoga maritime), tm1171 (thermotoga maritime), IcIR (thermotoga maritime), CarH (Thermus thermophilus), FadR (Vibrio cholerae), SmcR (Vibrio vulnificus), and RovA (Yersinia pestis).
- In various embodiments, engineered protein sensor and/or switch is an engineered version of MphR, AlkS, AlkR, CdaR, BenM, RUNX1, MarR, AphA, Pex, CatM, AtzR, CatR, ClcR, CbbR, CysB, CbnR, OxyR, OccR, and CrgA.
- In various embodiments, engineered protein sensor and/or switch is an engineered version of aN E. coli TF, such as ArcA, AtoC, BaeR, BasR, CitB, CpxR, CreB, CusR, DcuR, DpiA, EvgA, KdpE, NarL, NarP, OmpR, PhoB,
- PhoP, QseB, RcsB, RstA, TorR, UhpA, UvrY, YedW, YehT, YfhK, YgiX, YpdB, ZraR, RssB, AgaR, AIIR (ybbU), ArsR, AscG, Betl, BgIJ, CadC, CaiF, CeiD, CueR, CynR, ExuR, FecR, FucR, Fur, GatR, GutM, GutR (SrIR), ModE, MtIR, NagC, NanR (yhcK), NhaR, PhnF, PutA, RbsR, RhaR, RhaS, RpiR (AlsR), SdiA, UidR, XapR, XyIR, ZntR, AlIS (ybbS), Arac, ArgR, AsnC, CysB, CytR, DsdC, GaIR, GaiS, GcvA, GcvR, GIcC, GlpR, GntR, IdnR, LctR, Lrp, LysR, MeiR, MhpR, TdcA, TdcR, TetR, TreR, TrpR, and TyrR.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a plant transcriptional regulator family such as a member of the AP2, C2H2, Dof, LATA, HD-ZIP, M-type, NF-YA, S1Fa-like, TCP, YABBY, ARF, C3H, E2F/DP, GRAS, HRT-like, MIKC, NF-YB, SAP, Trihelix, ZF-HD, ARR-B, CAMTA, EIL, GRF, HSF, MYB, NF-YC, SBP, VOZ, bHLH, B3, CO-like, ERF, GeBP, LBD, MYB _related, NZZ/SPL, SRS, WOX, bZIP, BBR-BPC, CPP, FAR1, HB-PHD, LFY, NAC, Nin-like, STAT, WRKY, BES1, DBB, G2-like, HB-other, LSD, NF-X1, RAV, TALE, and Whirly families.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a yeast TF, such as Abf1p, Abf2p, Aca1p, Ace2p, Adr1p, Aft1p, Aft2p, Arg80p, Arg81p, Aro80p, Arr1p, Asg1p, Ash1p, Azf1p, Bas1p, Cad1p, Cat8p, Cbf1p, Cep3p, Cha4p, Cin5p, Crz1p, Cst6p, Cup2p, Cup9p, DaI80p, DaI81p, Dai82p, Dot6p, Ecm22p, Ecm23p, Eds1p, Ert1p, Fhl1p, Fkh1p, Fkh2p, Flo8p, Fzf1p, Gai4p, Gat1p, Gat3p, Gat4p, Gcn4p, Gcr1p, Gis1p, GIn3p, Gsm1p, Gzf3p, Haa1p, Hac1p, Hai9p, Hap1p, Hap2p, Hap3p, Hap4p, Hap5p,
- Hcm1p, Hmlalpha2p, Hmra2p, Hsf1p, Ime1p, Ino2p, Ino4p, Ixr1p, Kar4p, Leu3p, Lys14p, Mac1p, Mai63p, Matalpha2p, Mbp1p, Mcm1p, Met31p, Met32p, Met4p, Mga1p, Mig1p, Mig2p, Mig3p, Mot2p, Mot3p, Msn1p, Msn2p, Msn4p, Mss11p, Ndt80p, Nhp10p, Nhp6ap, Nhp6bp, Nrg1p, Nrg2p, Oaf1p, Pdr1p, Pdr3p, Pdr8p, Phd1p, Pho2p, Pho4p, Pip2p, Ppr1p, Put3p, Rap1p, Rdr1p, Rds1p, Rds2p, Reb1p, Rei1p, Rfx1p, Rgm1p, Rgt1p, Rim101p, RIm1p, Rme1p, Rox1p, Rph1p, Rpn4p, Rsc30p, Rsc3p, Rsf2p, Rtg1p, Rtg3p, Sfl1p, Sfp1p, Sip4p, Skn7p, Sko1p, Smp1p, Sok2p, Spt15p, Srd1p, Stb3p, Stb4p, Stb5p, Ste12p, Stp1p, Stp2p, Stp3p, Stp4p, Sum1p, Sut1p, Sut2p, Swi4p, Swi5p, Tbf1p, Tbs1p, Tea1p, Tec1p, Tod6p, Tos8p, Tye7p, Uga3p, Ume6p, Upc2p, Urc2p, Usv1p, Vhr1p, War1p, Xbp1p, YER064C, YER130C, YER184C, YGRO67C, YKL222C, YLL054C, YLR278C, YML081W, YNR063W, YPR013C, YPR015C, YPR022C, YPR196W, Yap1p, Yap3p, Yap5p, Yap6p, Yap7p, Yox1p, Yrm1p, Yrr1p, and Zap1p.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a nematode TF, such as ada-2, aha-1, ahr-1, alr-1, ast-1, atf-2, atf-5, atf-6, atf-7, athp-1, blmp-1, bra-2, brc-1, cbp-1, ccr-4, cdk-9, ced-6, ceh-1, ceh-10, ceh-12, ceh-13, ceh-14, ceh-16, ceh-17, ceh-18, ceh-19, ceh-2, ceh-20, ceh-21, ceh-22, ceh-23, ceh-24, ceh-26, ceh-27, ceh-28, ceh-30, ceh-31, ceh-32, ceh-33, ceh-34, ceh-36, ceh-37, ceh-38, ceh-39, ceh-40, ceh-41, ceh-43, ceh-44, ceh-45, ceh-48, ceh-49, ceh-5, ceh-6, ceh-60, ceh-7, ceh-8, ceh-9, cep-1, ces-1, ces-2, cey-1, cey-2, cey-3, cey-4, cfi-1, chd-3, cky-1, cnd-1, cog-1, crh-1, daf-12, daf-14, daf-16, daf-19, daf-3, daf-8, dcp-66, die-1, dlx-1, dmd-3, dmd-4, dmd-5, dmd-6, dnj-11, dpi-1, dpr-1, dpy-20, dpy-22, dpy-26, dro-1, dsc-1, efl-1, ef1-2, egl-13, egl-18, eg1-27, eg1-38, eg1-43, eg1-44, eg1-46, eg1-5, ek1-2, ek1-4, elc-1, elt-1, elt-2, elt-3, elt-4, elt-6, elt-7, end-1, end-3, eor-1, ets-4, ets-5, eya-1, fax-1, fkh-10, fkh-2, fkh-3, fkh-4, fkh-5, fkh-6, fkh-7, fkh-8, fkh-9, flt-1, fos-1, fozi-1, gei-11, gei-13, gei-3, gei-8, gfl-1, gla-3, ham-2, hbl-1, hif-1, hlh-1, hlh-10, hlh-11, hlh-12, hlh-13, hlh-14, hlh-15, hlh-16, hlh-17, hlh-19, hlh-2, hlh-25, hlh-26, hlh-27, hlh-28, hlh-29, hlh-3, hlh-30, hlh-4, hlh-6, hlh-8, hmg-1.1, hmg-1.2, hmg-1.2, hmg-11, hmg-12, hmg-3, hmg-4, hmg-5, hnd-1, hsf-1, irx-1, lag-1, let-381, let-418, Ifi-1, lim-4, lim-6, lim-7, lin-1, lin-11, lin-22, lin-26, lin-28, lin-31, lin-32, lin-35, lin-39, lin-40, lin-41, lin-48, lin-49, lin-54, lin-59, lin-61, hr-1, Ipd-2, Is1-1, Iss-4, Ist-3, mab-23, mab-3, mab-5, mab-9, mbf-1, mbr-1, mbr-1, mdl-1, mec-3, med-1, med-2, mef-2, mes-2, mes-4, mes-6, mex-1, mex-5, mex-6, mg1-2, mls-1, mis-2, mml-1, mua-1, mxl-1, mx1-2, mx1-3, nfi-1, ngn-1, nhr-1, nhr-10, nhr-100, nhr-101, nhr-102, nhr-103, nhr-104, nhr-105, nhr-106, nhr-107, nhr-108, nhr-109, nhr-11, nhr-110, nhr-111, nhr-112, nhr-113, nhr-114, nhr-115, nhr-116, nhr-117, nhr-118, nhr-119, nhr-12, nhr-120, nhr-121, nhr-122, nhr-123, nhr-124, nhr-125, nhr-126, nhr-127, nhr-128, nhr-129, nhr-13, nhr-130, nhr-131, nhr-132, nhr-133, nhr-134, nhr-135, nhr-136, nhr-137, nhr-138, nhr-139, nhr-14, nhr-140, nhr-141, nhr-142, nhr-143, nhr-145, nhr-146, nhr-147, nhr-148, nhr-149, nhr-15, nhr-150, nhr-152, nhr-153, nhr-154, nhr-155, nhr-156, nhr-157, nhr-158, nhr-159, nhr-16, nhr-161, nhr-162, nhr-163, nhr-164, nhr-165, nhr-166, nhr-167, nhr-168, nhr-169, nhr-17, nhr-170, nhr-171, nhr-172, nhr-173, nhr-174, nhr-175, nhr-176, nhr-177, nhr-178, nhr-179, nhr-18, nhr-180, nhr-181, nhr-182, nhr-183, nhr-184, nhr-185, nhr-186, nhr-187, nhr-188, nhr-189, nhr-19, nhr-190, nhr-191, nhr-192, nhr-193, nhr-194, nhr-195, nhr-196, nhr-197, nhr-198, nhr-199, nhr-2, nhr-20, nhr-201, nhr-202, nhr-203, nhr-204, nhr-205, nhr-206, nhr-207, nhr-208, nhr-209, nhr-21, nhr-210, nhr-211, nhr-212, nhr-213, nhr-214, nhr-215, nhr-216, nhr-217, nhr-218, nhr-219, nhr-22, nhr-220, nhr-221, nhr-222, nhr-223, nhr-225, nhr-226, nhr-227, nhr-228, nhr-229, nhr-23, nhr-230, nhr-231, nhr-232, nhr-233, nhr-234, nhr-237, nhr-238, nhr-239, nhr-241, nhr-242, nhr-243, nhr-244, nhr-245, nhr-246, nhr-247, nhr-248, nhr-249, nhr-25, nhr-250, nhr-251, nhr-252, nhr-253, nhr-254, nhr-255, nhr-256, nhr-257, nhr-258, nhr-26, nhr-260, nhr-261, nhr-262, nhr-263, nhr-264, nhr-265, nhr-266, nhr-267, nhr-268, nhr-269, nhr-27, nhr-270, nhr-271, nhr-272, nhr-273, nhr-274, nhr-275, nhr-276, nhr-277, nhr-278, nhr-28, nhr-280, nhr-281, nhr-282, nhr-283, nhr-285, nhr-286, nhr-288, nhr-3, nhr-30, nhr-31, nhr-32, nhr-33, nhr-34, nhr-35, nhr-36, nhr-37, nhr-38, nhr-39, nhr-4, nhr-40, nhr-41, nhr-42, nhr-43, nhr-44, nhr-45, nhr-46, nhr-47, nhr-47, nhr-48, nhr-49, nhr-5, nhr-50, nhr-51, nhr-52, nhr-53, nhr-54, nhr-55, nhr-56, nhr-57, nhr-58, nhr-59, nhr-6, nhr-60, nhr-61, nhr-62, nhr-63, nhr-64, nhr-65, nhr-66, nhr-67, nhr-68, nhr-69, nhr-7, nhr-70, nhr-71, nhr-72, nhr-73, nhr-74, nhr-75, nhr-76, nhr-77, nhr-78, nhr-79, nhr-8, nhr-80, nhr-81, nhr-82, nhr-83, nhr-84, nhr-85, nhr-86, nhr-87, nhr-88, nhr-89, nhr-9, nhr-90, nhr-91, nhr-92, nhr-94, nhr-95, nhr-96, nhr-97, nhr-98, nhr-99, nob-1, ntl-2, ntl-3, nurf-1, odr-7, oma-1, oma-2, pag-3, pal-1, pax-1, pax-3, peb-1, pes-1, pha-1, pha-2, pha-4, php-3, pie-1, pop-1, pos-1, pqn-47, pqn-75, psa-1, rabx-5, rbr-2, ref-1, mt-1, sbp-1, sdc-1, sdc-2, sdc-3, sea-1, sem-4, sex-1, skn-1, sknr-1, sma-2, sma-3, sma-4, smk-1, sop-2, sox-1, sox-2, sox-3, spr-1, sptf-2, sptf-3, srab-2, srt-58, srw-49, sta-1, tab-1, taf-4, taf-5, tag-153, tag-182, tag-185, tag-192, tag-295, tag-331, tag-347, tag-350, tag-68, tag-97, tbx-11, tbx-2, tbx-30, tbx-31, tbx-32, tbx-33, tbx-34, tbx-35, tbx-36, tbx-37, tbx-38, tbx-39, tbx-40, tbx-41, tbx-7, tbx-8, tbx-9, tra-1, tra-4, ttx-1, ttx-3, unc-120, unc-130, unc-3, unc-30, unc-37, unc-39, unc-4, unc-42, unc-55, unc-62, unc-86, vab-15, vab-3, vab-7, xbp-1, zag-1, zfp-1, zim-1, zip-1, zip-2, zip-3, zip-4, zip-5, and ztf-7.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a archeal TF, such as APE_0290.1, APE_0293, APE_0880b, APE_1602a, APE_2413, APE_2505, APE_0656a, APE_1799a,
- APE_1458a, APE_1495a, APE_2570.1, APE_0416b.1, APE_0883a, APE_0535, APE_0142, APE_2021.1, APE_0060.1, APE_0197.1, APE_0778, APE_2011.1, APE_0168.1, APE_2517.1, APE_0288, APE_0002, APE_1360.1, APE_2091.1, APE_0454, APE1 862.1, APE_0669.1, APE_2443.1, APE_0787.1, APE_2004.1, APE_0025.1, APE_0153.1, AF0653, AF1264, AF1270, AF1544, AF1743, AF1807, AF1853, AF2008, AF2136, AF2404, AF0529, AF0114, AF0396, AF1298, AF1564, AF1697, AF1869, AF2271, AF1404, AF1148, AF0474, AF0584, AF1723, AF1622, AF1448, AF0439, AF1493, AF0337, AF0743, AF0365, AF1591, AF0128, AF0005, AF1745, AF0569, AF2106, AF1785, AF1984, AF2395, AF2232, AF0805, AF1429, AF0111, AF1627, AF1787, AF1793, AF1977, AF2118, AF2414, AF0643, AF1022, AF1121, AF2127, AF0139, AF0363, AF0998, AF1596, AF0673, AF2227, AF1542, AF2203, AF1459, AF1968, AF1516, AF0373, AF1817, AF1299, AF0757, AF0213, AF1009, AF1232, AF0026, AF1662, AF1846, AF2143, AF0674, Cmaq_0146, Cmaq_0924, Cmaq_1273, Cmaq_1369, Cmaq_1488, Cmaq_1508, Cmaq_1561, Cmaq_1699, Cmaq_0215, Cmaq_1704, Cmaq_1956, Cmaq_0058, Cmaq_1637, Cmaq_0227, Cmaq_0287, Cmaq_1606, Cmaq_1720, Cmaq_0112, Cmaq_1149, Cmaq_1687, Cmaq_0411, Cmaq_1925, Cmaq_0078, Cmaq_0314, Cmaq_0768, Cmaq_1206, Cmaq_0480, Cmaq_0797, Cmaq_1388, Cmaq_0152, Cmaq_0601, Cmaq_1188, Mboo_0375, Mboo_0423, Mboo_0749, Mboo_1012, Mboo_1134, Mboo_1154, Mboo_1189, Mboo_1266, Mboo_1711, Mboo_1971, Mboo_0002, Mboo_0956, Mboo_1071, Mboo_1405, Mboo_1643, Mboo_0973, Mboo_1170, Mboo_0158, Mboo_0195, Mboo_0277, Mboo_1462, Mboo_1574, Mboo_1649, Mboo_2112, Mboo_0013, Mboo_0386, Mboo_0946, Mboo_0977, Mboo_1081, Mboo_2241, Mboo_0142, Mboo_0396, Mboo_0409, Mboo_0976, Mboo_2244, Mboo_0526, Mboo_0346, Mboo_1018, Mboo_0917, Mboo_0323, Mboo_0916, Mboo_1680, Mboo_1288, Mboo_2311, Mboo_2048, Mboo_1027, Mboo_2312, rrnAC0161, rrnAC0578, rrnAC0961, rrnAC3494, rrnB0118, pNG7045, pNG6160, rrnAC0867, rrnAC2723, rrnAC3399, rrnAC3447, rrnB0052, rrnAC1653, rrnAC2779, pNG7038, rrnAC1252, rrnAC3288, rrnAC3307, rrnAC0503, rrnAC1269, pNG6047, rrnAC2622, rrnAC3290, rrnAC3365, rrnAC2301, pNG6157, rrnAC2002, rrnAC1238, rrnAC3207, pNG2039, pNG7160, rrnAC2748, rrnB0134, rrnAC2283, rrnAC1714, rrnAC1715, rrnAC2338, rrnAC2339, rrnAC2900, rrnAC0341, rrnAC3191, rrnAC1825, rrnAC2037, rrnAC0496, rrnAC3074, rrnAC2669, rrnAC0019, rrnACO231, rrnAC0564, rrnAC0640, rrnAC 1193, rrnAC 1687, rrnAC 1786, rrnAC 1895, rrnAC1953, rrnAC 1996, rrnAC2017, rrnAC2022, rrnAC2052, rrnAC2070, rrnAC2160, rrnAC2472, rrnAC2785, rrnAC2936, rrnAC3167, rrnAC3451, rrnAC3486, rrnAC3490, rrnB0253, rrnB0269, pNG7159, pNG7188, pNG7357, pNG6134, rrnAC0376, rrnAC1217, rrnAC1541, rrnAC1663, rrnAC3229, pNG7223, rrnAC0440, rrnAC0535, rrnAC1742, rrnAC2519, rrnAC1764, rrnAC1777, rrnAC2762, rrnAC3264, rrnAC0417, rrnAC1303, rrnB0301, pNG6155, pNG7021, pNG7343, rrnAC1964, pNG7171, rrnAC1338, pNG7344, rrnACO230, rrnAC1971, rrnB0222, rrnAC0385, rrnAC0312, pNG7133, rrnAC0006, rrnAC1805, rrnAC3501, pNG7312, rrnAC0435, rrnAC0768, rrnAC0992, rrnAC2270, rrnAC3322, rrnB0112, rrnB0157, rrnB0161, pNG6058, pNG6092, pNG5119, pNG5140, pNG4042, pNG2006, pNG1015, rrnAC0199, rrnAC0681, rrnAC1765, rrnAC1767, pNG5067, pNG7180, pNG7307, pNG7183, rrnAC3384, pNG5131, rrnAC2777, pNG5071, rrnAC1472, pNG7308, rrnAC0869, rrnB0148, rrnAC2051, rrnAC0016, rrnAC1875, pNG6072, pNG6123, rrnAC2769, rrnAC1357, rrnAC1126, rrnAC0861, rrnAC0172, rrnAC0420, rrnAC0914, rrnAC2354, rrnAC3310, rrnAC3337, pNG5013, pNG5133, rrnAC3082, rrnB0074, pNG6075, pNG5024, rrnAC0924, rrnB0235, pNG7146, VNG0462C, VNG7122, VNG7125, VNG2445C, VNG0591C, VNG1843C, VNG0320H, VNG1123Gm, VNG1237C, VNG1285G, VNG2094G, VNG1351G, VNG1377G, VNG1179C, VNG1922G, VNG1816G, VNG0134G, VNG0194H, VNG0147C, VNG6193H, VNG2163H, VNG0101G, VNG1836G, VNG0530G, VNG0536G, VNG0835G, VNG2579G, VNG6349C, VNG1394H, VNG0113H, VNG0156C, VNG0160G, VNG0826C, VNG0852C, VNG1207C, VNG1488G, VNG6065G, VNG6461G, VNG7048, VNG7161, VNG1464G, VNG1548C, VNG0247C, VNG0471C, VNG0878Gm, VNG1029C, VNG1616C, VNG2112C, VNG6009H, VNG7007, VNG0704C, VNG1405C, VNG6318G, VNG0142C, VNG6072C, VNG6454C, VNG7053, VNG7156, VNG0703H, VNG0258H, VNG0751C, VNG1426H, VNG2020C, VNG6048H, VNG6126H, VNG6239G, VNG6478H, VNG7102, VNG6027G, VNG7023, VNG1786H, VNG2629G, VNG1598a, VNG7031, VNG6037G, VNG7171, VNG7114, VNG7038, VNG2243G, VNG6140G, VNG7100, VNG6476G, VNG6438G, VNG6050G, VNG0726C, VNG1390H, VNG6351G, VNG2184G, VNG0869G, VNG0254G, VNG6389G, VNG0315G, VNG0734G, VNG0757G, VNG1451C, VNG1886C, VNG1903Cm, VNG0985H, VNG6377H, HQ2607A, HQ2612A, HQ2779A, HQ1740A, HQ1541A, HQ1491A, HQ2619A, HQ1811A, HQ3063A, HQ3354A, HQ3642A, HQ2773A, HQ1436A, HQ2221A, HQ1414A, HQ3339A, HQ2484A, HQ3265A, HQ3620A, HQ1268A, HQ1388A, HQ1866A, HQ1563A, HQ1710A, HQ1962A, HQ1084A, HQ1739A, HQ1861A, HQ1863A, HQ2750A, HQ2664A, HQ2869A, HQ3058A, HQ3361A, HQ1277A, HQ2225A, HQ1993A, HQ1937A, HQ1088A, HQ1724A, HQ1568A, HQ2167A, HQ1230A, HQ2407A, HQ3108A, HQ1973A, HQ3260A, HQ2527A, HQ3410A, HQ2369A, HQ2564A, HQ1153A, HQ1227A, HQ3654A, HQ1867A, HQ2571A, HQ1625A, HQ3408A, HQ1689A, HQ2491A, HQ2726A, HQ2987A, HQ1041A, HQ1898A, HQ1900A, HQ1118A, Hbut_1261, Hbut_0073, Hbut_0009, Hbut_0100, Hbut_0987, Hbut_1340, Hbut_0120, Hbut_0990, Hbut_0316, Hbut_0659, Hbut_0660, Hbut_0366, Hbut_0204, Hbut_1 498, Hbut_1630, Hbut_1485, Hbut_1260, Hbut_0942, Hbut_0163, Hbut_0116, Hbut_0207, Hbut_1516, Hbut_0476, Hbut_1139, Hbut_0299, Hbut_0033, Hbut_0336, Hbut_1471, Hbut_1522, Hbut_0601, Hbut_0934, Hbut_0458, Hbut_0054, Hbut_1136, Hbut_0646, Hbut_0815, Igni_0122, Igni_0494, Igni_0706, Igni_1249, Igni_0226, Igni_0308, Igni_0658, Igni_0702, Igni_0486, Igni_0602, Igni_1394, Igni_0858, Igni_1361, Igni_0354, Igni_0989, Igni_1372, Igni_1124, Msed_0229, Msed_0717, Msed_1005, Msed_1190, Msed_1224, Msed_1970, Msed_2175, Msed_0166, Msed_0688, Msed_1202, Msed_1209, Msed_1765, Msed_1956, Msed_2295, Msed_0619, Msed_0621, Msed_2232, Msed_0140, Msed_2016, Msed_0767, Msed_1126, Msed_0856, Msed_0992, Msed_1773, Msed_1818, Msed_2183, Msed_1598, Msed_1725, Msed_2276, Msed_2293, Msed_1450, Msed_0265, Msed_0492, Msed_1279, Msed_1397, Msed_1563, Msed_1566, Msed_2027, Msed_0565, Msed_0868, Msed_1371, Msed_1483, Msed_1728, Msed_1351, Msed_1733, Msed_2209, Msed_2279, Msed_2233, MTH107, MTH517, MTH899, MTH1438, MTH1795, MTH163, MTH1288, MTH1349, MTH864, MTH1193, MTH254, MTH821, MTH1696, MTH739, MTH603, MTH214, MTH936, MTH659, MTH700, MTH729, MTH967, MTH1553, MTH1328, MTH1470, MTH1285, MTH1545, MTH931, MTH313, MTH1569, MTH281, MTH1488, MTH1521, MTH1627, MTH1063, MTH1787, MTH885, MTH1669, MTH1454, Msm_1107, Msm_1126, Msm_1350, Msm_1032, Msm_0213, Msm_0844, Msm_1260, Msm_0364, Msm_0218, Msm_0026, Msm_0329, Msm_0355, Msm_0453, Msm_1150, Msm_1408, Msm_0864, Msm_0413, Msm_1230, Msm_1499, Msm_1417, Msm_1250, Msm_1090, Msm_0720, Msm_0650, Msm_0424, Msm_0631, Msm_1445, Mbur_0656, Mbur_1148, Mbur_1658, Mbur_1965, Mbur_2405, Mbur_1168, Mbur_0166, Mbur_0946, Mbur_1817, Mbur_1830, Mbur_0231, Mbur_0234, Mbur_2100, Mbur_1375, Mbur_2041, Mbur_0776, Mbur_0783, Mbur_2071, Mbur_1477, Mbur_1871, Mbur_1635, Mbur_1221, Mbur_0292, Mbur_0512, Mbur_0609, Mbur_0661, Mbur_1211, Mbur_1719, Mbur_1811, Mbur_1931, Mbur_2112, Mbur_2130, Mbur_2048, Mbur_2144, Mbur_0368, Mbur_1483, Mbur_2274, Mbur_1359, Mbur_2306, Mbur_1647, Mbur_0631, Mbur_0378, Mbur_0085, Mbur_1496, Mbur_0963, Mbur_0372, Mbur_1140, Mbur_2097, Mbur_2262, Mbur_1532, Maeo_0092, Maeo_0872, Maeo_0888, Maeo_1298, Maeo_1146, Maeo_1061, Maeo_1147, Maeo_0865, Maeo_0659, Maeo_0679, Maeo_1305, Maeo_0977, Maeo_1182, Maeo_1472, Maeo_1362, Maeo_0019, Maeo_0277, Maeo_0356, Maeo_0719, Maeo_1032, Maeo_1289, Maeo_0698, Maeo_1183, Maeo_0223, Maeo_0822, Maeo_0218, Maeo_0186, Maeo_1155, Maeo_0575, Maeo_0728, Maeo_0696, Maeo_0664, MJ0432, MJ1082, MJ1325, MJ0229, MJ0361, MJ1553, MJ1563, MJ0774, MJ1398, MJ0723, MJ0151, MJ0589a, MJECL29, MJ1647, MJ1258, MJ0168, MJ0932, MJ0080, MJ0549, MJ0767, MJ1679, MJ0568, MJ1005, MJ0529, MJ0586, MJ0621, MJ1164, MJ1420, MJ1545, MJ0272, MJ0925, MJ0300, MJ1120, MJ0379, MJ0558, MJ1254, MJ0159, MJ0944, MJ0241, MJ0173, MJ0507, MJ0782, MJ0777, MJ1503, MJ1623, MmarC5_0244, MmarC5_1146, MmarC5_0136, MmarC5_1648, MmarC5_1124, MmarC5_0967, MmarC5_1647, MmarC5_0448, MmarC5_0231, MmarC5_0579, MmarC5_1252, MmarC5_1664, MmarC5_0974, MmarC5_0625, MmarC5_1666, MmarC5_0111, MmarC5_1039, MmarC5_0316, MmarC5_0131, MmarC5_1762, MmarC5_1579, MmarC5_0380, MmarC5_0898, MmarC5_0813, MmarC5_1143, MmarC5_1694, MmarC5_1294, MmarC5_1236, MmarC5_1150, MmarC5_1138, MmarC5_1543, MmarC5_0999, MmarC5_1507, MmarC5_0876, MmarC5_0202, MmarC5_1416, MmarC5_0612, MmarC5_0571, MmarC5_1100, MmarC5_1639, MmarC5_1644, MmarC5_0714, MmarC5_0484, MmarC5_0976, MmarC6_0024, MmarC6_0026, MmarC6_0104, MmarC6_0105, MmarC6_0128, MmarC6_0252, MmarC6_0566, MmarC6_0917, MmarC6_1231, MmarC6_0916, MmarC6_1531, MmarC6_0524, MmarC6_1326, MmarC6_1644, MmarC6_0165, MmarC6_0929, MmarC6_0258, MmarC6_0037, MmarC6_0055, MmarC6_1206, MmarC6_1606, MmarC6_0210, MmarC6_0325, MmarC6_0744, MmarC6_0850, MmarC6_1025, MmarC6_1226, MmarC6_1398, MmarC6_1462, MmarC6_1664, MmarC6_1175, MmarC6_0959, MmarC6_0931, MmarC6_0136, MmarC6_0425, MmarC6_0508, MmarC6_0285, MmarC6_0184, MmarC6_0443, MmarC6_0782, MmarC6_1297, MmarC6_0861, MmarC6_0696, MmarC6_1636, MmarC6_1817, MmarC6_0908, MmarC6_0913, MmarC6_0262, MmarC6_1567, MmarC6_1748, MmarC7_0274, MmarC7_0687, MmarC7_1029, MmarC7_1513, MmarC7_1661, MmarC7_1030, MmarC7_0388, MmarC7_0257, MmarC7_0592, MmarC7_1384, MmarC7_1017, MmarC7_1655, MmarC7_0306, MmarC7_0712, MmarC7_0235, MmarC7_0457, MmarC7_0521, MmarC7_0692, MmarC7_0743, MmarC7_0919, MmarC7_1096, MmarC7_1211, MmarC7_1587, MmarC7_1702, MmarC7_0987, MmarC7_1015, MmarC7_0031, MmarC7_1400, MmarC7_1790, MmarC7_1499, MmarC7_1629, MmarC7_1168, MmarC7_1727, MmarC7_0621, MmarC7_1085, MmarC7_1260, MmarC7_0085, MmarC7_0265, MmarC7_1461, MmarC7_1038, MmarC7_1033, MmarC7_0154, MmarC7_0352, MmarC7_1652, MmarC7_1455, MMP0499, MMP1442, MMP0480, MMP0752, MMP0032, MMP0460, MMP0637, MMP0033, MMP0217, MMP1137, MMP0386, MMP1347, MMP1015, MMP0719, MMP0020, MMP0631, MMP0742, MMP1467, MMP1052, MMP0097, MMP0209, MMP0568, MMP0674, MMP0678, MMP0993, MMP1210, MMP1275, MMP1447, MMP1646, MMP1499, MMP0018, MMP1712, MMP0402, MMP0787, MMP0607, MMP0168, MMP0700, MMP0465, MMP1376, MMP0086, MMP0257, MMP0840, MMP1023, MMP0791, MMP0799, MMP0041, MMP0036, MMP0907, MMP0629, MMP1100, Mevan_0753, Mevan_1029, Mevan_1232, Mevan_1560, Mevan_1502, Mevan_1030, Mevan_0459, Mevan_0343, Mevan_0658, Mevan_1373, Mevan_1201, Mevan_1594, Mevan_1567, Mevan_1203, Mevan_0375, Mevan_0778, Mevan_0320, Mevan_0525, Mevan_0587, Mevan_0758, Mevan_0808, Mevan_0951, Mevan_1109, Mevan_1444, Mevan_1514, Mevan_1517, Mevan_1014, Mevan_0136, Mevan_0295, Mevan_1389, Mevan_1479, Mevan_1173, Mevan_1578, Mevan_1653, Mevan_0686, Mevan_1098, Mevan_1270, Mevan_0270, Mevan_0282, Mevan_1620, Mevan_1668, Mevan_1038, Mevan_1044, Mevan_1050, Mayan _1056, Mayan _1033, Mevan_0014, Mevan_0425, Mevan_0095, Mlab_0303, Mlab_0817, Mlab_0821, Mlab_1236, Mlab_1381, Mlab_0824, Mlab_0002, Mlab_0494, Mlab_0162, Mlab_0744, Mlab_1629, Mlab_0854, Mlab_0909, Mlab_1549, Mlab_0037, Mlab_0071, Mlab_0160, Mlab_1173, Mlab_1603, Mlab_1630, Mlab_1666, Mlab_1628, Mlab_0070, Mlab_1522, Mlab_0331, Mlab_1259, Mlab_0324, Mlab_1366, Mlab_1576, Mlab_0353, Mlab_0010, Mlab_0295, Mlab_0588, Mlab_1668, Mlab_0447, Mlab_0440, Mlab_0197, Mlab_1697, Mlab_1694, Mlab_1710, Mlab_1511, Mlab_0458, Mlab_0497, Mlab_0762, Mlab_0988, Mlab_0826, Memar_0011, Memar_0013, Memar_1330, Memar_1512, Memar_1567, Memar_1770, Memar_2080, Memar_0129, Memar_0140, Memar_0431, Memar_1231, Memar_1756, Memar_2162, Memar_2068, Memar_1225, Memar_0002, Memar_1921, Memar_0834, Memar_2239, Memar_1448, Memar_0817, Memar_2411, Memar_2490, Memar_2264, Memar_1471, Memar_1420, Memar_0458, Memar_1291, Memar_1391, Memar_1410, Memar_1819, Memar_2218, Memar_2347, Memar_2360, Memar_2449, Memar_1304, Memar_0106, Memar_0096, Memar_0419, Memar_1120, Memar_0385, Memar_0555, Memar_1103, Memar_1319, Memar_2487, Memar_1252, Memar_1388, Memar_0473, Memar_1524, Memar_0459, Memar_0487, Memar_1209, Memar_1387, Memar_2116, MK0576, MK1025, MK0542, MK1515, MK0506, MK1677, MK1502, MK1190, MK0175, MK0800, MK0457, MK0449, MK1380, MK1430, MK0574, MK1482, MK0984, MK0337, MK1587, MK0839, MK0619, MK0858, MK0495, MK0253, Mthe_1108, Mthe_1291, Mthe_1230, Mthe_0612, Mthe_0503, Mthe_0879, Mthe_0047, Mthe_0598, Mthe_0023, Mthe_0662, Mthe_0543, Mthe_0154, Mthe_0459, Mthe_1389, Mthe_1446, Mthe_1633, Mthe_1233, Mthe_0669, Mthe_0067, Mthe_0404, Mthe_0982, Mthe_1201, Mthe_0152, Mthe_0265, Mthe_1650, Mthe_1683, Mthe_0889, MA0191, MA0342, MA0380, MA1458, MA2551, MA3784, MA3925, MA3940, MA3952, MA4076, MA4344, MA4484, MA4576, MA0207, MA0750, MA2499, MA3597, MA4479, MA2544, MA4480, MA0504, MA2921, MA0862, MA0205, MA0460, MA0622, MA0629, MA1953, MA4398, MA4560, MA0723, MA1529, MA1551, MA2421, MA1531, MA0924, MA0575, MA1588, MA0672, MA1395, MA4075, MA1763, MA2814, MA3468, MA0022, MA4338, MA2133, MA0971, MA1005, MA0067, MA1424, MA1815, MA4668, MA2914, MA3524, MA4040, MA4267, MA3984, MA0283, MA0333, MA0414, MA1339, MA3166, MA0176, MA0180, MA0743, MA1863, MA2051, MA2055, MA2206, MA2211, MA2771, MA3189, MA4167, MA1122, MA3015, MA0079, MA0989, MA4404, MA2093, MA1671, MA4106, MA4346, MA0278, MA4331, MA0179, MA2948, MA3586, MA2761, MA1487, MA1771, MA2746, MA0364, MA2951, MA0354, MA2902, MA0368, MA2764, MA2766, MA0178, MA2782, MA2493, MA0610, MA3871, MA0287, MA0359, MA1835, MA2057, MA2207, MA2212, MA3151, MA4622, MA0926, MA1664, MA4408, MA1868, Mbar_A0506, Mbar_A0581, Mbar_A0738, Mbar_A0909, Mbar_A1363, Mbar_A1705, Mbar_A1707, Mbar_A1708, Mbar_A1719, Mbar_A2323, Mbar_A2748, Mbar_A3221, Mbar_A3427, Mbar_A1541, Mbar_A1729, Mbar_A2416, Mbar_A3312, Mbar_A0803, Mbar_A3558, Mbar_A0794, Mbar_A2965, Mbar_A1070, Mbar_A1333, Mbar_A2865, Mbar_A1639, Mbar_A3371, Mbar_A0650, Mbar_A3377, Mbar_A3361, Mbar_A0654, Mbar_A3464, Mbar_A1460, Mbar_A2808, Mbar_A1584, Mbar_A2743, Mbar_A2250, Mbar_A0507, Mbar_A0992, Mbar_A1457, Mbar_A0588, Mbar_A0122, Mbar_A2068, Mbar_A0552, Mbar_A0621, Mbar_A0692, Mbar_A1033, Mbar_A2079, Mbar_A2171, Mbar_A2318, Mbar_A2819, Mbar_A2992, Mbar_A3339, Mbar_A1265, Mbar_A1377, Mbar_A1884, Mbar_A2294, Mbar_A3663, Mbar_A2575, Mbar_A2637, Mbar_A3146, Mbar_A3330, Mbar_A3493, Mbar_A2012, Mbar_A2036, Mbar_A2688, Mbar_A3560, Mbar_A1076, Mbar_A0340, Mbar_A0520, Mbar_A1497, Mbar_A3486, Mbar_A1949, Mbar_A0475, Mbar_A0579, Mbar_A1062, Mbar_A0595, Mbar_A3297, Mbar_A3442, Mbar_A3419, Mbar_A0834, Mbar_A0787, Mbar_A2740, Mbar_A1394, Mbar_A0196, Mbar_A1270, Mbar_A3331, Mbar_A3578, Mbar_A3670, Mbar_A1080, MM0272, MM0662, MM0841, MM1040, MM1257, MM1484, MM1796, MM2237, MM2242, MM2246, MM2247, MM2261, MM2525, MM2985, MM3068, MM3208, MM1882, MM1494, MM3092, MM1595, MM3173, MM0565, MM1492, MM0266, MM1080, MM1605, MM1650, MM2809, MM2861, MM2446, MM2441, MM2040, MM1728, MM1739, MM2416, MM1825, MM0666, MM0842, MM2657, MM1332, MM2573, MM1034, MM2606, MM0247, MM0444, MM0872, MM0927, MM1363, MM2394, MM2895, MM3179, MM1005, MM3233, MM1550, MM0359, MM0361, MM1586, MM1863, MM2851, MM2853, MM3117, MM0116, MM0289, MM0346, MM1903, MM3195, MM3170, MM1085, MM0386, MM2835, MM0811, MM1042, MM1027, MM2184, MM1028, MM0432, MM2546, MM1614, MM1772, MM0692, MM0146, MM0345, MM0369, MM1554, MM2854, MM1094, MM2042, MM3115, Msp_0061, Msp_0120, Msp_1519, Msp_0293, Msp_1556, Msp_0769, Msp_0168, Msp_0614, Msp_0518, Msp_0122, Msp_0383, Msp_1218, Msp_0446, Msp_0265, Msp_0608, Msp_1143, Msp_1207, Msp_0248, Msp_0512, Msp_0823, Msp_1188, Msp_0235, Msp_0194, Msp_1057, Msp_1097, Msp_0717, Msp_0971, Msp_1360, Msp_1272, Msp_1125, Msp_0149, Mhun_0040, Mhun_0316, Mhun_0873, Mhun_1073, Mhun_1644, Mhun_2448, Mhun_2633, Mhun_2472, Mhun_0365, Mhun_0919, Mhun_0576, Mhun_0165, Mhun_2458, Mhun_0842, Mhun_0941, Mhun_1324, Mhun_1346, Mhun_2089, Mhun_1313, Mhun_1731, Mhun_1706, Mhun_0152, Mhun_0501, Mhun_1037, Mhun_2548, Mhun_2928, Mhun_3036, Mhun_0241, Mhun_1541, Mhun_2190, Mhun_0646, Mhun_1347, Mhun_1533, Mhun_1553, Mhun_1866, Mhun_1954, Mhun_0253, Mhun_1259, Mhun_1451, Mhun_2502, Mhun_0684, Mhun_2259, Mhun_0763, Mhun_1327, Mhun_1530, Mhun_2935, Mhun_2804, Mhun_0568, Mhun_0593, Mhun_1236, Mhun_1656, Mhun_2481, Mhun_2797, Mhun_0497, Mhun_0575, Mhun_0588, NEQ328, NEQ229, NEQ348, NEQ288, NEQ453, NEQ143, NEQ039, NEQ276, NEQ098, NEQ541, NP1838A, NP2534A, NP3936A, NP6056A, NP2558A, NP1144A, NP0458A, NP2490A, NP2664A, NP3370A, NP0078A, NP5052A, NP4026A, NP6200A, NP0924A, NP4828A, NP2752A, NP6106A, NP2470A, NP2474A, NP0316A, NP0252A, NP5326A, NP1048A, NP2958A, NP5152A, NP4632A, NP3636A, NP3734A, NP4552A, NP5064A, NP1496A, NP4726A, NP2878A, NP0136A, NP0162A, NP0654A, NP1532A, NP1538A, NP1564A, NP2794A, NP4286A, NP4406A, NP5130A, NP5298A, NP6030A, NP6220A, NP4436A, NP1320A, NP2146A, NP3466A, NP4796A, NP5168A, NP3046A, NP2812A, NP3608A, NP2618A, NP6176A, NP3330A, NP7054A, NP2762A, NP4124A, NP3490A, NP1128A, NP1628A, NP2114A, NP0674A, NP2366A, NP3002A, NP3776A, NP4444A, NP1296A, NP1064A, NP4080A, NP4082A, NP0534A, NP2466A, NP3718A, NP5096A, NP2220A, NP5186A, NP1684A, NP2246A, NP4822A, NP4326A, NP4106A, NP2518A, NP5272A, NP6088A, NP4258A, PT00082, PT00457, PT00754, PT00795, PT00420, PT01287, PT00595, PT00891, PT00200, PT01201, PT00428, PT00376, PT00514, PT00375, PT00781, PT01148, PT00979, PT00276, PT00843, PT00557, PT01105, PT01211, PT01517, PT01052, PT01150, PT00114, PT01041, PT01176, PT00063, PT00799, PT01388, PT01389, PT00914, PT01110, PT01216, PT00675, PT01123, PT00506, PT01258, PT01372, PT00363, PT01340, PT01338, PT01067, PT01454, PT01523, PT00576, PT00198, PAE0731, PAE0738, PAE1612, PAE2042, PAE2911, PAE1948, PAE2655, PAE0385, PAE2225, PAE3116, PAE2186, PAE1103, PAE1592, PAE1848, PAE3387, PAE1507, PAE1986, PAE3469, PAE3471, PAE0659, PAE1443, PAE1484, PAE0296, PAE2022, PAE2357, PAE1544, PAE0640, PAE2309, PAE3163, PAE2449, PAE3605, PAE0783, PAE1627, PAE1638, PAE2071, PAE3208, PAE0019, PAE0813, PAE3327, PAE0146, PAE2679, PAE2684, PAE1218, PAE1760, PAE0013, PAE3437, PAE2640, PAE3378, PAE2164, PAE0171, PAE0170, PAE3329, PAE2120, PAE1645, PAE0781, PAE2282, Pars_0006, Pars_0433, Pars_0703, Pars_0836, Pars_0990, Pars_1924, Pars_2088, Pars_2298, Pars_0264, Pars_2028, Pars_0627, Pars_1855, Pars_2059, Pars_1853, Pars_0399, Pars_0425, Pars_1561, Pars_2084, Pars_0343, Pars_0668, Pars_2155, Pars_0438, Pars_1526, Pars_2364, Pars_1428, Pars_0037, Pars_1981, Pars_1988, Pars_2104, Pars_0057, Pars_0792, Pars_0504, Pars_0550, Pars_1742, Pars_1776, Pars_0311, Pars_0752, Pars_1087, Pars_1872, Pars_1005, Pars_0806, Pars_2186, Pars_2187, Pars_1743, Pars_2132, Pars_1649, Pars_1976, Pars_0035, Pars_1810, Pars_2125, Pcal_0142, Pcal_0905, Pcal_0946, Pcal_0412, Pcal_0495, Pcal_0687, Pcal_1273, Pcal_0822, Pcal_1595, Pcal_1185, Pcal_0610, Pcal_1183, Pcal_2085, Pcal_0796, Pcal_0536, Pcal_1689, Pcal_0008, Pcal_1198, Pcal_1653, Pcal_0295, Pcal_1924, Pcal_1927, Pcal_0200, Pcal_0589, Pcal_0596, Pcal_2145, Pcal_0791, Pcal_0023, Pcal_1415, Pcal_1735, Pcal_0266, Pcal_0346, Pcal_0543, Pcal_0792, Pcal_1032, Pcal_0159, Pcal_1078, Pcal_1890, Pcal_1316, Pcal_1055, Pcal_0584, Pcal_1734, Pcal_2147, Pcal_1638, Pcal_2070, Pisl_1759, Pisl_2001, Pisl_0858, Pisl_1838, Pisl_0307, Pisl_0653, Pisl_1426, Pisl_1248, Pisl_1639, Pisl_1808, Pisl_0995, Pisl_1590, Pisl_0997, Pisl_0709, Pisl_1563, Pisl_1834, Pisl_1578, Pisl_0622, Pisl_1613, Pisl_0725, Pisl_1023, Pisl_0410, Pisl_1076, Pisl_1655, Pisl_1662, Pisl_1854, Pisl_0045, Pisl_1100, Pisl_0810, Pisl_0572, Pisl_1971, Pisl_1303, Pisl_1717, Pisl_0038, Pisl_0979, Pisl_0565, Pisl_1878, Pisl_0807, Pisl_1975, Pisl_1974, Pisl_0573, Pisl_0955, Pisl_1667, Pisl_1074, Pisl_1008, Pisl_1250, PAB2298, PAB1869, PAB0625, PAB0751, PAB1002, PAB2328, PAB0125, PAB0208, PAB0619, PAB1229, PAB1227, PAB0108, PAB0322, PAB0392, PAB2312, PAB7115, PAB2062.1n, PAB1938, PAB1236, PAB2257, PAB7359, PAB2299, PAB0758a, PAB3089, PAB3117, PAB0960, PAB1522.1n, PAB2324, PAB0714, PAB2311, PAB1533, PAB0211, PAB2104, PAB2035, PAB0475, PAB0842, PAB0668, PAB7155, PAB3293, PAB0917, PAB0661, PAB0953, PAB1243, PAB1544, PAB0331, PAB1922, PAB7338, PAB0603, PAB1517, PAB1726, PAB1641, PAB1642, PAB0976, PAB1912, PAB0950, PAB0838, PF0007, PF0230, PF1072, PF1406, PF2051, PF0113, PF0232, PF1790, PF1088, PF0095, PF1734, PF0054, PF1543, PF1732, PF0250, PF0739, PF1231, PF1601, PF1022, PF1893, PF0607, PF0829, PF1722, PF1831, PF0322, PF0524, PF2053, PF0851, PF1194, PF0055, PF0505, PF0512, PF1386, PF1735, PF1794, PF1851, PF0691, PF0487, PF0988, PF1029, PF2062, PF0263, PF0709, PF1476, PF0584, PF1198, PF0535, PF1295, PF1338, PF1337, PF0687, PF1377, PF0491, PF0496, PF0661, PF1743, PF0124, PF0649, PH0062, PH1101, PH0199, PH0289, PH0825, PH1061, PH1406, PH1744, PH1930, PH1932, PH0977, PH0952, PH0180, PH1692, PH0045, PH1856.1n, PH0061, PHS045, PH1592, PH1916, PH0140, PH1519, PHS023, PH1055, PHS034, PHS051, PHSO46, PH0601, PHS024, PH0468, PH1163, PH0046, PH0787, PH0783, PH1471, PH1691, PH1748, PH1808, PH0660, PH0804, PH0995, PH0614, PH0914, PH0718.1n, PH1080, PH0763, PH1009, PH1161, PH1160, PH1482, PH0864, PH0619, PH0751, PH0799, PH1034, PH0588, Smar_0567, Smar_0017, Smar_0429, Smar_1295, Smar_0048, Smar_0184, Smar_0954, Smar_1451, Smar_0205, Smar_0336, Smar_0366, Smar_1141, Smar_0476, Smar_0879, Smar_0338, Smar_0194, Smar_0612, Smar_0915, Smar_1254, Smar_1341, Smar_0279, Smar_1409, Smar_0319, Smar_0758, Smar_1442, Smar_1514, Smar_1075, Smar_1322, Smar_0054, Smar_1137, Smar_1250, Smar_0918, Smar_0086, Saci_0006, Saci_0446, Saci_1068, Saci_1787, Saci_1979, Saci_0800, Saci_1710, Saci_2236, Saci_2266, Saci_2136, Saci_0992, Saci_0731, Saci_0752, Saci_1304, Saci_1588, Saci_0944, Saci_0843, Saci_0942, Saci_0264, Saci_1391, Saci_0476, Saci_1223, Saci_0112, Saci_0048, Saci_1851, Saci_0455, Saci_2061, Saci_2116, Saci_2167, Saci_2183, Saci_2296, Saci_0655, Saci_1344, Saci_1505, Saci_2359, Saci_1192, Saci_2313, Saci_0161, Saci_0102, Saci_0133, Saci_0874, Saci_1219, Saci_1482, Saci_1670, Saci_1956, Saci_2112, Saci_0488, Saci_0483, Saci_1180, Saci_1171, Saci_1186, Saci_1242, Saci_0489, Saci_1005, Saci_2352, Saci_0380, Saci_1336, Saci_1230, Saci_2283, Saci_1107, Saci_0866, Saci_1341, Saci_0652, Saci_0842, Saci_1161, SSO0458, SSO0620, SSO9953, SSO2688, SSO0200, SSO1423, SSO2114, SSO2347, SSO3103, SSO5522, SSO0977, SSO0606, SSO2131, SSO10340, SSO0157, SSO6024, SSO0659, SSO5826, SSO10342, SSO3242, SSO0669, SSO2273, SSO2244, SSO1589, SSO1255, SSO0447, SSO0785, SSO1008, SSO1219, SSO1306, SSO1536, SSO2058, SSO3061, SSO3080, SSO1868, SSO3097, SSO2474, SSO3188, SSO0107, SSO0270, SSO0387, SSO0942, SSO1066, SSO0040, SSO1264, SSO1384, SSO1750, SSO1897, SSO2090, SSO2132, SSO2933, SSO2992, SSO2897, SSO3176, SSO0048, SSO0365, SSO1082, SSO1108, SSO1352, SSO1101, SSO1110, SSO2652, SSO1695, SSO1748, SSO2957, SSO2327, SSO0038, SSO0049, SSO0994, SSO2138, SSO2571, SSO0951, SSO2206, SSO2089, SSO2598, SSO2506, SSO0446, SSO0946, SSO0266, SSO0426, SSO2073, STO236, ST1060, ST1064, ST1076, ST1486, ST1604, ST1889, STS229, STO720, STO173, STS095, ST2514, ST1022, ST2372, STO193, STO489, ST1115, ST1301, STSO42, ST1473, STS071, STS074, STS163, STS072, STS250, STS248, ST2039, ST2236, ST2114, ST2562, STO051, STO164, STO722, ST2550, ST1593, STO256, STO331, ST1268, ST2084, ST2190, ST1409, STO808, STS035, STO758, ST1043, ST1386, ST1710, ST1716, ST1867, ST1890, ST2388, STS086, STO749, STO837, STO980, ST2050, STO757, STO766, ST2210, ST1773, ST1340, ST1054, ST1275, ST1007, ST1041, STO684, STO072, STO349, ST1271, STO334, ST1630, STO371, TK0063, TK0559, TK1041, TK1261, TK1826, TK1881, TK2190, TK1086, TK1883, TK1955, TK2291, TK2134, TK1285, TK1487, TK0168, TK1331, TK0567, TK0834, TK1491, TK1210, TK2110, TK2052, TK0143, TK1413, TK2289, TK2270, TK1815, TK1439, TK0695, TK1259, TK0107, TK0448, TK1057, TK1058, TK1272, TK0697, TK0126, TK0539, TK1266, TK1688, TK2197, TK2218, TK1489, TK1339, TK0142, TK0169, TK1246, TK0770, TK1494, TK1924, TK2107, TK1143, TK1654, TK0151, TK0779, TK2151, TK0132, TK2287, TK1280, TK2024, TK0471, TK1769, TK1913, TK1050, Tpen_0466, Tpen_0552, Tpen_0860, Tpen_1509, Tpen_0232, Tpen_0836, Tpen_1499, Tpen_0577, Tpen_0018, Tpen_0579, Tpen_0150, Tpen_0366, Tpen_0869, Tpen_0668, Tpen_0348, Tpen_1236, Tpen_0124, Tpen_0102, Tpen_0973, Tpen_1621, Tpen_0378, Tpen_0538, Tpen_0707, Tpen_0776, Tpen_0069, Tpen_0090, Tpen_0173, Tpen_1796, Tpen_1358, Tpen_0115, Tpen_1464, Tpen_1595, Tpen_1401, Tpen_0901, Tpen_1818, Tpen_0293, Tpen_0690, Tpen_0374, Tpen_0710, Tpen_0070, Tpen_1551, Tpen_1591, Tpen_1154, Tpen_1562, Ta0472, Ta0731, Ta1110, Ta0115, Ta1173, Ta1443, Ta0185, Ta0678, Ta0608, Ta0257, Ta0981, Ta0093, Ta0550m, Ta0842, Ta0872, Ta1362m, Ta0736, Ta1394, Ta0166, Ta0675, Ta0748, Ta1231, Ta1186, Ta0106, Ta0948, Ta1282m, Ta1363, Ta0131, Ta0320m, Ta0411, Ta1064, Ta1166, Ta1218, Ta1503, Ta0201, Ta0346, Ta1496, Ta0868m, Ta1061m, Ta0825, Ta0795, Ta0199, Ta1485, Ta0945, Ta0940, Ta0134, Ta0685, Ta0890, Ta1324, TVN0192, TVN0983, TVN1251, TVN0658, TVN0295, TVN1196, TVN1337, TVN1127, TVN0160, TVN0945, TVN0938, TVN0292, TVN0236, TVN0364, TVN0447, TVN0906, TVN1422, TVN0185, TVN0291, TVN0514, TVN 1093, TVN0210, TVN 1272, TVN0519, TVN0603, TVN 1246, TVN 1408, TVN 1203, TVN1162, TVN0516, TVN1265, TVN1392, TVN1493, TVN0934, TVN0728, TVN0704, TVN1394, TVN0084, TVN1083, TVN1089, TVN0213, TVN1149, TVN0972, TVN0377, LRC567, RCIX1274, RCIX1420, RCIX1655, RCIX1698, RCIX2213, RCIX2336, RRC298, RRC486, RRC76, RCIX1140, RCIX2193, RCIX670, RCIX684, RCIX808, RCIX820, LRC582, RCIX785, LRC109, RCIX103, RCIX105, RCIX106, RCIX1508, RCIX1739, RCIX2247, RRC465, RCIX1740, RCIX2328, RRC178, LRC575, RCIX1349, RCIX1520, LRC520, RCIX125, RCIX1430, RCIX148, RCIX1527, RCIX1743, RCIX2456, RCIX449, RCIX571, RRC212, RCIX960, LRC190, RCIX1230, RCIX414, RCIX1747, LRC319, RCIX1292, RCIX1376, RCIX2173, RCIX2196, RRC154, RCIX1238, RCIX1068, RCIX1190, RCIX1914, RCIX2177, RCIX824, RCIX989, RCIX2108, LRC274, LRC304, RCIX1189, RCIX1785, RCIX1790, and RCIX90.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a B. subtilis TF, such as Abh, AbrB, AcoR, AdaA, AhrC, AlaR, AIsR, AnsR, AraR, ArfM, ArsR, AzIB, BirA, BkdR, BItR, BmrR, CcpA, CcpB, CcpC, CggR, CheB, CheV, CheY, CitR, CitT, CodY, ComA, ComK, ComZ, CssR, CtsR, DctR, DegA, DegU, DeoR, DnaA, ExuR, FNR, FruR, Fur, GabR, GerE, GIcK, GIcR, GIcT, GInR, GIpP, GItC, GItR, GntR, GutR, Hbs, Hpr, HrcA, HtrA, HutP, HxIR, loiR, Ipi, KdgR, KipR, LacR, LevR, LexA, LicR, LicT, LmrA, LrpA, LrpB, LrpC, LytR, LytT, ManR, MecA, Med, MntR, MsmR, Mta, MtIR, MtrB, NhaX, PadR, PaiA, PaiB, PerR, Phage PBSX transcriptional regulator, PhoP, PksA, PucR, PurR, PyrR, RbsR, ResD, Rho, RocR, Rok, RpIT, RsfA, SacT, SacV, SacY, SenS, SigA, SigB, SigD, SigE, SigF, SigG, SigH, Sigl, SigK, SigL, SigM, SigV, SigW, SigX, SigY, SigZ, SinR, Slr, SpIA, SpoOA, SpoOF, SpoIIID, SpoVT, TenA, Tenl, TnrA, TreR, TrnB-GIy1, TrnB-Phe, TrnD-Cys, TrnD-Gly, TrnD-Phe, TrnD-Ser, TrnD-Trp, TrnD-Tyr, Trnl-Gly, Trnl-Thr, TrnJ-Gly, TrnS-Leu2, TrnSL-Tyr1, TrnSL-VaI2, Xpf, Xre, XyIR, YacF, YazB, YbaL, YbbB, YbbH, YbdJ, YbfA, Ybfl, YbfP, YbgA, YcbA, YcbB, YcbG, YcbL, YccF, YccH, YceK, YcgE, YcgK, YcIA, YcIJ, YcnC, YcnK, YcxD, YczG, YdcH, YdcN, YdeB, YdeC, YdeE, YdeF, YdeL, YdeP, YdeS, YdeT, YdfD, YdfF, Ydfl, YdfL, YdgC, YdgG, YdgJ, YdhC, YdhQ, YdhR, YdiH, YdzF, YerO, YesN, YesS, YetL, YezC, YezE, YfhP, YfiA, YfiF, YfiK, YfiR, YfiV, YfmP, Yhbl, YhcB, YhcF, YhcZ, YhdE, Yhdl, YhdQ, YhgD, YhjH, YhjM, YisR, YisV, YjbD, Yjdl, YkmA, YkoG, YkoM, YkvE, YkvN, YkvZ, YlaC, YlbO, YIpC, YmfC, Ynel, YoaU, YobD, YobQ, YocG, YodB, YofA, YonR, YopO, YopS, YozA, YozG, YpbH, YpIP, YpoP, YpuH, YqaE, YqaF, YgaG, YqfL, YqzB, YraB, YraN, YrdQ, Yrhl, YrhM, YrkP, YrxA, YrzC, YsiA, YsmB, YtcD, YtdP, YtII, YtrA, YtsA, YttP, YtzE, YufM, YuIB, YurK, YusO, YusT, YuxN, YvaF, YvaN, YvaO, YvaP, YvbA, YvbU, YvcP, YvdE, YvdT, Yvfl, YyfU, YvhJ, YvkB, YvmB, YvnA, YvoA, YvqC, YvrH, Yvrl, YvyD, YvzC, YwaE, Ywbl, YwcC, YwfK, YwgB, YwhA, YwoH, YwqM, YwrC, YwtF, YxaD, YxaF, YxbF, YxdJ, YxjL, YxjO, YyaN, YybA, YybE, YybR, YycF, YydK, and Zur.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a Arabidopsis thaliana TF, such as AT1G01060, AT1G01380, AT1G01530, AT1G02340, AT1G04370, AT1G06160, AT1G07640, AT1G09530, AT1G09770, AT1G10170, AT1G12610, AT1G12860, AT1G12980, AT1G13960, AT1G14350, AT1G14920, AT1G15360, AT1G16490, AT1G18570, AT1G19220, AT1G19350, AT1G19850, AT1G21970, AT1G22070, AT1G23420, AT1G24260, AT1G24590, AT1G25560, AT1G26310, AT1G26870, AT1G26945, AT1G27730, AT1G28300, AT1G30210, AT1G30330, AT1G30490, AT1G32330, AT1G32540, AT1G32640, AT1G32770, AT1G33240, AT1G34370, AT1G34790, AT1G35515, AT1G42990, AT1G45249, AT1G46768, AT1G47870, AT1G51700, AT1G52150, AT1G52880, AT1G52890, AT1G53230, AT1G53910, AT1G54060, AT1G55580, AT1G55600, AT1G56010, AT1G56650, AT1G62300, AT1G62360, AT1G63650, AT1G65620, AT1G66350, AT1G66390, AT1G66600, AT1G67260, AT1G68640, AT1G69120, AT1G69180, AT1G69490, AT1G69600, AT1G70510, AT1G71030, AT1G71692, AT1G71930, AT1G73730, AT1G74930, AT1G75080, AT1G76420, AT1G77850, AT1G78600, AT1G79180, AT1G79580, AT1G79840, AT2G01500, AT2G01570, AT2G01930, AT2G02450, AT2G03340, AT2G16910, AT2G17950, AT2G20180, AT2G22300, AT2G22540, AT2G22630, AT2G22770, AT2G23760, AT2G24570, AT2G26150, AT2G27050, AT2G27300, AT2G27990, AT2G28160, AT2G28350, AT2G28550, AT2G28610, AT2G30250, AT2G30432, AT2G33810, AT2G33835, AT2G33860, AT2G33880, AT2G34710, AT2G36010, AT2G36270, AT2G36890, AT2G37260, AT2G37630, AT2G38470, AT2G40220, AT2G40950, AT2G42200, AT2G42830, AT2G43010, AT2G45190, AT2G45660, AT2G46270, AT2G46410, AT2G46680, AT2G46770, AT2G46830, AT2G46870, AT2G46970, AT2G47190, AT2G47460, AT3G01140, AT3G01470, AT3G02990, AT3G03450, AT3G04670, AT3G07650, AT3G10800, AT3G11440, AT3G12250, AT3G13540, AT3G13890, AT3G15170, AT3G15210, AT3G15500, AT3G15510, AT3G16770, AT3G16857, AT3G17609, AT3G18990, AT3G19290, AT3G20310, AT3G20770, AT3G22170, AT3G23130, AT3G23250, AT3G24650, AT3G25710, AT3G26744, AT3G26790, AT3G27785, AT3G27810, AT3G27920, AT3G28470, AT3G28910, AT3G44750, AT3G46640, AT3G48160, AT3G48430, AT3G49940, AT3G50410, AT3G51060, AT3G54220, AT3G54320, AT3G54340, AT3G54620, AT3G55370, AT3G56400, AT3G58070, AT3G58780, AT3G59060, AT3G61850, AT3G61890, AT3G61910, AT3G62420, AT4G00120, AT4G00180, AT4G00220, AT4G01250, AT4G01540, AT4G02560, AT4G04450, AT4G08150, AT4G09820, AT4G09960, AT4G15090, AT4G16110, AT4G16780, AT4G17750, AT4G18960, AT4G20380, AT4G21330, AT4G21750, AT4G23550, AT4G23810, AT4G24020, AT4G24240, AT4G24470, AT4G24540, AT4G25470, AT4G25480, AT4G25490, AT4G25530, AT4G26150, AT4G27330, AT4G27410, AT4G28110, AT4G28610, AT4G30080, AT4G31550, AT4G31800, AT4G31920, AT4G32730, AT4G32880, AT4G32980, AT4G34000, AT4G34590, AT4G34990, AT4G35900, AT4G36730, AT4G36870, AT4G36920, AT4G36930, AT4G37540, AT4G37650, AT4G37750, AT4G38620, AT5G01900, AT5G02030, AT5G02470, AT5G03150, AT5G03680, AT5G03790, AT5G04240, AT5G05410, AT5G06070, AT5G06100, AT5G06650, AT5G06950, AT5G06960, AT5G07100, AT5G07690, AT5G07700, AT5G08130, AT5G09750, AT5G10140, AT5G10510, AT5G11260, AT5G11510, AT5G12870, AT5G13790, AT5G14010, AT5G14750, AT5G14960, AT5G15840, AT5G15850, AT5G16560, AT5G16820, AT5G17300, AT5G17430, AT5G18560, AT5G18830, AT5G20240, AT5G20730, AT5G21120, AT5G22220, AT5G22570, AT5G23000, AT5G23260, AT5G26660, AT5G35550, AT5G35770, AT5G37020, AT5G37260, AT5G40330, AT5G40350, AT5G40360, AT5G41315, AT5G41410, AT5G42630, AT5G43270, AT5G45980, AT5G47220, AT5G48670, AT5G51990, AT5G52830, AT5G53200, AT5G53210, AT5G53950, AT5G54070, AT5G56110, AT5G56270, AT5G56860, AT5G59570, AT5G59820,
- AT5G60690, AT5G60890, AT5G60910, AT5G61270, AT5G61420, AT5G61850, AT5G62000, AT5G62020, AT5G62380, AT5G62430, AT5G65050, AT5G66870, AT5G67300, and AT5G67420.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a Drosophila melanogaster TF, such as CG10325, CG11648, CG6093, CG3796, CG9151, CG15845, CG3935, CG3166, CG8376, CG3258, CG6677, CG3629, CG1034, CG3578, CG11491, CG12653, CG1759, CG6384, CG11924, CG4881, CG8367, CG17894, CG8669, CG2714, CG5893, CG9745, CG5102, CG2189, CG33183, CG9908, CG10798, CG1897, CG11094, CG2711, CG10604, CG32346, CG5714, CG1765, CG7383, CG32180, CG8127, CG1007, CG2988, CG9015, CG14941, CG8365, CG2328, CG8933, CG10488, CG6502, CG10002, CG2707, CG10034, CG2047, CG4059, CG33133, CG9656, CG2692, CG3388, CG7952, CG6494, CG11607, CG9786, CG4694, CG9768, CG1619, CG5748, CG17117, CG17835, CG2275, CG33956, CG10197, CG4717, CG4761, CG3340, CG3647, CG3758, CG4158, CG4148, CG7664, CG10699, CG5954, CG17743, CG1264, CG3839, CG32120, CG1689, CG8346, CG6096, CG8361, CG1705, CG14548, CG8328, CG8333, CG2050, CG18740, CG9045, CG10250, CG11450, CG6534, CG3851, CG1133, CG7467, CG6824, CG5109, CG12212, CG3978, CG17077, CG9610, CG8246, CG6716, CG7230, CG6348, CG10393, CG1849, CG9495, CG1030, CG8544, CG7734, CG1641, CG16738, CG3956, CG3836, CG11121, CG7847, CG3992, CG7938, CG17958, CG6993, CG8573, CG8599, CG8409, CG8068, CG11502, CG4216, CG16778, CG1378, CG6883, CG8651, CG1374, CG1856, CG10619, CG2956, CG10388, CG2762, CG4380, CG6172, CG7803, CG1046, CG1048, CG3411, CG12154, CG7895, CG3827, CG11387, CG17950, CG12287, CG7450, CG2368, CG6143, CG6338, CG2939, CG6464, CG17228, CG1322, CG1449, CG7672, CG14307, CG7771, CG5403, CG3497, CG5488, CG4220, CG2125, CG18412, CG7902, CG7937, CG18023, CG9097, CG2102, CG1130, CG3242, CG10021, CG1132, CG3668, CG11921, CG11922, CG9310, CG8887, CG3114, CG6634, CG1464, CG11049, CG14513, CG3090, CG8404, CG3886, CG12052, CG4354, CG1454, CG7018, CG5583, CG2914, CG4952, CG5683, CG4491, CG33152, CG9930, CG5441, CG6570, CG3905, CG8704, CG17921, CG4817, CG7562, CG2851, CG5965, CG7508, CG5580, CG5557, CG6964, CG5575, CG6794, CG2655, CG3052, CG6545, CG7187, CG17161, CG8625, CG12399, CG1775, CG1429, CG31240, CG7260, CG5529, CG4654, CG12223, CG6376, CG5247, CG11494, CG33261, CG12296, CG8103, CG1072, CG7959, CG7960, CG8567, CG18389, CG11992, CG5069, CG12245, CG10601, CG6103, CG1864, CG2678, CG5264, CG11987, CG6215, CG8522, CG7199, CG11783, CG8396, CG11798, CG9019, CG4029, CG10036, CG7951, CG7659, CG1650, CG10159, CG15319, CG5838, CG9398, CG7413, CG5393, CG10571, CG10605, CG14029, CG6604, CG17888, CG13598, CG4257, CG13951, CG9648, CG11186, CG3858, CG9696, CG5799, CG14938, CG1343, CG6312, CG5201, CG10052, CG8013, CG1447, CG32788, CG11202, CG9415, CG1507, CG10270, CG3998, CG5005, CG10269, CG7391, CG8667, CG8727, CG5206, CG13316, CG7807, CG2819, CG3848, CG16902, CG6269, CG10016, CG7760, CG9653, CG1414, CG15552, CG4013, CG8524, CG1071, CG5649, CG2712, CG1605, CG11182, CG18455, CG4303, CG9102, CG17829, CG2932, CG11551, CG2262, CG8474, CG6352, CG6121, CG7958, CG4143, CG11354, CG5935, CG8290, CG32575, CG9418, CG11352, CG3871, CG6627, CG1024, CG8108, CG2790, CG1966, CG11194, CG9776, CG7758, CG8208, CG2244, CG5067, CG5229, CG18783, CG18124, CG15286, CG11405, CG3268, CG11902, CG5133, CG15269, CG3491, CG17328, CG4185, CG16863, CG12630, CG32904, CG17594, CG1922, CG13906, CG18024, CG9233, CG12690, CG2875, CG17592, CG4136, CG12236, CG3726, CG3815, CG3847, CG14441, CG14438, CG3075, CG4575, CG3032, CG4617, CG9650, CG2116, CG2120, CG2129, CG15336, CG10959, CG18262, CG11294, CG12075, CG15365, CG7041, CG7055, CG2889, CG9817, CG2202, CG11122, CG11696, CG11695, CG11085, CG4404, CG4318, CG15749, CG1716, CG11172, CG11071, CG6211, CG9215, CG8119, CG8944, CG8578, CG8909, CG8924, CG9609, CG6769, CG5927, CG6470, CG7101, CG7556, CG14200, CG9571, CG11710, CG1529, CG11617, CG4133, CG31670, CG11723, CG17257, CG3407, CG17612, CG15435, CG15436, CG9088, CG13775, CG9200, CG4496, CG3838, CG13123, CG18619, CG18144, CG5034, CG12299, CG4621, CG6686, CG6792, CG9932, CG5204, CG9305, CG7099, CG5953, CG17912, CG5545, CG10348, CG10431, CG10446, CG17568, CG10263, CG10366, CG10462, CG10447, CG10631, CG10949, CG9342, CG18362, CG15216, CG1832, CG3136, CG2682, CG1845, CG1621, CG1620, CG1603, CG1602, CG12769, CG11641, CG8643, CG8216, CG1663, CG18446, CG12744, CG1407, CG18011, CG12942, CG12391, CG13204, CG12370, CG8821, CG8819, CG3850, CG4676, CG6061, CG6701, CG17385, CG17390, CG10209, CG8089, CG8092, CG16801, CG8314, CG8388, CG7786, CG4282, CG15710, CG17287, CG18468, CG4903, CG15073, CG11906, CG13424, CG9954, CG10543, CG9437, CG10321, CG10318, CG13493, CG11301, CG10344, CG9895, CG9890, CG9876, CG3941, CG5591, CG3065, CG3328, CG11414, CG4707, CG6905, CG1233, CG17181, CG13897, CG9139, CG2199, CG12104, CG1244, CG15812, CG14962, CG14965, CG12029, CG12605, CG15011, CG5249, CG17334, CG13287, CG13296, CG10274, CG7386, CG10147, CG8591, CG7404, CG7015, CG6683, CG6765, CG5093, CG5187, CG3891, CG3445, CG3654, CG7839, CG6272, CG11799, CG7368, CG4328, CG10704, CG10654, CG14117, CG17361, CG17359, CG7345, CG3919, CG6854, CG13458, CG7372, CG15715, CG9705, CG32171, CG18265, CG7271, CG4076, CG8765, CG11456, CG10565, CG7204, CG11247, CG14451, CG14655, CG14667, CG12162, CG10979, CG10296, CG9727, CG10267, CG33323, CG2702, CG9638, CG7963, CG8145, CG11762, CG8159, CG9793, CG9797, CG8359, CG11966, CG11984, CG11033, CG12952, CG16779, CG8301, CG8319, CG16899, CG8478, CG8484, CG6254, CG4570, CG4820, CG6689, CG6791, CG14710, CG6808, CG14711, CG6813, CG18476, CG6913, CG10042, CG5196, CG5245, CG33976, CG7518, CG15889, CG3143, CG7987, CG14860, CG6654, CG6276, CG5083, CG10278, CG5952, CG10309, CG3995, CG17803, CG17806, CG17802, CG17801, CG7357, CG7785, CG18599, CG7691, CG17186, CG4424, CG4854, CG4413, CG4936, CG4360, CG4217, CG15696, CG5737, CG7056, CG7045, CG7046, CG6990, CG4677, CG33336, CG4374, CG6129, CG5669, CG13617, CG13624, CG6892, CG11375, CG10669, CG4553, CG4730, CG17198, CG17197, CG17195, CG4956, CG32474, CG3350, CG5586, CG1647, CG14514, CG15504, CG15514, CG7928, CG2229, CG12071, CG11317, CG12054, CG1792, CG2052, CG11093, CG11152, CG11153, CG17172, CG6889, CG3743, CG13475, CG3526, CG11398, CG12767, CG15367, CG33473, CG14767, CG3576, CG12659, CG13109, CG12809, CG8817, CG8254, CG16910, CG3274, CG18764, CG32139, CG32577, CG2380, CG15736, CG13399, CG4427, CG12219, CG18647, CG31753, CG33720, CG30011, CG30020, CG30077, CG30401, CG30403, CG30420, CG30431, CG30443, CG31169, CG31224, CG31365, CG31388, CG31392, CG31441, CG31460, CG31481, CG31510, CG31612, CG31632, CG31642, CG31782, CG31835, CG31875, CG31955, CG32006, CG32050, CG32105, CG32121, CG32264, CG32296, CG32532, CG32719, CG32767, CG32772, CG32778, CG32830, CG33695, CG32982, CG33178, CG33213, CG33221, CG33520, CG33525, CG33557, CG33936, CG33980, CG34031, CG12632, CG17469, CG34100, CG34145, CG34149, CG34340, CG34346, CG34367, CG34376, CG34395, CG34403, CG34406, CG34407, CG34415, CG34419, CG34421, CG34422, CG8961, CG9397, CG10037, CG31258, CG31666, CG12196, CG6930, CG12238, CG33546, CG42234, CG34360, CG42267, CG42277, CG42281, CG42311, CG42332, CG42344, CG4807, CG7752, CG12701, CG17100, CG11971, CG42516, CG42515, CG6667, CG1028, CG3281, CG12124, CG42599, CG8506, CG17836, CG1070, and CG8676.
- In various embodiments, the engineered protein sensor and/or switch is an engineered version of a mouse TF, such as mouse loci 11538, 11568, 11569, 11614, 11622, 11624, 11632, 11634, 11694, 11695, 11733, 11736, 11819, 11835, 11859, 11863, 11864, 11865, 11878, 11906, 11908, 11909, 11910, 11911, 11920, 11921, 11922, 11923, 11924, 11925, 11991, 12013, 12014, 12020, 12021, 12022, 12023, 12029, 12051, 12053, 12142, 12151, 12173, 12180, 12189, 12192, 12224, 12265, 12326, 12355, 12387, 12393, 12394, 12395, 12399, 12400, 12416, 12417, 12418, 12454, 12455, 12566, 12567, 12572, 12578, 12579, 12580, 12581, 12590, 12591, 12592, 12606, 12607, 12608, 12609, 12611, 12653, 12677, 12705, 12753, 12785, 12848, 12912, 12913, 12914, 12915, 12916, 12951, 13017, 13018, 13047, 13048, 13134, 13163, 13170, 13172, 13180, 13196, 13198, 13345, 13390, 13392, 13393, 13394, 13395, 13396, 13433, 13435, 13486, 13494, 13496, 13555, 13557, 13559, 13560, 13591, 13592, 13593, 13626, 13653, 13654, 13655, 13656, 13661, 13709, 13710, 13711, 13712, 13713, 13714, 13716, 13796, 13797, 13798, 13799, 13813, 13819, 13864, 13865, 13871, 13872, 13875, 13876, 13982, 13983, 13984, 14008, 14009, 14011, 14013, 14025, 14028, 14029, 14030, 14055, 14056, 14085, 14105, 14106, 14154, 14155, 14200, 14233, 14234, 14235, 14236, 14237, 14238, 14239, 14240, 14241, 14247, 14281, 14282, 14283, 14284, 14359, 14390, 14391, 14457, 14460, 14461, 14462, 14463, 14464, 14465, 14472, 14489, 14531, 14534, 14536, 14581, 14582, 14605, 14632, 14633, 14634, 14659, 14797, 14815, 14836, 14842, 14843, 14884, 14885, 14886, 14896, 14912, 15110, 15111, 15161, 15163, 15181, 15182, 15183, 15184, 15185, 15193, 15205, 15206, 15207, 15208, 15209, 15213, 15214, 15218, 15220, 15221, 15223, 15227, 15228, 15229, 15242, 15248, 15251, 15258, 15260, 15273, 15284, 15285, 15331, 15353, 15354, 15361, 15364, 15370, 15371, 15372, 15373, 15375, 15376, 15377, 15378, 15379, 15384, 15394, 15395, 15396, 15397, 15398, 15399, 15400, 15401, 15402, 15403, 15404, 15405, 15407, 15408, 15410, 15412, 15413, 15414, 15415, 15416, 15417, 15421, 15422, 15423, 15424, 15425, 15426, 15427, 15429, 15430, 15431, 15432, 15433, 15434, 15436, 15437, 15438, 15460, 15499, 15500, 15563, 15569, 15900, 15901, 15902, 15903, 15904, 15951, 15976, 16150, 16151, 16201, 16348, 16362, 16363, 16364, 16371, 16372, 16373, 16391, 16392, 16476, 16477, 16478, 16596, 16597, 16598, 16599, 16600, 16601, 16656, 16658, 16761, 16764, 16814, 16815, 16825, 16826, 16842, 16869, 16870, 16871, 16872, 16873, 16874, 16875, 16876, 16909, 16911, 16917, 16918, 16969, 17095, 17119, 17121, 17122, 17125, 17126, 17127, 17128, 17129, 17130, 17131, 17132, 17133, 17134, 17135, 17172, 17173, 17187, 17188, 17191, 17192, 17215, 17216, 17217, 17218, 17219, 17220, 17257, 17258, 17259, 17260, 17261, 17268, 17274, 17283, 17285, 17286, 17300, 17301, 17318, 17341, 17342, 17344, 17354, 17355, 17420, 17425, 17428, 17480, 17536, 17537, 17681, 17684, 17692, 17701, 17702, 17703, 17749, 17764, 17765, 17859, 17863, 17864, 17865, 17869, 17870, 17876, 17877, 17878, 17927, 17928, 17932, 17933, 17936, 17937, 17938, 17977, 17978, 17979, 17984, 18002, 18012, 18013, 18014, 18018, 18019, 18020, 18021, 18022, 18023, 18024, 18025, 18027, 18028, 18029, 18030, 18032, 18033, 18034, 18036, 18037, 18038, 18044, 18045, 18046, 18071, 18072, 18088, 18089, 18091, 18092, 18094, 18095, 18096, 18109, 18124, 18128, 18129, 18131, 18132, 18140, 18142, 18143, 18171, 18181, 18185, 18193, 18198, 18227, 18291, 18292, 18393, 18412, 18420, 18423, 18424, 18426, 18432, 18503, 18504, 18505, 18506, 18507, 18508, 18509, 18510, 18511, 18514, 18515, 18516, 18519, 18572, 18606, 18609, 18612, 18616, 18617, 18626, 18627, 18628, 18667, 18676, 18685, 18736, 18740, 18741, 18742, 18771, 18789, 18854, 18933, 18935, 18983, 18985, 18986, 18987, 18988, 18990, 18991, 18992, 18993, 18994, 18995, 18996, 18997, 18998, 18999, 19009, 19013, 19014, 19015, 19016, 19017, 19018, 19049, 19056, 19060, 19084, 19099, 19127, 19130, 19182, 19184, 19202, 19213, 19231, 19290, 19291, 19326, 19330, 19377, 19401, 19411, 19434, 19645, 19650, 19651, 19664, 19668, 19687, 19696, 19697, 19698, 19708, 19712, 19724, 19725, 19726, 19727, 19763, 19820, 19822, 19826, 19883, 19885, 20016, 20017, 20018, 20019, 20020, 20021, 20022, 20024, 20128, 20174, 20181, 20182, 20183, 20185, 20186, 20204, 20218, 20220, 20230, 20231, 20232, 20289, 20371, 20375, 20384, 20409, 20429, 20439, 20464, 20465, 20466, 20467, 20471, 20472, 20473, 20474, 20475, 20476, 20480, 20481, 20583, 20585, 20586, 20587, 20589, 20591, 20592, 20602, 20613, 20638, 20664, 20665, 20666, 20667, 20668, 20669, 20670, 20671, 20672, 20673, 20674, 20675, 20677, 20678, 20679, 20680, 20681, 20682, 20683, 20687, 20688, 20689, 20728, 20787, 20788, 20807, 20819, 20833, 20841, 20842, 20846, 20847, 20848, 20849, 20850, 20851, 20852, 20893, 20901, 20904, 20922, 20923, 20924, 20997, 21339, 21340, 21341, 21343, 21349, 21350, 21374, 21375, 21380, 21382, 21383, 21384, 21385, 21386, 21387, 21388, 21389, 21399, 21400, 21401, 21405, 21406, 21407, 21408, 21410, 21411, 21412, 21413, 21414, 21415, 21416, 21417, 21418, 21419, 21420, 21422, 21423, 21425, 21426, 21427, 21428, 21429, 21652, 21674, 21676, 21677, 21678, 21679, 21685, 21780, 21781, 21783, 21804, 21807, 21815, 21833, 21834, 21835, 21843, 21847, 21848, 21849, 21869, 21885, 21886, 21887, 21888, 21907, 21908, 21909, 21917, 21929, 21945, 21981, 22025, 22026, 22051, 22057, 22059, 22061, 22062, 22088, 22160, 22200, 22221, 22255, 22259, 22260, 22278, 22282, 22286, 22326, 22337, 22383, 22385, 22431, 22433, 22608, 22632, 22634, 22639, 22640, 22642, 22646, 22654, 22658, 22661, 22666, 22668, 22678, 22680, 22685, 22689, 22691, 22694, 22695, 22696, 22697, 22698, 22700, 22701, 22702, 22704, 22709, 22710, 22712, 22715, 22717, 22718, 22719, 22722, 22750, 22751, 22754, 22755, 22756, 22757, 22758, 22759, 22761, 22762, 22764, 22767, 22768, 22770, 22771, 22772, 22773, 22775, 22776, 22778, 22779, 22780, 23808, 23827, 23849, 23850, 23856, 23857, 23871, 23872, 23885, 23894, 23942, 23957, 23958, 23989, 23994, 24068, 24074, 24075, 24113, 24116, 24135, 24136, 26356, 26371, 26379, 26380, 26381, 26386, 26404, 26413, 26417, 26419, 26423, 26424, 26427, 26461, 26465, 26573, 26754, 26927, 26939, 27049, 27056, 27057, 27059, 27081, 27140, 27217, 27223, 27224, 27274, 27386, 28019, 29806, 29808, 29813, 29861, 29871, 30046, 30051, 30794, 30841, 30923, 30927, 30928, 30942, 30944, 30946, 30951, 50496, 50524, 50721, 50754, 50777, 50783, 50794, 50796, 50817, 50868, 50887, 50907, 50913, 50914, 50916, 50996, 51792, 51813, 52024, 52040, 52231, 52502, 52609, 52615, 52705, 52708, 52712, 52897, 53314, 53317, 53357, 53380, 53415, 53417, 53626, 53868, 53869, 53970, 53975, 54006, 54123, 54131, 54132, 54139, 54169, 54343, 54352, 54388, 54422, 54446, 54562, 54601, 54633, 54678, 54711, 55927, 55942, 55994, 56030, 56070, 56196, 56198, 56218, 56220, 56222, 56233, 56275, 56309, 56312, 56314, 56321, 56353, 56380, 56381, 56404, 56406, 56449, 56458, 56469, 56484, 56490, 56501, 56503, 56505, 56522, 56523, 56525, 56613, 56642, 56707, 56736, 56771, 56784, 56787, 56805, 56809, 56856, 56869, 57080, 57230, 57246, 57314, 57316, 57376, 57737, 57745, 57748, 57756, 57765, 57782, 58172, 58180, 58198, 58202, 58206, 58234, 58805, 59004, 59021, 59024, 59026, 59035, 59057, 59058, 60345, 60406, 60611, 64050, 64144, 64290, 64379, 64383, 64384, 64406, 64453, 64685, 65020, 65247, 65255, 65256, 65257, 66056, 66118, 66136, 66213, 66233, 66277, 66352, 66376, 66420, 66464, 66491, 66505, 66556, 66596, 66622, 66634, 66642, 66671, 66698, 66729, 66799, 66867, 66880, 66923, 66930, 66959, 66970, 66980, 66985, 67057, 67065, 67122, 67150, 67151, 67155, 67199, 67235, 67260, 67279, 67288, 67367, 67370, 67379, 67381, 67389, 67419, 67439, 67575, 67657, 67673, 67692, 67710, 67815, 67847, 67873, 67949, 67985, 67993, 68040, 68153, 68196, 68268, 68346, 68479, 68558, 68701, 68705, 68776, 68839, 68842, 68854, 68910, 68911, 68992, 69020, 69125, 69167, 69168, 69188, 69234, 69241, 69257, 69260, 69299, 69317, 69389, 69539, 69606, 69656, 69716, 69790, 69833, 69890, 69920, 69944, 70073, 70122, 70127, 70315, 70350, 70392, 70408, 70428, 70459, 70497, 70508, 70601, 70625, 70637, 70650, 70673, 70779, 70796, 70797, 70823, 70859, 70981, 71041, 71063, 71131, 71137, 71163, 71176, 71241, 71280, 71371, 71375, 71409, 71458, 71468, 71592, 71597, 71702, 71722, 71752, 71767, 71777, 71782, 71793, 71828, 71834, 71838, 71839, 71939, 71949, 71990, 71991, 72057, 72074, 72135, 72180, 72195, 72199, 72290, 72293, 72323, 72325, 72388, 72459, 72465, 72475, 72556, 72567, 72615, 72720, 72727, 72739, 72823, 72949, 72958, 73178, 73181, 73340, 73389, 73451, 73469, 73503, 73610, 73614, 73844, 73845, 73945, 74007, 74068, 74106, 74120, 74123, 74149, 74164, 74168, 74197, 74282, 74318, 74322, 74326, 74335, 74352, 74377, 74481, 74533, 74561, 74570, 74838, 75196, 75199, 75210, 75291, 75305, 75339, 75387, 75480, 75482, 75507, 75572, 75599, 75605, 75646, 75725, 75901, 76007, 76022, 76294, 76308, 76365, 76389, 76467, 76572, 76580, 76793, 76803, 76804, 76834, 76893, 76900, 77057, 77114, 77117, 77264, 77286, 77318, 77480, 77683, 77889, 77907, 77913, 78020, 78088, 78246, 78251, 78284, 78455, 78469, 78541, 78619, 78656, 78699, 78703, 78783, 78829, 78910, 78912, 78921, 78929, 79221, 79233, 79362, 79401, 80283, 80509, 80720, 80732, 80859, 80902, 81601, 81630, 81703, 81845, 81879, 83383, 83395, 83396, 83557, 83602, 83925, 83993, 84653, 93674, 93681, 93686, 93691, 93759, 93760, 93761, 93762, 93837, 93871, 94047, 94112, 94187, 94275, 96979, 97064, 97165, 98053, 98403, 99377, 99730, 100090, 100563, 100710, 100978, 101095, 101206, 102162, 102209, 102334, 103136, 103806, 103889, 104328, 104349, 104360, 104383, 104384, 104394, 104886, 105377, 105594, 105859, 106795, 106894, 107351, 107433, 107499, 107503, 107568, 107586, 107751, 107765, 107771, 107889, 107932, 107951, 108060, 108098, 108143, 108655, 108672, 108857, 109113, 109115, 109575, 109594, 109663, 109676, 109889, 109910, 109958, 109972, 109973, 109995, 110052, 110061, 110068, 110109, 110147, 110506, 110521, 110616, 110641, 110647, 110648, 110784, 110796, 110805, 110913, 112077, 114142, 114565, 114606, 114642, 114774, 114889, 116810, 116848, 116870, 116871, 116912, 117168, 117198, 117590, 118445, 140477, 140490, 140500, 140577, 140743, 170574, 170644, 170729, 170740, 170767, 170787, 170791, 170826, 170938, 192195, 192231, 192285, 192651, 192657, 193796, 195333, 208076, 208258, 208266, 208292, 208439, 208677, 208715, 209011, 209357, 209361, 209416, 209446, 209448, 209707, 210135, 210162, 211378, 212168, 212276, 212391, 212712, 213010, 213990, 214105, 214162, 214384, 214669, 214899, 215031, 216151, 216154, 216285, 216456, 216558, 216578, 217031, 217082, 217127, 217166, 217558, 218030, 218440, 218490, 218624, 218772, 218989, 219150, 223227, 223690, 223701, 223922, 224419, 224585, 224656, 224694, 224829, 224902, 224903, 225876, 225895, 225998, 226049, 226182, 226442, 226641, 226747, 226896, 227099, 227644, 227656, 227940, 228136, 228598, 228731, 228775, 228790, 228829, 228839, 228852, 228869, 228876, 228880, 228980, 229004, 229534, 229663, 229906, 230073, 230162, 230587, 230674, 230700, 230753, 230908, 230936, 230991, 231044, 231051, 231329, 231386, 231986, 231991, 232232, 232337, 232807, 232853, 232854, 232878, 232906, 233056, 233410, 233490, 233863, 233887, 233890, 233908, 233987, 234725, 234959, 235028, 235041, 235050, 235320, 235442, 235582, 235623, 235682, 236193, 237052, 237336, 237409, 237615, 237758, 237960, 238247, 239099, 239546, 239652, 240064, 240120, 240263, 240427, 240442, 240476, 240590, 240690, 241066, 241447, 241520, 242523, 242620, 242705, 243187, 243833, 243906, 243931, 243963, 243983, 244349, 244713, 244813, 244954, 245572, 245583, 245596, 245688, 245841, 246086, 246196, 246198, 246791, 252829, 260298, 268281, 268301, 268396, 268448, 268564, 268741, 268903, 268932, 269252, 269713, 269870, 270076, 270627, 271278, 271305, 272347, 272359, 272382, 277353, 319196, 319207, 319535, 319594, 319599, 319601, 319615, 319695, 319785, 320067, 320376, 320429, 320586, 320595, 320790, 320799, 320875, 320995, 328572, 330301, 330361, 330502, 332937, 338353, 347691, 353187, 353208, 378435, 381319, 386626, and 386655.
- Illustrative aTFs are found in Ramos, et al. Microbiology and Molecular Biology Reviews, June 2005, p. 326-356 and Tropell, et al. Microbiol Mol Biol Rev. 2004 September; 68(3):474-500, the contents of which are hereby incorporated by reference in their entireties.
- Protein sensor and/or switch amino acid sequences upon which engineering is to occur may, in various embodiments, be selected by sequence homology using one or more of BLASTP, PSI-BLAST, DELTA-BLAST, OR HMMER, JackHMMER, or the corresponding nucleotide sequences selected by sequence homology search.
- Methods of identifying protein sequences that can be candidate protein sensors and/or switches are found in US 2016/0063177, the entire contents of which are hereby incorporated by reference in its entirety.
- Various protein sensor and/or switches are engineered as part of the invention and can be interrogated with target molecules (cellularly or acellularly). Illustrative engineering approaches include mutagenesis that alters the binding activity of an allosteric protein, e.g. making the allosteric protein suitable for binding the target molecule at the expense of the allosteric proteins cognate ligand (i.e. the ligand that binds to the wild type allosteric protein). In some embodiments, mutagenesis comprises introducing one or more amino acid mutations, e.g. independently selected from substitutions, insertions, deletions, and truncations.
- In some embodiments, the amino acid mutations are amino acid substitutions, and may include conservative and/or non-conservative substitutions.
- “Conservative substitutions” may be made, for instance, on the basis of similarity in polarity, charge, size, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the amino acid residues involved. The 20 naturally occurring amino acids can be grouped into the following six standard amino acid groups: (1) hydrophobic: Met, Ala, Val, Leu, Ile; (2) neutral hydrophilic: Cys, Ser, Thr; Asn, Gln; (3) acidic: Asp, Glu; (4) basic: His, Lys, Arg; (5) residues that influence chain orientation: Gly, Pro; and (6) aromatic: Trp, Tyr, Phe.
- As used herein, “conservative substitutions” are defined as exchanges of an amino acid by another amino acid listed within the same group of the six standard amino acid groups shown above. For example, the exchange of Asp by Glu retains one negative charge in the so modified polypeptide. In addition, glycine and proline may be substituted for one another based on their ability to disrupt α-helices.
- As used herein, “non-conservative substitutions” are defined as exchanges of an amino acid by another amino acid listed in a different group of the six standard amino acid groups (1) to (6) shown above.
- In various embodiments, the substitutions may also include non-classical amino acids (e.g. selenocysteine, pyrrolysine, N-formylmethionine β-alanine, GABA and δ-Aminolevulinic acid, 4-aminobenzoic acid (PABA), D-isomers of the common amino acids, 2,4-diaminobutyric acid, α-amino isobutyric acid, 4-aminobutyric acid, Abu, 2-amino butyric acid, γ-Abu, ε-Ahx, 6-amino hexanoic acid, Aib, 2-amino isobutyric acid, 3-amino propionic acid, ornithine, norleucine, norvaline, hydroxyproline, sarcosme, citrulline, homocitrulline, cysteic acid, t-butylglycine, t-butylalanine, phenylglycine, cyclohexylalanine, 6-alanine, fluoro-amino acids, designer amino acids such as β methyl amino acids, C α-methyl amino acids, N α-methyl amino acids, and amino acid analogs in general).
- The present invention pertains to various target molecules, for which a protein sensor and/or switch may be engineered. Illustrative target molecules include one or more of the compounds described in WO 2015/017866, e.g. at paragraphs [00107]-[00112], the entire contents of which are hereby incorporated by reference in its entirety. In various embodiments, the various target molecules of the invention are toxic to a cell and/or cannot be readily bind or interact with a protein sensor and/or switch in a detectable manner in a cellular environment. In various embodiments, the protein sensor and/or switch is selected based on its cognate ligand identity and any commonality the cognate ligand may have with a target molecules. For example, a shared chemical group between a cognate ligand and a target molecule may direct one to the protein sensor and/or switch which binds to the cognate ligand and lead to the engineering of the protein sensor and/or switch so it can bind to the target molecule.
- In some embodiments, the present invention relates to antibiotics. To circumvent toxicity of antibiotics, various resistance mechanisms may be introduced into a producing cell. Without limitation, these may include enzymes which degrade or chemically render the antibiotic less toxic to the producing cell. Resistance to the antibiotics mechanism of action may be conferred by alterations introduced into the cellular context of the producing cell. For instance, the ribosome may be altered to avoid antibiotic binding and relieve inhibition of protein synthesis. A cell wall biosynthetic enzyme may be mutated to ablate antibiotic binding and relieve inhibition of cell wall biosynthesis. A pump which lowers the intracellular concentration may be expressed. A specific antibiotic binding protein may be expressed.
- In some embodiments, the target molecule is an antibiotic (e.g. one which is lethal to a host cell). In some embodiments, the antibiotic is a beta-lactam antibiotic, such as a penicillin, e.g., Penicillin, Amoxicillin, Ampicillin, Azlocillin, Carbenicillin, Cloxacillin, Dicloxacillin, Flucloxacillin, Mezlocillin, Methicillin, Nafcillin, Oxacillin, Penicillin G, Penicillin V, Piperacillin, Penicillin G, Temocillin, Ticarcillin. In some embodiments, the antibiotic is an Aminoglycoside, e.g., Amikacin, Gentamicin, Kanamycin, Neomycin, Netilmicin, Tobramycin, Paromomycin, Streptomycin, or Spectinomycin. In some embodiments, the antibiotic is an Ansamycin, e.g., Geldanamycin, Herbimycin, or Rifaximin. In other embodiments, the antibiotic is a penem such as faropenem or Ritipenem; or a Carbacephem such as Loracarbef; or a carbapenem such as Ertapenem, Doripenem, Imipenem/Cilastatin, or Meropenem. In other embodiments, the antibiotic is an Cephalosporin, e.g., Cefadroxil, Cefazolin, Cefalotin or Cefalothin, Cefalexin (or cephalexin), Cefaclor, Cefamandole, Cefoxitin, Cefprozil, Cefuroxime, Cefixime, Cefdinir, Cefditoren, Cefoperazone, Cefotaxime, Cefpodoxime, Ceftazidime, Ceftibuten, Ceftizoxime, Ceftriaxone (IV and IM), Cefepime, Ceftaroline fosamil, Ceftobiprole, Ceftiofur, Cefquinome, or Cefovecin. In yet other embodiments, the antibiotic is a p-lactamase inhibitor, such as, for example, Penam (Sulbactam Tazobactam), Clavam (Clavulanic acid), Avibactam, or Vaborbactam. In other embodiments, the antibiotic is a glycopeptide such as Teicoplanin, Vancomycin, Telavancin, Dalbavancin, or Oritavancin. In some embodiments, the antibiotic is a lincosamides such as, e.g., Clindamycin or Lincomycin. In yet other embodiments, the antibiotic is a lipopeptide such as Daptomycin. In some embodiments, the antibiotic is a Macrolide such as, e.g., Azithromycin, Clarithromycin, Dirithromycin, Erythromycin, Roxithromycin, Troleandomycin, Telithromycin, or Spiramycin. In some embodiments, the antibiotic is a Monobactam such as Aztreonam, Tigemonam, Carumonam, or Nocardicin A. In some embodiments, the antibiotic is a nitrofuran, such as, e.g., Furazolidone or Nitrofurantoin. In some other embodiments, the antibiotic is an oxazolidinones such as, e.g., Linezolid, Posizolid, Radezolid, or Torezolid. In other embodiments, the antibiotic is a polypeptide, such as Bacitracin, Colistin, or Polymyxin B. In yet other embodiments, the antibiotic is a Quinolone or Fluoroquinolone such as, e.g., Ciprofloxacin, Enoxacin, Gatifloxacin, Gemifloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Nalidixic acid, Norfloxacin, Ofloxacin, Trovafloxacin, Grepafloxacin, Sparfloxacin, or Temafloxacin. In some embodiments, the antibiotic is a sulfonamide such as Mafenide, Sulfacetamide, Sulfadiazine, Silver sulfadiazine, Sulfadimethoxine, Sulfamethizole, Sulfamethoxazole, Sulfanilimide (archaic), Sulfasalazine, Sulfisoxazole, Trimethoprim, Trimethoprim-Sulfamethoxazole(Co-trimoxazole) (TMP-SMX), or Sulfonamidochrysoidine. In some embodiments, the antibiotic is a Tetracycline, e.g., Demeclocycline, Doxycycline, Minocycline, Oxytetracycline, or Tetracycline. In some embodiments, the antibiotic is a drug against mycobacteria, such as Clofazimine, Dapsone, Capreomycin, Cycloserine, Ethambutol(Bs), Ethionamide, Isoniazid, Pyrazinamide, Rifampicin (Rifampin in US), Rifabutin, Rifapentine, Streptomycin. In some embodiments, the antibiotic is Arsphenamine, Chloramphenicol(Bs), Fosfomycin, Fusidic acid, Metronidazole, Mupirocin, Platensimycin, Quinupristin/Dalfopristin, Thiamphenicol, Tigecycline(Bs), Tinidazole. In yet other embodiments the antibiotic is teixobactin, or related molecules in this new class of antibiotics, which harm bacteria by binding lipid II and/or lipid III, which are important cell wall precursors.
- Illustrative protein sensors and/or switches and cognate ligands are found in WO 2015/127242, for instance in the table of page 7, the contents of which are hereby incorporated by reference in their entirety.
- In various embodiments, the protein sensor and/or switch is an engineered using design from existing allosteric proteins, e.g. aTFs. In various embodiments, the designing comprises in silico design. Illustrative design principles are found in US 2016/0063177, the entire contents of which are hereby incorporated by reference in their entirety.
- For example, in various embodiments, molecular modeling is used to predict mutations in an allosteric protein which may render the allosteric protein able to bind one or more target molecules. In various embodiments, reference to an experimentally derived three-dimensional protein structure, typically obtained through experimental methods including, but not limited to, x-ray crystallography, nuclear magnetic resonance (NMR), scattering, or diffraction techniques, is employed to model and/or predict mutations in an allosteric protein which may render the allosteric protein able to bind one or more target molecule. In various embodiments, the ROSETTA software suite is employed to assist with modelling (see Kaufmann et al. Biochemistry. 2010 Apr. 13; 49(14):2987-98, the entire contents of which are hereby incorporated by reference in its entirety). Alternatively, or in combination, a homology modeling algorithm such as ROBETTA, TASSER, I-TASSER, HHpred, HHsearch, or MODELLER, or SWISS-MODEL can be used. In some embodiments, such as (without limitation) those in which allosteric protein lacks an experimentally derived three-dimensional protein structure, a homology modeling algorithm can be used to build the sequence homology models. In various embodiments, one or more sequence or structural homologs have less than 90% amino acid sequence identity, less than 85% amino acid sequence identity, less than 80% amino acid sequence identity, less than 75% amino acid sequence identity, less than 70% amino acid sequence identity, less than 65% amino acid sequence identity, less than 60% amino acid sequence identity, less than 55% amino acid sequence identity, less than 50% amino acid sequence identity, less than 45% amino acid sequence identity, less than 40% amino acid sequence identity, less than 35% amino acid sequence identity, less than 30% amino acid sequence identity, less than 25% amino acid sequence identity, or less amino acid sequence identity to the amino acid sequence of the three-dimensional protein structure. Illustrative homology modelling methods and principles are found in US 2016/0063177, e.g. at paragraphs [0085]-[0093], the entire contents of which are hereby incorporated by reference in its entirety.
- In some embodiments, a structure of an allosteric protein is evaluated for alterations which may render the allosteric protein able to bind one or more target molecules (e.g. by docking a one or more target molecules into the structure of an allosteric protein). Illustrative docking methods and principles are found in US 2016/0063177, e.g. at paragraphs [0095]-[0101], the entire contents of which are hereby incorporated by reference in its entirety.
- In various embodiments, libraries of potential mutations to the allosteric protein are made and selection, positive or negative, is used to screen desired mutants.
- In various embodiments, engineering may use the technique of computational protein design (as disclosed in U.S. Pat. No. 7,574,306 and U.S. Pat. No. 8,340,951, which are hereby incorporated by reference in their entirety) directed evolution techniques, rational mutagenesis, or any suitable combination thereof.
- In other embodiments, mutation techniques such as gene shuffling, homologous recombination, domain swapping, deep mutation scanning, and/or random mutagenesis may be employed.
- In various embodiments, the following table provides illustrative sensors that may be designed in accordance with various embodiments of the present invention. For instance, in various embodiments, one may select an aTF (“Chassis”) and/or native ligand and make reference to a provided representative structure (PDB) to, in accordance with the disclosure herein, design a senor to a target molecule or class of target molecules (see Target Molecule Property column).
-
TABLE 1 aTF Representative Target Molecule (“Chassis”) Native Ligand Native Host Structure (PDB) Property QscR Bound to N-3-oxo- Psudemonas 3SZT long chain fatty acids and dodecanoyl-L- aeruginosa homoserine lactones Homoserine Lactone NtcA 2-oxoglutarate, Anabaena 3LA2, LA3, 3LA7 3-7 carbon acids/ 2,2- cyanobacterium alcohols difluoropentanoic acid CarH adenosylcobalamin Thermus 5C8A, 5C8D, 5C8E, cobalamine thermophilus 5C8F CcpN ADP Bacillus subtilis 3FV6, 3FWR, 3FWS nucleotides, nucleosides repressor BtAraR arabinose Bacteriodes 5BS6, 5DD4, 5DDG, saccharides thetaiotaomicron 5DEQ AraR arabinose Bacteroides 5BS6, 5DD4, 5DDG, saccharides thetaiotaomicron VPI 5DEQ AhrR Arginine Bacillus subtilis 2P5L 2P5M charged amino acids, quanidino groups Rv1846c betalactams Mycobacterium 2G9W betalactams tuberculosis. CviR C6 HSL Chromobacterium 3QP1, 3QP2, 3QP4, short chain fatty acids violaceum 3QP5, 3QP6, 3QP8 and homoserine lactones MtbCRP cAMP Myco tuberculosis 3I54 cyclic nucleotides BmrR cationic antibiotics, Bacillus subtilis 3Q1M, 3Q2Y, 3Q3D, cationic multirings dyes, and 3Q5P, 3Q5R, 3Q5S disinfectants Rrf2 cysteine Bacillus subtilis 2Y75 hydrophobic amino acids, sulfur containing molecules CGL2612 drugs Corynebacterium 1V7B, 2ZOY rigid multiring molecules glutamicum TtgR drugs Pseudomonas 2UXH, 2UXI, 2UXO, rigid multiring molecules putida 2UXP, 2UXU QacR Ethidium, Staphylococcus 3BR3 3BR6 2DTZ chemically rigid, bivalent rhodamine, Aureus 2HQ5 compounds. Cra fructose 1 Pseudomonas 3O74, 3O75 sugar phosphates phosphate putida GabR gamma- Bacillus subtilis 4N0B short chain amines and aminobutyric acid acids YvoA glucosamine-6- Bacillus subtilis 4U0V, 4U0W, 4U0Y, C5, C6 sugars phosphate, 4WWC acetylglucosamine- 6-phosphate CggR glucose-6- Bacillus subtilis 2OKG, 3BXE, 3BXF, C5, C6 sugars phosphate and 3BXG, 3BXH fructose-6- Also Cited By: 4OQP, phosphate 4OQQ CodY GTP, Isoleucine Bacillus subtilis 2B0L, 2B18, 2GX5, hydrophobic amino acids 2HGV nucleosids, nucleotides, nucleotide phosphates HrcA heat Thermotoga 1STZ temperature, useful for maritima circular permutation/stability measurements RovA heat Yersinia pestis 4AIH, 4AIJ, 4AIK temperature, useful for circular permutation/stability measurements LldR lactose Corynebacterium 2DI3 saccharides (CGL2915) glutamicum LacI Lactose/IPTG E. coli 2p9h saccharides NMB0573/ leucine methionine Neisseria 2P5V, 2P6S, 2P6T hydrophobic amino acids, AsnC meningitidis sulfer containing compounds FapR malonyl-CoA Bacillus subtilis 2F3X, 2F41 c3-c7 molecules, CoA cofactors FapR malonyl-CoA Staphylococcus 4A0X, 4A0Y, 4A0Z, c3-c7 molecules, CoA Aureus 4A12 cofactors LmrR MDR pump Lactococcus lactis 3F8B, 3F8C, 3F8F rigid multiring molecules controller SMET MDR pump Stenotrophomonas 2W53 rigid multiring molecules controller maltophilia SCO4008 methylene blue, Streptomyces 2D6Y crystal coelicolor violetcationic antibiotics, dyes, and disinfectants MntR Mn2+ Bacillus subtilis 4hv6 metals and cations Rex NADH Bacillus subtilis, 2VT2, 2VT3 cofactors Thermus thermophilus, Thermus aquaticus NikR Nickle Helobacter pylori 3PHT, 3QSI, 2WVB DNR NO (via heme) Pseudomonas 2Z69 metals and cations aeruginosa FadR oleoyl-CoA Vibrio cholerae 4P96, 4P9U, 4PDK long chain fatty acids and cofactors MosR oxidative state Mycobacterium 4FX0, 4FX4 oxidative state, useful for tuberculosis. circular permutation OhrR oxidative state Bacillus subtilis 1Z91, 1Z9C oxidative state, useful for (cys) circular permutation SarZ oxidative stress Staphylococcus 3HRM, 3HSE, 3HSR oxidative state, useful for Aureus circular permutation TsaR para- Comamonas 3FXQ, 3FXR, 3FXU, c6-c12 aromatics toluensulfonate testosteroni 3FZJ HetR PatS Anabaena sp. 4YNL, 4YRV peptides and proteins NprR peptide Bacillus thuringiensis 4GPK peptides and proteins MexR peptide Pseudomonas 3ECH peptides and proteins aeruginosa PhoP PhoR Mycobacterium 2PMU peptides and proteins tuberculosis. PurR Phosphoribosyl- Bacillus subtilis 1P4A phosphorilated sugars pyrophosphate PcaV protocatechuate (a Streptomyces 4FHT, 4G9Y aromatic acids, c4-c10 (SCO6704) dihyroxy benzoic coelicolor acids acid) DesR self His-PO4 Bacillus subtilis 4LDZ, 4LE0, 4LE1, useful for circular 4LE2 permutation SinR sinL dimer? Bacillus subtilis 2YAL, 3QQ6 peptides and proteins EthR something Mycobacterium 1T56 c4-c20 hydrophobic hydrophobic tuberculosis. molecules BlcR succinate Agrobacterium 3MQ0 short chain aldehydes semialdehyde tumefaciens TetR-class Tet Pasteurella 2VPR rigid multiring molecules H multocida TetR Tetracycline E. coli Tn10 4AC0 rigid multiring molecules TreR trehalose Bacillus subtilis 2OGG saccharides DntR TsaR type LTTR Burkholderia cepacia 5AE3, 5AE4 c6-c12 aromatics HyIIIR unknown large Bacillus cereus 2FX0 large moledules molecule CprB γ-butyrolactones Streptomyces 4PXI short chain lactones coelicolor AcuR acrylic acid Rhodobacter 3BRU Short chain acid and sphaeroides hydrocarbons - In various embodiments, the amino acids targeted for mutation or in silico design are those within about 3, or about 5, or about 7, or about 10, or about 12 Angstroms (e.g. between about 3 to about 12 Angstroms, or between about 5 to about 12 Angstroms, or between about 7 to about 12 Angstroms, or between about 10 to about 12 Angstroms, or between about 3 to about 5 Angstroms, or between about 3 to about 7 Angstroms, or between about 3 to about 10 Angstroms) of a ligand modeled into a binding pocket either through docking or by experimental methods such as X-ray crystallography.
- Mutated allosteric proteins that may be protein sensors and/or switches able to bind one or more target molecules can be screen using standard binding assays (e.g. fluorescent, radioactive assays, etc.).
- In various embodiments, the protein sensor and/or switch is engineered as described in Taylor, et al. Nat. Methods 13(2): 177, the entire contents of which are hereby incorporated by reference in its entirety.
- In various embodiments, the host cells of the present invention include eukaryotic and/or prokaryotic cells, including bacterial, yeast, algal, plant, insect, mammalian cells (human or non-human), and immortal cell lines.
- For example, the host cell may be Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Saccharomyces castellii, Kluyveromyces lactis, Pichia stipitis, Schizosaccharomyces pombe, Chlamydomonas reinhardtii, Arabidopsis thaliana, or Caenorhabditis elegans. In some embodiments the host cell is a bacterial cell, such as Escherichia spp., Streptomyces spp., Zymonas spp., Acetobacter spp., Citrobacter spp., Synechocystis spp., Rhizobium spp., Clostridium spp., Corynebacterium spp., Streptococcus spp., Xanthomonas spp., Lactobacillus spp., Lactococcus spp., Bacillus spp., Pedobacter spp., Bacteroides spp., Alcaligenes spp., Pseudomonas spp., Aeromonas spp., Azotobacter spp., Comamonas spp., Mycobacterium spp., Rhodococcus spp., Gluconobacter spp., Ralstonia spp., Acidithiobacillus spp., Microlunatus spp., Geobacter spp., Geobacillus spp., Arthrobacter spp., Flavobacterium spp., Serratia spp., Saccharopolyspora spp., Thermus spp., Stenotrophomonas spp., Chromobacterium spp., Sinorhizobium spp., Saccharopolyspora spp., Agrobacterium spp. and Pantoea spp. The bacterial cell can be a Gram-negative cell such as an E. coli, or a Gram-positive cell such as a species of Bacillus.
- In other embodiments, the cell is a fungal cell such as a yeast cell, e.g., Saccharomyces spp., Schizosaccharomyces spp., Pichia spp., Paffia spp., Kluyveromyces spp., Candida spp., Talaromyces spp., Brettanomyces spp., Pachysolen spp., Debaryomyces spp., Yarrowia spp., and industrial polyploid yeast strains. Preferably the yeast strain is a S. cerevisiae strain or a Yarrowia spp. strain. Other examples of fungi include Aspergillus spp., Pennicilium spp., Fusarium spp., Rhizopus spp., Acremonium spp., Neurospora spp., Sordaria spp., Magnaporthe spp., Allomyces spp., Ustilago spp., Botrytis spp., and Trichoderma spp.
- In other embodiments, the cell is an algal cell or a plant cell (e.g., A. thaliana, C. reinhardtii, Arthrospira, P. tricomutum, T. suecica, P. carterae, P. tricomutum, Chlorella spp., such as Chlorella vulgaris).
- Target cells can include transgenic and recombinant cell lines. In addition, heterologous cell lines can be used, such as Chinese Hamster Ovary cells (CHO).
- In some embodiments, the host cell is an Actinomycetes spp. cell. Actinomycetes are a heterogeneous collection of bacteria that form branching filaments which include, for example, Actinomyces, Actinomadura, Nocardia, Streptomyces and related genera. In some embodiments, Actinomyces comprise Streptomyces. In some embodiments, the Actinomycetes spp. cell is a Streptomyces cell. (e.g. S. coelicolor). Streptomyces include, by way of non-limiting example, S. noursei, S. nodosus, S. natalensis, S. venezuelae, S. roseosporus, S. fradiae, S. lincolnensis, S. alboniger, S. griseus, S. rimosus, S. aureofaciens, S. clavuligerus, S. avermitilis, S. platensis, S. verticillus, S. hygroscopicus, and S. viridochromeogenes.
- In some embodiments, the host cell is a Bacillus spp. cell. In some embodiments, the Bacillus spp. cell is selected from B. alcalophilus, B. alvei, B. aminovorans, B. amyloliquefaciens, B. aneurinolyticus, B. anthracis, B. aquaemaris, B. atrophaeus, B. boroniphilus, B. brevis, B. caldolyticus, B. centrosporus, B. cereus, B. circulans, B. coagulans, B. firmus, B. flavothermus, B. fusiformis, B. galliciensis, B. globigii, B. infernus, B. larvae, B. laterosporus, B. lentus, B. licheniformis, B. megaterium, B. mesentericus, B. mucilaginosus, B. mycoides, B. natto, B. pantothenticus, B. polymyxa, B. pseudoanthracis, B. pumilus, B. schlegelii, B. sphaericus, B. sporothermodurans, B. stearothermophilus, B. subtilis, B. thermoglucosidasius, B. thuringiensis, B. vulgatis, and B. weihenstephanensis.
- In various embodiments, the nucleic acid is provided to host cell by one or more of by electroporation, chemical transformation, ballistic transformation, pressure induced transformation, electrospray injection, mechanical shear forces induced, for example, in microfluids, and carbon nanotubes, nanotube puncture, induced natural competence mechanisms of an organism, merging of protoplasts, and conjugation with Agrobacterium.
- In vitro transcription, i.e. the in vitro synthesis of single-stranded RNA molecules, is a routine laboratory procedure. While variations in the methodology are possible, the same basic procedure is followed in most in vitro transcription protocols. Specifically, one prepares a DNA template corresponding to the sequence of interest. To allow run off transcription, plasmid DNA template is generally linearized with a restriction enzyme. In addition to plasmid DNA, PCR products and synthetic oligonucleotides, among others, can be used as templates for transcription reactions. The template DNA is then transcribed by an RNA polymerase, e.g. T7, T3 or SP6 RNA phage polymerase, in the presence of ribonucleoside triphosphates (rNTPs). The polymerase traverses the template strand and uses base pairing with the DNA to synthesize a complementary RNA strand (using uracil in the place of thymine). The RNA polymerase travels from the 3→5′ end of the DNA template strand, to produce an RNA molecule in the 5→3′ direction. Further details are available in Rio, et al. RNA: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2011, 205-220, the contents of which are hereby incorporated by reference in their entirety.
- The most frequently used in vitro or cell-free translation systems consist of extracts from a biological source, e.g. rabbit reticulocytes, wheat germ, HeLa, and E. coli. All are typically prepared as crude extracts containing all the macromolecular components (e.g. 70 S or 80 S ribosomes, tRNAs, aminoacyl-tRNA synthetases, initiation, elongation and termination factors, etc.) required for translation of exogenous RNA. Extracts may be supplemented with amino acids, energy sources (e.g. ATP, GTP), energy regenerating systems (e.g. creatine phosphate and creatine phosphokinase for eukaryotic systems, and phosphoenol pyruvate and pyruvate kinase for the E. coli lysate), and other co-factors (e.g. Me, etc.).
- In various embodiments, the present invention employs “coupled” or “linked” IVTT. In various embodiments, the present invention employs IVTT in which the transcription and translation are not coupled, i.e. separate.
- There are two approaches to in vitro protein synthesis based on the starting genetic material i.e. RNA or DNA. Standard translation systems, such as reticulocyte lysates and wheat germ extracts, use RNA as a template; whereas “coupled” and “linked” systems start with DNA templates, which are transcribed into RNA then translated. Either is suitable for use in the invention described herein.
- Rabbit reticulocyte lysate is a highly efficient in vitro eukaryotic protein synthesis system used for translation of exogenous RNAs (either natural or generated in vitro). In vivo, reticulocytes are highly specialized cells primarily responsible for the synthesis of hemoglobin and these immature red cells have adequate mRNA, as well as complete translation machinery, for extensive globin synthesis. The endogenous globin mRNA is eliminated by incubation with a nuclease, e.g. a Cat2+dependent micrococcal nuclease, which is later inactivated, e.g. by chelation of the Cat2+ by, for example, EGTA. Untreated reticulocyte lysate translates endogenous globin mRNA, exogenous RNAs, or both. This type of lysate is typically used for studying the translation machinery, e.g. studying the effects of inhibitors on globin translation. Both the untreated and treated rabbit reticulocyte lysates have low nuclease activity and are capable of synthesizing a large amount of full-length product. Both lysates are appropriate for the synthesis of larger proteins from either capped or uncapped RNAs.
- Wheat germ extract has low background incorporation due to its low level of endogenous mRNA. Wheat germ lysate efficiently translates exogenous RNA from a variety of different organisms. Both reticulocyte and wheat germ extracts translate RNA isolated from cells and tissue or those generated by in vitro transcription. When using RNA synthesized in vitro, the presence of a 5′ cap structure may enhance translational activity. Typically, translation by wheat germ extract is more cap-dependent than translation by reticulocyte extracts. If capping of the RNA is impossible and the protein yield from an uncapped mRNA is low, the coding sequence can be subcloned into a prokaryotic vector and expressed directly from a DNA template in an E. coli cell-free system.
- E. coli cell-free systems consist of a crude extract that is rich in endogenous mRNA. The extract is incubated during preparation so that this endogenous mRNA is translated and subsequently degraded. Because the levels of endogenous mRNA in the prepared lysate is low, the exogenous product is easily identified. In comparison to eukaryotic systems, the E. coli extract has a relatively simple translational apparatus with less complicated control at the initiation level, allowing this system to be very efficient in protein synthesis. E. coli are particularly suited for coupled transcription:translation from DNA templates.
- In standard translation reactions, purified RNA is used as a template for translation. Linked or coupled systems, on the other hand, use DNA as a template. RNA is transcribed from the DNA and subsequently translated without any purification. Such systems typically combine a prokaryotic phage RNA polymerase and promoter (T7, T3, or SP6) with eukaryotic or prokaryotic extracts to synthesize proteins from exogenous DNA templates. DNA templates for IVT or IVTT reactions may be cloned into plasmid vectors or generated by PCR. The linked or coupled system is a two-step reaction, based on transcription with a bacteriophage polymerase followed by translation in the rabbit reticulocyte lysate or wheat germ lysate. Because the transcription and translation reactions are separate, each can be optimized to ensure that both are functioning at their full potential.
- Unlike eukaryotic systems where transcription and translation occur sequentially, in E. coli, transcription and translation occur simultaneously within the cell. In vitro E. coli translation systems are thus performed the same way, coupled, in the same tube under the same reaction conditions. During transcription, the 5′ end of the RNA becomes available for ribosomal binding and undergoes translation while its 3′ end is still being transcribed. This early binding of ribosomes to the RNA maintains transcript stability and promotes efficient translation. This bacterial translation system gives efficient expression of either prokaryotic or eukaryotic gene products in a short amount of time. For the highest protein yield and the best initiation fidelity, one may ensure that the DNA template has a Shine-Dalgarno ribosome binding site upstream of the initiator codon. Capping of eukaryotic RNA is not required. Use of E. coli extract also eliminates cross-reactivity or other problems associated with endogenous proteins in eukaryotic lysates. Also, the E. coli S30 extract system allows expression from DNA vectors containing natural E. coli promoter sequences (such as lac or tac). In various embodiments, the present methods employ a bactenophage promoter (e.g., without limitation, T7, T3, or SP6). In various embodiments, the present methods employ the TX-TL system as described in Shin and Noireaux, J Biol. Eng. 4,8 (2010) and US Patent PL:blication No. 2016/0002611, the entire contents of which are hereby incorporated by reference in their entireties.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system comprises a single nucleic acid vector.
- In various embodiments, the nucleic acid encoding the candidate allosteric DNA-binding protein sensor and/or switch and a reporter gene system comprises two nucleic acid vectors. In an illustrative embodiment, the protein sensor and/or switch, e.g. transcription factor library, resides on a first plasmid while the reporter gene system resides on a second plasmid. By having two separate plasmids, the effective concentration of reporter gene to sensor library members may be adjusted to facilitate identification of active library members. This is useful, for example where simply using higher versus lower promoter strength is not enough control.
- During the strain improvement process, it can be useful to rapidly swap from one sensor plasmid to another sensor plasmid. For instance, a highly sensitive plasmid required for initial strain improvement may saturate as the strain or strain library is improved. Rapidly swapping the sensitive sensor plasmid for another harboring a less sensitive plasmid facilitates further strain improvement. Another instance could be that the desired molecule to be sensed for further strain improvement may change. To facilitate swapping between sensors, a sensor plasmid may additionally express a method directing the restriction of another sensor plasmid. By having three or more unique targets it allow at will restriction of any plasmid for another, i.e. Type A restriction targets Type B, Type B restriction targets Type C, and Type C targets Type A.
- As used herein, a vector (or plasmid) refers to discrete elements that are used to, for example, introduce heterologous nucleic acid into cells for expression or replication thereof. The vectors can remain episomal or can be designed to effect integration of a gene or portion thereof into a chromosome of the genome. Also contemplated are vectors that are artificial chromosomes, such as yeast artificial chromosomes and mammalian artificial chromosomes. Selection and use of such vehicles are well known to those of skill in the art. Included are vectors capable of expressing DNA that is operatively linked with regulatory sequences, such as promoter regions, that are capable of effecting expression of such DNA fragments (e.g. expression vectors). Thus, a vector refers to a recombinant DNA or RNA construct, such as a plasmid, a phage, recombinant virus or other vector that, upon introduction into an appropriate host cell, results in expression of the DNA. Appropriate vectors are well known to those of skill in the art and include those that are replicable in eukaryotic cells and/or prokaryotic cells and those that remain episomal or those that integrate into the host cell genome.
- In some embodiments, the present compositions and methods can include vectors based and/or generated using commercially available expression constructs, which can optionally be adapted or optimized for use in certain species and/or cell types. Examples of such expression constructs include the GATEWAY cloning vector available from INVITROGEN, which is available for multiple species. Examples of other expression constructs suitable for use in various species are known in the art. By way of example, expression constructs suitable for use in, for example, Pichia pastoris include, for example, pAO815, pGAPZ, pGAPZa, pHIL-D2, pHIL-S1, pPIC3.5K, pPIC9K, pPICZ, and pPICZa. By way of example, expression constructs suitable for episomal maintenance in for example, Kluyveromyces lactis include, for example, pKD1. Expression constructs suitable for integration in Kluyveromyces lactis include, for example, pGB-HSb20 vector (Swinkels et al. Antonie van Leeuwenhoek, 64:187-201 (1993); Bergkamp et al., Current Genetics, 21(4-5):365-370 (1992); Rossolini et al. Gene, 21; 119(1):75-81 (1992); Dominguez et al., the Official Journal of the Spanish Society for Microbiology, 1:131-142 (1998)), pKLAC1 or pKLAC2 (Paul A. Colussi and Christopher H. Taron, Appl Environ Microbiol. 71(11): 7092-7098 (2005)).
- The art provides a variety of vectors that find use in the present invention. By way of non-limiting illustration, phage vectors, plasmid vectors, phagemid vectors, phasmid vectors, cosmid vectors, virus vectors and YAC vectors may be used in the present invention.
- Illustrative vectors are found in WO 2015/017866, e.g. at paragraphs [00154]-[00160], the entire contents of which are hereby incorporated by reference in its entirety.
- Certain embodiments require the use of cloning methods, which are known in the art and include, by way of non-limiting example, fusion PCR and assembly PCR see, e.g. Stemmer et al. Gene 164(1): 49-53 (1995), inverse fusion PCR see, e.g. Spiliotis et al. PLoS ONE 7(4): 35407 (2012), site directed mutagenesis see, e.g. Ruvkun et al. Nature 289(5793): 85-88 (1981), Gibson assembly (see, e.g. Gibson et al. Nature Methods 6 (5): 343-345, (2009), the contents of which are hereby incorporated by reference in their entirety), Quick Change see, e.g. Kalnins et al. EMBO 2(4): 593-7 (1983), Gateway see, e.g. Hartley et al. Genome Res. 10(11):1788-95 (2000), Golden Gate see, e.g. Engler et al. Methods Mol Biol. 1116:119-31 (2014), restriction digest and ligation including but not Limited to blunt end, sticky end, and TA methods see, e.g. Cohen et al. PNAS 70 (11): 3240-4 (1973).
- The invention is further described with reference to the following non-limiting examples.
- To identify potential fluorogenic reporter molecule and enzyme pairs for cell-free aTF screening, the compounds fluorescein di-(beta-D-glucopyranoside) (FDG) and fluorescein diphosphate (FDP) were screen in vitro with their corresponding enzymes beta-glucosidase and Antarctic phosphatase. The following reactions were performed in 1× NEB PURE lysate to simulate the cell-free conditions in which they would be deployed when selecting for engineered aTFs with novel ligand binding activity.
- For FDG, reactions were initiated lx NEB PURE lysate spiked with 100 nM FDG substrate and a titrating amount of recombinant beta-glucosidase enzyme from 1 mM to 0 mM in 2-fold dilutions. The reactions were incubated at 37° C. for 8 hrs in a fluorescence plate reader, recording the fluorescence every 5 min. Decreasing the enzyme concentration resulted in a linear decrease in the fluorescence production rate. This assay has a sensitivity to as low as 33 nM enzyme concentration with a dynamic range greater than 30-fold (
FIG. 6 ). There was no detectable background fluorescence production in the absence of exogenous beta-glucosidase suggesting no enzymatic breakdown of the substrate by the lysate constituents that could interfere with cell-free aTF screening. - For FDP, reactions were initiated lx NEB PURE lysate spiked with 100 nM FDP substrate and a titrating amount of recombinant Antarctic phosphatase enzyme from 0.5 uU to 0 uU in 2-fold dilutions. The reactions were incubated at 37° C. for 8 hours in a fluorescence plate reader, recording the fluorescence every 5 min. Decreasing the enzyme concentration resulted in a linear decrease in the fluorescence production rate. This assay has a sensitivity to as low as 19 nM enzyme concentration with a dynamic range greater than 75-fold (
FIG. 7 ). There was no detectable background fluorescence production in the absence of exogenous beta-glucosidase suggesting no enzymatic breakdown of the substrate by the lysate constituents that could interfere with cell-free aTF screening. - The tetR gene was cloned into the pET28a(+) E. coli expression plasmid with a C-terminal 6× his tag. The plasmid was cloned into BL21(DE3) cells inoculated into expression medium (LB+kanamycin) at a starting OD600 of 0.05 and grown to mid log phase. Cells were induced with 1 mM IPTG and protein expression occurred for 4 hours. After 4 hours, cells were pelleted at 5, 000 rpm for 10 min, the supernatant was aspirated, and the cells were resuspended in TGN500 buffer [10 mM tris pH 7.5, 10% glycerol, 500 mM NaCl]. Cells were lysed by sonication following a 5 sec on 55 sec off protocol for a total of 1 min on time. Cellular debris was pelleted by centrifugation at 12, 000 rpm for 30 min. Clarified lysate containing the recombinant tetR was incubated with nickel affinity resin, washed 10× with TGN500 buffer, and eluted stepwise with increasing concentrations of imidazole. TetR eluted from the nickel column with 150 mM imidazole in >95% purity.
- The T7 RNA polymerase gene was cloned into the pET28a(+) E. coli expression plasmid with a C-terminal 6× his tag. The plasmid was cloned into BL21(DE3) cells inoculated into expression medium (LB+kanamycin) at a starting OD600 of 0.05 and grown to mid log phase. Cells were induced with 1 mM IPTG and protein expression occurred for 4 hours. After 4 hours, cells were pelleted at 5, 000 rpm for 10 min, the supernatant was aspirated, and the cells were resuspended in TGN500 buffer [10 mM tris pH 7.5, 10% glycerol, 500 mM NaCI]. Cells were lysed by sonication following a 5 sec on 55 sec off protocol for a total of 1 min on time. Cellular debris was pelleted by centrifugation at 12, 000 rpm for 30 min. Clarified lysate containing the recombinant tetR was incubated with nickel affinity resin, washed 10× with TGN500 buffer, and eluted stepwise with increasing concentrations of imidazole. T7 RNA polymerase eluted from the nickel column with 150 mM imidazole in >95% purity.
- A plasmid was constructed containing a T7 reporter construct [T7 promoter upstream of a tetR operator followed by a tetR expression cassette and a T7 terminator]. This reporter construct allows for tetR controlled of T7 amplification of the tetR gene. T7 transcription in 2× IVT mix [100 mM tris-HCI pH 7.5, 30 mM MgCl2, 10 mM DTT, 4 mM spermidine, 5 mM each NTP, 4 U/uL RNase inhibitor, 4 U/uL T7 RNA polymerase] and diluted to lx with 100 nM final reporter plasmid as described above, and a titration of purified tetR from 2 uM to 0 uM. The reactions were incubated at 37° C. for 4 hours. Transcripts were denatured in 2x RNA loading dye and run on a 1% agarose gel for 1 hr at 90V constant, stained with SYBR Safe, and imaged on a gel doc. Effective transcription repression was seen with a stoichiometric amount of tetR as plasmid, in this
case 100 nM plasmid and 100 nM tetR (FIG. 4 ,FIG. 7 ). This data demonstrates the ability of tetR to repress T7 RNA polymerase activity in vitro. - Using a fixed amount of tetR and plasmid, 100 nM each, T7 transcription reactions were set up as described above with the inclusion of a titrating amount of anhydrotetracycline (ATC), the native ligand for tetR. The ATC titration ranged from 2 uM to 0 uM. The IVT transcripts were analyzed by gel as described above. At low ATC concentrations, there was no generation of RNA transcripts suggesting complete repression of transcription by tetR in vitro. At a concentration of 2 stoichiometric units of ATC (200 nM), a strong RNA band was generated similar to that when no tetR in included in the reaction suggesting full depression of the tetR gene by the ligand in vitro (
FIG. 9 ). Additionally, titrated amounts of ATC show a titratable amount of RNA produced demonstrating the potential of a range of ligand binding affinities to produce differential amounts of RNA product (FIG. 4 ,FIG. 7 ). This titratable response is a requirement when working with engineered sensors cell-free to enrich a population for those members with improved ligand binding function in the pool. - This strategy may be used in microfluidically generated emulsions as shown in (
FIG. 4 ) or bulk emulsions and shown in (FIG. 2 ) for the screening of engineered sensor activity in a cell-free context. - These results demonstrate the utility of aTFs in cell-free environments as well as the ability to screen for aTF activity using transcription as a response.
- This is particularly useful in situations when, inter alia, a target molecule is toxic to cells in vivo and therefore a sensor to conduct cell-based detection is impractical. By way of illustration,
FIG. 10 shows the dose response of 4 TetR sensors engineered to detect the target molecule nootkatone (CE3, GF1, GA3, and CG5) and wild type TetR (p523) to nootkatone and ATc. As seen in this cell-based assay, after 0.5 mg/mL nootkatone, there is a toxic effect and the cells start to die. Accordingly, the detection of this target molecule would benefit from the cell-free methods described herein. - As an example, a population of cells was generated with a primary sensor plasmid harboring a single I-Scel restriction enzyme cut site and an ampicillin selection marker and expressing GFP (p1057). A secondary sensor plasmid was generated containing an expression cassette for the I-Scel enzyme and a kanamycin resistance cassette and RFP (p1174). Removal of the ampicillin from the selective medium did not result in a stochastic removal of the primary sensor plasmid. Based on flow cytometry, no difference was observed between a clean background strain transformed only with p1174 and the strain harboring the p1057 plasmid. However, introduction of the secondary sensor plasmid and subsequent growth on kanamycin selective medium resulted in a 200, 000-fold reduction in cells harboring the primary plasmid in the population (
FIGS. 11 and 12 ). - The following references are incorporated by reference in their entireties:
- J. R. Davis et al. Study of PcaV from Streptomyces coelicolor yields new insights into ligand-responsive MarR family transcription factors. 2013, Nucleic Acids Research, 41(6) 3888-3900
- S. Kosuri, et al. Composability of regulatory sequences controlling transcription and translation in Escherichia coli. 2013, PNAS 110(34) 14024-14029
- D. L. Stauff and B. L. Bassler. Quorum Sensing in Chromobacterium violaceum: DNA Recognition and Gene Regulation by the CviR Receptor. 2011 Journal of Bacteriology 193(15) 3871-3878
- S. Grkovic, et al. The Staphylococcal QacR Multidrug Regulator Binds a Correctly Spaced Operator as a Pair of Dimers. 2001 Journal of Bacteriology 183(24) 7102-7109
- Z. Nie, et al. Polymer Particles with Various Shapes and Morphologies Produced in Continuous Microfluidic Reactors. 2005, Journal of the American Chemical Society 127 8058-63.
- All of the numerical ranges, amounts, values and percentages, such as those for amounts of materials, elemental contents, times and temperatures of reaction, ratios of amounts, and others, in the following portion of the specification and attached claims may be read as if prefaced by the word “about” even though the term “about” may not expressly appear with the value, amount, or range. Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
- Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains error necessarily resulting from the standard deviation found in its underlying respective testing measurements. Furthermore, when numerical ranges are set forth herein, these ranges are inclusive of the recited range end points (e.g., end points may be used). When percentages by weight are used herein, the numerical values reported are relative to the total weight.
- Also, it should be understood that any numerical range recited herein is intended to include all sub-ranges subsumed therein. For example, a range of “1 to 10” is intended to include all sub-ranges between (and including) the recited minimum value of 1 and the recited maximum value of 10, that is, having a minimum value equal to or greater than 1 and a maximum value of equal to or less than 10. The terms “one, ” “a, ” or “an” as used herein are intended to include “at least one” or “one or more, ” unless otherwise indicated.
- Any aspect or embodiment disclosed herein can be combined with any other aspect or embodiment as disclosed herein.
- Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
- While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
Claims (55)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/325,649 US20190195864A1 (en) | 2016-08-15 | 2017-08-15 | Cell-free sensor systems |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662375301P | 2016-08-15 | 2016-08-15 | |
US201662375305P | 2016-08-15 | 2016-08-15 | |
US201662378999P | 2016-08-24 | 2016-08-24 | |
US201662379002P | 2016-08-24 | 2016-08-24 | |
US16/325,649 US20190195864A1 (en) | 2016-08-15 | 2017-08-15 | Cell-free sensor systems |
PCT/US2017/047009 WO2018035158A1 (en) | 2016-08-15 | 2017-08-15 | Cell-free sensor systems |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190195864A1 true US20190195864A1 (en) | 2019-06-27 |
Family
ID=61197003
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/325,649 Pending US20190195864A1 (en) | 2016-08-15 | 2017-08-15 | Cell-free sensor systems |
US16/325,650 Active 2041-02-02 US11774442B2 (en) | 2016-08-15 | 2017-08-15 | Molecule sensor systems |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/325,650 Active 2041-02-02 US11774442B2 (en) | 2016-08-15 | 2017-08-15 | Molecule sensor systems |
Country Status (4)
Country | Link |
---|---|
US (2) | US20190195864A1 (en) |
EP (3) | EP3497115A4 (en) |
CA (2) | CA3033372A1 (en) |
WO (2) | WO2018035158A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112538538A (en) * | 2020-11-26 | 2021-03-23 | 中国医学科学院北京协和医院 | Kit and system for detecting mycobacterium abscessus |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3443001A4 (en) | 2016-04-11 | 2020-04-29 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
CN110283887B (en) * | 2018-03-19 | 2021-03-09 | 中国科学院微生物研究所 | Biosensor containing allosteric transcription factor regulation system, kit and application of biosensor in small molecule detection |
EP3877766A4 (en) * | 2018-11-09 | 2022-09-07 | Northwestern University | Analytes' detection using regulated in vitro transcription |
CN109553664B (en) * | 2018-12-12 | 2021-08-03 | 山东大学 | Fungal alpha-L-arabinofuranosidase synthesis regulation protein mutant and application thereof |
WO2020237028A1 (en) * | 2019-05-21 | 2020-11-26 | North Carolina State University | Biosensors for polyketide extender units and uses thereof |
CA3149497A1 (en) | 2019-08-09 | 2021-02-18 | Nutcracker Therapeutics, Inc. | Methods and apparatuses for manufacturing for removing material from a therapeutic composition |
WO2022183102A1 (en) * | 2021-02-26 | 2022-09-01 | Northwestern University | Cell-free biosensors with dna strand displacement circuits |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678554B2 (en) | 2001-03-19 | 2010-03-16 | President And Fellows Of Harvard College | Nucleic acid shuffling |
US7476500B1 (en) | 2001-03-19 | 2009-01-13 | President And Fellows Of Harvard College | In vivo selection system for enzyme activity |
US20030186281A1 (en) * | 2001-12-21 | 2003-10-02 | Wolfgang Hillen | Modified tetracycline repressor protein compositions and methods of use |
DE60310202T2 (en) | 2002-01-23 | 2007-11-22 | The University Of Utah Research Foundation, Salt Lake City | TARGETED CHROMOSOMAL MUTAGENESIS WITH ZINC FINGERUCLEASES |
US20030232410A1 (en) | 2002-03-21 | 2003-12-18 | Monika Liljedahl | Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
CA2497913C (en) | 2002-09-05 | 2014-06-03 | California Institute Of Technology | Use of chimeric nucleases to stimulate gene targeting |
US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
US7574306B1 (en) | 2003-11-20 | 2009-08-11 | University Of Washington | Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
CA2615532C (en) | 2005-07-26 | 2016-06-28 | Sangamo Biosciences, Inc. | Targeted integration and expression of exogenous nucleic acid sequences |
WO2008052101A2 (en) | 2006-10-25 | 2008-05-02 | President And Fellows Of Harvard College | Multiplex automated genome engineering |
US7465697B1 (en) | 2006-11-02 | 2008-12-16 | Ohsoclean, Inc. | Essential oils based cleaning and disinfecting compositions |
JP2010520748A (en) | 2007-02-20 | 2010-06-17 | アナプティスバイオ インコーポレイティッド | Somatic hypermutation system |
EP2205752B1 (en) | 2007-10-25 | 2016-08-10 | Sangamo BioSciences, Inc. | Methods and compositions for targeted integration |
US8340951B2 (en) | 2007-12-13 | 2012-12-25 | University Of Washington | Synthetic enzymes derived from computational design |
CA2720903C (en) | 2008-04-14 | 2019-01-15 | Sangamo Biosciences, Inc. | Linear donor constructs for targeted integration |
WO2009131948A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | High-throughput cell-based cftr assay |
SG10201609144RA (en) | 2008-08-22 | 2016-12-29 | Sangamo Biosciences Inc | Methods and compositions for targeted single-stranded cleavage and targeted integration |
EP2364322A1 (en) * | 2008-10-28 | 2011-09-14 | Pioneer Hi-Bred International Inc. | Sulfonylurea-responsive repressor proteins |
CN101824463A (en) | 2009-03-03 | 2010-09-08 | 毛文伟 | In-vitro detection method for mammal nuclear receptor transcriptional activity |
US8552169B2 (en) | 2009-04-24 | 2013-10-08 | The Regents Of The University Of California | Transcription factor-based biosensor |
EP2534163B1 (en) | 2010-02-09 | 2015-11-04 | Sangamo BioSciences, Inc. | Targeted genomic modification with partially single-stranded donor molecules |
EP2571512B1 (en) | 2010-05-17 | 2017-08-23 | Sangamo BioSciences, Inc. | Novel dna-binding proteins and uses thereof |
US8652804B2 (en) | 2011-02-18 | 2014-02-18 | The Regents Of The University Of California | Transcription factor-based biosensors for detecting dicarboxylic acids |
US10025900B2 (en) | 2013-03-15 | 2018-07-17 | Arzeda Corp. | Automated method of computational enzyme identification and design |
WO2015017866A1 (en) | 2013-08-02 | 2015-02-05 | Enevolv, Inc. | Processes and host cells for genome, pathway, and biomolecular engineering |
AU2015218821B2 (en) | 2014-02-21 | 2019-01-24 | President And Fellows Of Harvard College | De novo design of allosteric proteins |
US20160002611A1 (en) | 2014-06-09 | 2016-01-07 | Regents Of The University Of Minnesota | Methods and Apparatus for Cell-Free Microfluidic-Assisted Biosynthesis |
US9766255B2 (en) * | 2015-01-12 | 2017-09-19 | President And Fellows Of Harvard College | Biosensors engineered from conditionally stable ligand-binding domains |
-
2017
- 2017-08-15 CA CA3033372A patent/CA3033372A1/en active Pending
- 2017-08-15 WO PCT/US2017/047009 patent/WO2018035158A1/en unknown
- 2017-08-15 US US16/325,649 patent/US20190195864A1/en active Pending
- 2017-08-15 CA CA3033374A patent/CA3033374A1/en active Pending
- 2017-08-15 EP EP17842016.2A patent/EP3497115A4/en not_active Withdrawn
- 2017-08-15 EP EP17842015.4A patent/EP3497605A4/en active Pending
- 2017-08-15 WO PCT/US2017/047012 patent/WO2018035159A1/en unknown
- 2017-08-15 US US16/325,650 patent/US11774442B2/en active Active
- 2017-08-15 EP EP21214814.2A patent/EP4053146A3/en not_active Withdrawn
Non-Patent Citations (11)
Title |
---|
ALAB, Zeocin, Selection Antibiotic: Endotoxin Tested, InvivoGen, 2024, 1. Obtained online at: https://alab.com.pl/produkt/1152/zeocin/#:~:text=InvivoGen%20is%20the%20sole%20worldwide,effective%20on%20most%20aerobic%20cells on June 24, 2024. (Year: 2024) * |
GOLDBio, 19 Common Questions About Kanamycin, Gold Biotechnology, 2024, 1-16. Obtained online at: https://goldbio.com/articles/article/19-Common-Questions-About-Kanamycin#:~:text=Kanamycin%20is%20a%20bactericidal%20antibiotic,accumulate%2C%20causing%20bacterial%20cell%20death on June 24, 2024. (Year: 2024) * |
Hamblin et al., Tetracyclines: Light-Activated Antibiotics?, Future Medicinal Chemistry, 2019, 11(18), 2427-2445. (Year: 2019) * |
Larsen et al., A General Strategy For Expanding Polymerase Function by Droplet Microfluidics, Nature Communications, April 2016, 1-9; and Supplementary Figures, lines 1-13. (Year: 2016) * |
Larsen et al., Supplementary Information, A General Strategy for Expanding Polymerase Function by Droplet Microfluidics, Nature Communications, 2016, 7(11235), 1-13. (Year: 2016) * |
Stacey et al., Electroporation and DNA-Dependent Cell Death in Murine Macrophages, Immunology and Cell Biology, 1993, 71, 75-85. (Year: 1993) * |
Taylor et al., Engineering an Allosteric Transcription Factor to Respond to New Ligands, Nature Methods, epub Dec 2015, 13(2), 177-187. (Year: 2015) * |
Taylor et al., Supplementary Texts and Figures, Engineering an Allosteric Transcription Factor to Respond to New Ligands, Nature Methods, epub Dec 2015, 13(2), 177-187. (Year: 2015) * |
Torre et al., Multiphase Water-In-Oil Emulsion Droplets for Cell-Free Transcription-Translation, Langmuir, 2014, 30, 5695-5699. (Year: 2014) * |
Zimmerman et al., In Vivo Selection of Spectinomycin-Binding RNAs, Nucleic Acids Research, 2002, 30(24), 5425-5435. (Year: 2002) * |
Zinchenko et al., One in a Million: Flow Cytometric Sorting of Single Cell-Lysate Assays in Monodisperse Picolitre Double Emulsion Droplets for Directed Evolution, Analytical Chemistry, 2014, 86, 2526-2533. (Year: 214) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112538538A (en) * | 2020-11-26 | 2021-03-23 | 中国医学科学院北京协和医院 | Kit and system for detecting mycobacterium abscessus |
Also Published As
Publication number | Publication date |
---|---|
EP3497115A1 (en) | 2019-06-19 |
CA3033372A1 (en) | 2018-02-22 |
WO2018035159A1 (en) | 2018-02-22 |
EP3497605A4 (en) | 2020-04-15 |
EP3497115A4 (en) | 2020-07-29 |
EP4053146A2 (en) | 2022-09-07 |
CA3033374A1 (en) | 2018-02-22 |
US11774442B2 (en) | 2023-10-03 |
US20190204303A1 (en) | 2019-07-04 |
EP4053146A3 (en) | 2022-12-07 |
WO2018035158A1 (en) | 2018-02-22 |
EP3497605A1 (en) | 2019-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190195864A1 (en) | Cell-free sensor systems | |
Marchand et al. | Peptide‐based communication system enables Escherichia coli to Bacillus megaterium interspecies signaling | |
Chao et al. | PdeB, a cyclic Di-GMP-specific phosphodiesterase that regulates Shewanella oneidensis MR-1 motility and biofilm formation | |
Chiba et al. | Multisite ribosomal stalling: a unique mode of regulatory nascent chain action revealed for MifM | |
Orelle et al. | Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition | |
Kelly et al. | Synthetic chemical inducers and genetic decoupling enable orthogonal control of the rhaBAD promoter | |
US10961513B2 (en) | Methods and compositions for recombinase-based genetic diversification | |
Horng et al. | The RssB/RssA two-component system regulates biosynthesis of the tripyrrole antibiotic, prodigiosin, in Serratia marcescens | |
Bianco | I came to a fork in the DNA and there was RecG | |
WO2017176347A2 (en) | Pathway integration and expression in host cells | |
Ruwe et al. | Identification and functional characterization of small alarmone synthetases in Corynebacterium glutamicum | |
Leiva et al. | Modulation of Escherichia coli translation by the specific inactivation of tRNAGly under oxidative stress | |
US20200399632A1 (en) | Sensor systems | |
Fujiwara et al. | Proteome-wide capture of co-translational protein dynamics in Bacillus subtilis using TnDR, a transposable protein-dynamics reporter | |
US20170226503A1 (en) | Methods for Sequential Screening with Co-Culture Based Detection of Metagenomic Elements Conferring Heterologous Metabolite Secretion | |
Tobias et al. | Heterogeneity in bacterial specialized metabolism | |
Pedrolli et al. | Bacterial flavin mononucleotide riboswitches as targets for flavin analogs | |
Luo et al. | Extracellular lipopeptide bacillomycin L regulates serial expression of genes for modulating multicellular behavior in Bacillus velezensis Bs916 | |
Leiva et al. | Enhanced translation of leaderless mRNAs under oxidative stress in Escherichia coli | |
Sungkeeree et al. | The esterase B from Sphingobium sp. SM42 has the new de-arenethiolase activity against cephalosporin antibiotics | |
Chadani et al. | Nascent polypeptide within the exit tunnel ensures continuous translation elongation by stabilizing the translating ribosome | |
van Zyl et al. | Engineering resistance to phage GVE3 in Geobacillus thermoglucosidasius | |
US8636999B2 (en) | Stable plasmid expression vector for bacteria | |
Turner | A Synthetic tmRNA Platform for Elucidation of Bacterial Proteome Remodeling under Stress | |
Verdonk | Investigating the structure and function of RdfS, a recombination directionality factor from an Integrative and Conjugative Element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
AS | Assignment |
Owner name: ENEVOLV, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SPOONAMORE, JAMES E.;DUNN, MATTHEW R.;TAYLOR, NOAH D.;AND OTHERS;SIGNING DATES FROM 20170817 TO 20170825;REEL/FRAME:049761/0076 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: PERCEPTIVE CREDIT HOLDINGS II, LP, NEW YORK Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:ENEVOLV, INC.;REEL/FRAME:053116/0712 Effective date: 20200630 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: ENEVOLV, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT;REEL/FRAME:060422/0201 Effective date: 20220630 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |